LHC GROUP, INC.
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form 10-K
ANNUAL REPORT
PURSUANT TO SECTIONS 13 OR
15(d)
OF THE SECURITIES EXCHANGE ACT
OF 1934
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the fiscal year ended
December 31, 2007
|
or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the transition period
from to
|
Commission file number: 0-8082
LHC GROUP, INC.
(Exact Name of Registrant as
Specified in Charter)
|
|
|
Delaware
|
|
71-0918189
|
(State or Other Jurisdiction
of
|
|
(I.R.S. Employer
|
Incorporation or
Organization)
|
|
Identification
No.)
|
420 West Pinhook Rd, Suite A
Lafayette, Louisiana 70503
(Address of principal executive
offices)
(337) 233-1307
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the
Exchange Act:
|
|
|
Common Stock, par value $.001 per share
|
|
NASDAQ Global Select Market
|
(Title of each class)
|
|
(Name of each exchange on which registered)
|
Securities registered pursuant to Section 12(g) of the
Exchange Act:
None
Indicate by check mark if the registrant is a well-known
seasoned issuer, as defined by Rule 405 of the Securities
Act. Yes o No þ
Indicate by check mark if the registrant is not required to file
reports pursuant to Section 13 or Section 15(d) of the
Act. Yes o No þ
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports) and (2) has been subject
to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of
Regulation S-K
is not contained herein and will not be contained, to the best
of registrants knowledge, in definitive proxy or
information statements incorporated by reference in
Part III of this
Form 10-K
or any amendment to this
Form 10-K. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
o
|
|
Accelerated filer
þ
|
|
Non-accelerated
filer o
|
|
Smaller reporting
Company o
|
|
|
|
|
Do not check if a smaller reporting company)
|
|
|
Indicate by check mark whether the registrant is a shell company
(as defined in
Rule 12b-2
of the
Act). Yes o No þ
As of December 31, 2007, the aggregate market value of the
registrants common stock held by non-affiliates of the
registrant was $368,067,910 based on the closing sale price as
reported on the NASDAQ Global Select Market. For purposes of
this determination shares beneficially owned by officers,
directors and ten percent shareholders have been excluded, which
does not constitute a determination that such persons are
affiliates.
There were 18,085,329 shares of common stock, $.01 par
value, issued and outstanding as of March 5, 2008.
DOCUMENTS
INCORPORATED BY REFERENCE
Portions of the Registrants Annual Report to stockholders
for the fiscal year ended December 31, 2007 are
incorporated by reference in Part II of this
Form 10-K.
Portions of the Registrants Proxy Statement for its 2008
Annual Meeting of Stockholders are incorporated by reference in
Part III of this annual report on
Form 10-K.
LHC
GROUP, INC.
TABLE OF
CONTENTS
2
This report contains forward-looking statements.
Forward-looking statements relate to our expectations, beliefs,
future plans and strategies, anticipated events or trends and
similar expressions concerning matters that are not historical
facts or that necessarily depend upon future events. In some
cases, you can identify forward-looking statements by words like
may, will, should,
could, would, expect,
plan, anticipate, believe,
estimate, predict, potential
and similar expressions. Specifically, this report contains,
among others, forward-looking statements about:
|
|
|
|
|
our expectations regarding financial condition or results of
operations for periods after December 31, 2007;
|
|
|
|
our critical accounting policies;
|
|
|
|
our business strategies and our ability to grow our business;
|
|
|
|
our participation in the Medicare and Medicaid programs;
|
|
|
|
the reimbursement levels of Medicare and other third-party
payors;
|
|
|
|
the prompt receipt of payments from Medicare and other
third-party payors;
|
|
|
|
our future sources of and needs for liquidity and capital
resources;
|
|
|
|
our ability to obtain financing;
|
|
|
|
our ability to make payments as they become due;
|
|
|
|
the outcomes of various routine and non-routine governmental
reviews, audits and investigations;
|
|
|
|
our expansion strategy, the successful integration of recent
acquisitions and, if necessary, the ability to relocate or
restructure our current facilities;
|
|
|
|
the value of our propriety technology;
|
|
|
|
our ability to maintain a secure and current IT infrastructure;
|
|
|
|
the impact of legal proceedings;
|
|
|
|
our insurance coverage;
|
|
|
|
the costs of medical supplies;
|
|
|
|
our competitors and our competitive advantages;
|
|
|
|
our ability to attract and retain valuable employees;
|
|
|
|
the payment of dividends;
|
|
|
|
the price of our stock;
|
|
|
|
our compliance with environmental, health and safety laws and
regulations;
|
|
|
|
our compliance with health care laws and regulations;
|
|
|
|
our compliance with SEC laws and regulations and Sarbanes-Oxley
requirements;
|
|
|
|
the impact of federal and state government regulation on our
business; and
|
|
|
|
the impact of changes in or future interpretations of fraud,
anti-kickback or other laws.
|
The forward-looking statements included in this report reflect
our current views about future events. They are based on
assumptions and are subject to known and unknown risks and
uncertainties. Many factors could cause actual results or
achievements to materially differ from future results or
achievements that may be expressed in or implied by our
forward-looking statements. Many of the factors that will
determine future events or achievements are beyond our ability
to control or predict. Important factors that could cause actual
results or achievements to materially differ from the results or
achievements reflected in our forward-looking
3
statements include, among other things, the factors discussed on
pages 27 to 39 of this report under the heading Risk
Factors.
You should read this report, the information incorporated by
reference into this report and the documents filed as exhibits
to this report completely and with the understanding that our
actual future results or achievements may be materially
different from what we expect or anticipate.
The forward-looking statements contained in this report reflect
our views and assumptions only as of the date this report is
filed with the Securities and Exchange Commission. Except as
required by law, we assume no responsibility to update any
forward-looking statements.
Before you invest in our common stock, you should understand
that the occurrence of any of the events described in the Risk
Factors section, located in Part I, Item 1A in this
annual report on
Form 10-K
or incorporated by reference into this annual report on
Form 10-K,
and other events that we have not predicted or assessed could
have a material adverse effect on our earnings, financial
condition and business. If the events described in the Risk
Factors or other unpredicted events occur, then the trading
price of our common stock could decline and you may lose all or
part of your investment.
We qualify all of our forward-looking statements by these
cautionary statements. In addition, with respect to all of our
forward-looking statements, we claim the protection of the safe
harbor for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995.
Unless otherwise indicated, LHC Group,
we, us, our and the
Company refer to LHC Group, Inc. and our consolidated
subsidiaries.
4
PART I
Overview
We provide post-acute health care services primarily to Medicare
beneficiaries in non-urban markets in the United States. We
provide home-based services, primarily through home nursing
agencies and hospices and facility-based services, primarily
through long-term acute care hospitals and outpatient
rehabilitation clinics. Through our wholly and majority owned
subsidiaries, equity joint ventures and controlled affiliates,
we currently operate in Louisiana, Mississippi, Arkansas,
Alabama, Texas, Kentucky, Florida, Tennessee, Georgia, West
Virginia, Ohio and Missouri. As of December 31, 2007, we
owned and operated 144 home nursing locations, nine hospices, a
diabetes management company and a private duty agency. As of
December 31, 2007, we also managed the operations of four
home nursing agencies in which we do not have an ownership
interest. With respect to our facility-based services
operations, we owned and operated four long-term acute care
hospitals with a total of seven locations, an outpatient
rehabilitation clinic, a pharmacy, two medical equipment
locations and a family health center as of December 31,
2007. We also manage the operations of one inpatient
rehabilitation facility in which we have no ownership interest.
We provide home-based post-acute health care services through
our home nursing agencies and hospices. Our home nursing
locations offer a wide range of services, including skilled
nursing, nursing, physical, occupational and speech therapy and
medically-oriented social services. The nurses, home health
aides and therapists in our home nursing agencies work closely
with patients and their families to design and implement
individualized treatments in accordance with a
physician-prescribed plan of care. Our hospices provide
palliative care to patients with terminal illnesses through
interdisciplinary teams of physicians, nurses, home health
aides, counselors and volunteers. Of our 155 home-based services
locations, 90 are wholly-owned by us, 60 are majority-owned or
controlled by us through joint ventures and five are operated
through license lease arrangements. For the years ended
December 31, 2007, 2006 and 2005, our home-based services
provided $244.1 million, $164.7 million and
$105.6 million, respectively, of our net service revenue.
We provide facility-based health care services through our
long-term acute care hospitals, an outpatient rehabilitation
clinic, a pharmacy, two medical equipment locations and a family
health center. As of December 31, 2007, we owned and
operated four long-term acute care hospitals in seven locations,
with a total of 156 licensed beds. Our long-term acute care
hospitals, six of which are within host hospitals, provide
services primarily to patients with complex medical conditions
who have transitioned out of a hospital intensive care unit but
remain too severe for treatment in a non-acute setting. We
provide outpatient rehabilitation services through physical
therapists, occupational therapists and speech pathologists at
our outpatient rehabilitation clinic in which we maintain an
ownership interest. We also provide outpatient rehabilitation
services on a contractual basis. In addition, we manage the
operations of one inpatient rehabilitation facility in which we
do not have an ownership interest. Of our 12 facility-based
services locations in which we maintain an ownership interest,
six are wholly-owned by us and six are majority-owned or
controlled by us through joint ventures. For the years ended
December 31, 2007, 2006 and 2005, our facility-based
services provided $53.9 million, $53.8 million and
$50.1 million, respectively, of our net service revenue.
Our founders began operations in September 1994 as St. Landry
Home Health, Inc. in Palmetto, Louisiana. After several years of
expansion, our founders reorganized their business and began
operating as Louisiana Healthcare Group, Inc. in June 2000. In
March 2001, Louisiana Healthcare Group, Inc. reorganized and
became a wholly owned subsidiary of The Healthcare Group, Inc.,
a Louisiana business corporation. Effective December 2002, The
Healthcare Group, Inc. merged into LHC Group, LLC, a Louisiana
limited liability company, with LHC Group, LLC being the
surviving entity. In January 2005, LHC Group, LLC established a
wholly owned Delaware subsidiary, LHC Group, Inc. Effective
February 9, 2005, LHC Group, LLC merged into LHC Group,
Inc. LHC Group, Inc. is a Delaware corporation and our principal
executive offices are located at 420 West Pinhook Road,
Suite A, Lafayette, Louisiana, 70503. Our telephone number
is
(337) 233-1307
and our website is www.lhcgroup.com.
5
Industry
and Market Opportunity
According to the Medicare Payment Advisory Committee (MedPAC),
an independent federal body established in 1997 to advise
Congress on issues affecting the Medicare program, approximately
one-third of all general acute care hospital patients require
additional care following their discharge from the hospital.
Post-acute care currently comprises approximately
13 percent of Medicares total spending. Some of these
patients receive less intensive care in settings such as skilled
nursing facilities, outpatient rehabilitation clinics or the
home, while others receive continuing care in more intensive
care settings such as inpatient rehabilitation facilities or
long-term acute care hospitals that are either freestanding or
co-located within general acute care facilities. According to
MedPAC estimates, Medicare spending totaled $16.9 billion
in 2005 for the two primary post-acute sectors in which we
operate: home nursing and long-term acute care hospitals.
MedPAC estimates Medicare spending on home nursing services
totaled $13.1 billion in 2006. The Centers for Medicare and
Medicaid (CMS), estimates that there were approximately 8,813
Medicare-certified home nursing agencies in the United States in
2006, the majority of which are operated by small local or
regional providers. MedPAC estimates that in 2005,
62 percent of freestanding home health agencies were urban,
12 percent were rural and 25 percent were mixed. Also,
16 percent were not-for-profit, 77 percent were for
profit and 7 percent were government. CMS predicts that
Medicare spending will increase at an average annual growth rate
of 6.7 percent between 2007 and 2017. Growth is being
driven by:
|
|
|
|
|
a U.S. population that is getting older and living longer;
|
|
|
|
patient preference for less restrictive care settings;
|
|
|
|
incentives for general acute care hospitals to discharge
patients into less intensive treatment settings as quickly as
medically appropriate;
|
|
|
|
higher incidences of chronic conditions and disease; and
|
|
|
|
a continued movement of institutionalized people into home and
community-based care.
|
Long-term acute care hospitals provide specialized medical and
rehabilitative care to patients with complex medical conditions
requiring higher intensity care and monitoring that cannot be
provided effectively in other health care settings. These
facilities typically serve as an intermediate step between the
intensive care unit of a general acute care hospital and a less
intensive treatment setting, such as a skilled nursing facility
or the home. According to MedPAC estimates, Medicare spending
for services provided by long-term acute care hospitals grew
from $2.7 billion in 2004 to an estimated $4.5 billion
in 2005.
According to the U.S. Census Bureau, rural areas have a
higher percentage of residents over the age of 65, who, in 2005,
accounted for 12.9 percent of the total population in rural
markets compared to 11.8 percent in urban markets.
Additionally, according to the American Public Health
Association (APHA), rural areas typically do not offer the range
of post-acute health care services that are available in urban
or suburban markets. As such, patients in rural markets face
challenges in accessing health care in a convenient and
appropriate setting. For example, APHA estimates that although
20 percent of Americans live in rural areas, less than
11 percent of the nations physicians practice in
rural areas. According to APHA, individuals in rural areas may
also have difficulty reaching health care facilities due to
greater travel time or a lack of public transportation. The
economic characteristics and population dispersion of rural
markets also make these markets less attractive to health
maintenance organizations and other managed care payors.
Government studies cited by APHA have shown rural residents also
tend to have more health complications than urban residents.
Additionally, APHA has noted that residents in rural areas are
less likely to use preventive screening services and have a
higher prevalence of disabilities, heart disease, cancer,
diabetes and other chronic conditions when compared to urban
residents. Therefore, we believe our post-acute service provides
valuable alternatives to this underserved, rural patient
population.
In our experience, because most rural areas have the population
size to support only one or two general acute care hospitals,
the local hospital often plays a significant role in rural
market health care delivery systems. Rural patients who require
home nursing frequently receive care from a small home care
agency or an agency that, while owned and run by the hospital,
is not an area of focus for that hospital. Similarly,
6
patients in these markets who require services typically offered
by long-term acute care hospitals are more likely to remain in
the community hospital because it is often the only local
facility equipped to deal with severe, complex medical
conditions. By entering these markets through affiliations with
local hospitals, we usually face less competition for the
services we provide. Therefore, we believe we are well
positioned to build and maintain long-term relationships with
local hospitals, physicians and other health care providers and
to become the highest quality post-acute provider in our markets.
Business
Strategy
Our objective is to become the leading provider of post-acute
services to Medicare beneficiaries in non-urban markets in the
United States. To achieve this objective, we intend to:
Drive internal growth in existing markets. We
intend to drive internal growth in our current markets by
increasing the number of healthcare providers in each market
from whom we receive referrals and by expanding the breadth of
our services. We intend to achieve this growth by:
(1) continuing to educate healthcare providers about the
benefits of our services; (2) reinforcing the position of
our agencies and facilities as community assets;
(3) maintaining our emphasis on high-quality medical care
for our patients; and (4) providing a superior work
environment for our employees.
Achieve margin improvement through the active management of
costs. The majority of our net service revenue is
generated under Medicare prospective payment systems (PPS)
through which we are paid pre-determined rates based upon the
clinical condition and severity of the patients in our care.
Because our profitability in a fixed payment system depends upon
our ability to manage the costs of providing care, we continue
to pursue initiatives to improve our margins and net income.
Expand into new markets. We will continue
expanding into new markets by developing de novo locations and
by acquiring existing Medicare-certified home nursing agencies
in attractive markets throughout the United States. We will
continue our unique strategy of partnering with non-profit
hospitals in home health services as these ventures provide
significant return on investment and we will look to acquire
larger freestanding agencies that can serve as growth platforms
in markets that we do not currently serve in order to support
our growth into new states.
Pursue strategic acquisitions. We will
continue to identify and evaluate opportunities for strategic
acquisitions in new and existing markets that will enhance our
market position, increase our referral base and expand the
breadth of services we offer.
Services
We provide post-acute health care services primarily to Medicare
beneficiaries in non-urban markets in the United States. Our
services can be broadly classified into two principal
categories: (1) home-based services offered through our
home nursing agencies and hospices; and (2) facility-based
services offered through our long-term acute care hospitals and
outpatient rehabilitation clinic.
Home-Based
Services
Home Nursing. Our registered and licensed
practical nurses provide a variety of medically necessary
services to homebound patients who are suffering from acute or
chronic illness, recovering from injury or surgery, or who
otherwise require care or monitoring. These services include
wound care and dressing changes, cardiac rehabilitation,
infusion therapy, pain management, pharmaceutical
administration, skilled observation and assessment and patient
education. We have also designed guidelines to treat chronic
diseases and conditions including diabetes, hypertension,
arthritis, Alzheimers disease, low vision, spinal
stenosis, Parkinsons disease, osteoporosis, complex wound
care and chronic pain. Our home health aides provide assistance
with daily activities such as housekeeping, meal preparation,
medication management, bathing and walking. Through our medical
social workers we counsel patients and their families with
regard to financial, personal and social concerns that arise
from a patients health-related problems. We also provide
skilled nursing, ventilator and tracheotomy services, extended
care specialties, medication administration and
7
management and patient and family assistance and education. We
also provide management services to third-party home nursing
agencies, often as an interim solution until proper state and
regulatory approvals for an acquisition can be obtained.
Our physical, occupational and speech therapists provide therapy
services to patients in their home. Our therapists coordinate
multi-disciplinary treatment plans with physicians, nurses and
social workers to restore basic mobility skills such as getting
out of bed, walking safely with crutches or a walker and
restoring range of motion to specific joints. As part of the
treatment and rehabilitation process, a therapist will stretch
and strengthen muscles, test balance and coordination abilities
and teach home exercise programs. Our therapists assist patients
and their families with improving and maintaining a
patients ability to perform functional activities of daily
living, such as the ability to dress, cook, clean and manage
other activities safely in the home environment. Our speech and
language therapists provide corrective and rehabilitative
treatment to patients who suffer from physical or cognitive
deficits or disorders that create difficulty with verbal
communication or swallowing.
All of our home nursing agencies offer 24 hour personal
emergency response and support services through Philips Lifeline
for qualified patients who require close medical monitoring but
who want to maintain an independent lifestyle. These services
consist principally of a communicator that connects to the
telephone line in the subscribers home and a personal help
button that is worn or carried by the individual subscriber and
that, when activated, initiates a telephone call from the
subscribers communicator to Lifelines central
monitoring facilities. Lifelines trained personnel
identify the nature and extent of the subscribers
particular need and notify the subscribers family members,
neighbors
and/or
emergency personnel, as needed. Our use of the Lifeline system
increases customer satisfaction and loyalty by providing our
patients a point of contact between scheduled nursing visits. As
a result, we offer our patients a more complete regimen of care
management than our competitors in the markets in which we
operate by offering this service to qualified patients as part
of their home health plan of care.
Hospice. Our Medicare-certified hospice
operations provide a full range of hospice services designed to
meet the individual physical, spiritual and psychosocial needs
of terminally ill patients and their families. Our hospice
services are primarily provided in a patients home but can
also be provided in a nursing home, assisted living facility or
hospital. Key services provided include pain and symptom
management accompanied by palliative medication, emotional and
spiritual support, inpatient and respite care, homemaker
services, dietary counseling, social worker visits, spiritual
counseling and bereavement counseling for up to 13 months
after a patients death.
Facility-Based
Services
Long-term Acute Care Hospitals. Our long-term
acute care hospitals treat patients with severe medical
conditions who require high-level care along and provide
frequent monitoring by physicians and other clinical personnel.
Patients who receive our services in a long-term acute care
hospital are too medically unstable to be treated in a non-acute
setting. Examples of these medical conditions include
respiratory failure, neuromuscular disorders, cardiac disorders,
non-healing wounds, renal disorders, cancer, head and neck
injuries and mental disorders. These impairments often are
associated with accidents, strokes, heart attacks and other
serious medical conditions. We also treat patients diagnosed
with musculoskeletal impairments that restrict their ability to
perform normal activities of daily living. As part of our
facility-based services, we operate an institutional pharmacy,
which focuses on providing a full array of institutional
pharmacy services to our long-term acute care hospitals and
inpatient rehabilitation facility.
Rehabilitation Services. We provide
rehabilitation services in multiple settings, including both
inpatient and outpatient settings. In our facilities and through
our contractual relationships, we provide physical, occupational
and speech rehabilitation services. We also provide certain
specialized services such as hand therapy or sports performance
enhancement that treat sports and work related injuries,
musculoskeletal disorders, chronic or acute pain and orthopedic
conditions. Our patients are often diagnosed with
musculoskeletal impairments that restrict their ability to
perform normal activities of daily living. These impairments are
often associated with accidents, sports injuries, strokes, heart
attacks and other medical conditions. Our
8
rehabilitation services are designed to help these patients
minimize physical and cognitive impairments and maximize
functional ability. We also design services to prevent
short-term disabilities from becoming chronic conditions. Our
rehabilitation services are provided by our physical,
occupational and respiratory therapists and
speech-language
pathologists. We also provide management services to one
inpatient rehabilitation facility and operate one health and
wellness center.
Operations
Financial information relating to the home- and facility- based
segments is found in the consolidated financial statements of
the Company which are included in this report. All of our
operations are based in the United States; therefore
100.0 percent of our revenues from external customers for
the years ended December 31, 2007, 2006 and 2005 and
100.0 percent of our long-lived assets were attributed to
the United States.
Home-Based
Services
Each of our home nursing agencies is staffed with experienced
clinical home health professionals who provide a wide range of
patient care services. Our home nursing agencies are managed by
a Director of Nursing or Branch Manager who is also a licensed
registered nurse. Our Directors of Nursing and Branch Managers
are overseen by State Managers who report to Division Vice
Presidents. The Senior Vice President of Operations is
accountable for the oversight of the aforementioned and directly
reports to the President and Chief Operations Officer of the
Company. Our patient care operating model for our home nursing
agencies is structured on a base model that requires a Medicare
patient minimum census of 50 patients. At the base model
level, one registered nurse is responsible for all aspects of
the management of each patients plan of care. A home
nursing agency based on this model is also staffed with an
office manager, a field-registered nurse, a field-licensed
professional nurse and a home health aide. We also contract with
local community therapists and other clinicians as appropriate,
to provide additional required services. As the size and patient
census of a particular home nursing agency grows, these staffing
patterns are increased appropriately.
Our home nursing agencies use our Service Value Point system, a
proprietary clinical resource allocation model and cost
management system. The system is a quantitative tool that
assigns a target level of resource units to a group of patients
based upon their initial assessment and estimated skilled
nursing and therapy needs. The Service Value Point system allows
the Director of Nursing or Branch Manager to allocate adequate
resources throughout the group of patients assigned to
his/her
care, rather than focusing on the profitability of an individual
patient.
Patient care is handled at the home nursing agency level.
Functions that are centralized into the home office include
payroll, accounting, financial reporting, billing, collections,
regulatory and legal compliance, risk management, pharmacy and
general clinical oversight accomplished by periodic
on-site
surveys. Each of our home nursing agencies is licensed and
certified by the state and federal governments and 34 of them
also are accredited by the Joint Commission (JC). Those not yet
accredited are working towards achieving this accreditation, a
process which can take up to six months.
Facility-Based
Services
Long-Term Acute Care Hospitals. Each of our
long-term acute care hospital locations is managed by a hospital
administrator, while the clinical operations are directed by a
Director of Nursing who is also a licensed registered nurse. The
individual hospital administrators are responsible for managing
the day-to-day operating activities of the hospital within
appropriate budgetary constraints. Each hospital administrator
reports to the Vice President of Facility-Based Services. Each
Director of Nursing reports directly to his or her respective
hospital administrator as well as indirectly to our Clinical
Operations Officer responsible for the oversight of the quality
of patient care services. The medical management of each patient
is overseen by a Medical Director who is responsible for
ensuring the appropriateness of admissions, as well as leading
weekly patient care conferences.
9
We follow a clinical approach under which each patient is
discussed in weekly, multidisciplinary team meetings, at which
patient progress is assessed, compared to goals and future goals
are set. Attendees at these meetings include a patients
family and referring physician. We believe that this model
results in higher quality care, predictable discharge patterns
and the avoidance of unnecessary delays.
All coding, medical records, human resources, case management,
utilization review and medical staff credentialing are provided
at the hospital level. Centralized functions that are provided
by the home office include payroll, accounting, financial
reporting, billing, collections, regulatory and legal
compliance, risk management, pharmacy and general clinical
oversight accomplished by periodic
on-site
surveys.
Rehabilitation Services. Our rehabilitation
services are overseen by an administrator, who is a licensed
physical therapist. Our clinic also has an
on-site
therapist responsible for addressing staffing needs and concerns
as well as managing the day-to-day operations of the outpatient
rehabilitation clinic.
As with our long-term acute care hospitals, all coding, medical
records, human resources, charge/data entry, front end
collections and marketing for our rehabilitation centers are
provided at the individual center level. Centralized functions
provided by the home office include payroll, accounting,
financial reporting, billing, collections, regulatory and legal
compliance, risk management and general clinical oversight
accomplished by periodic
on-site
surveys.
Joint
Ventures
As of December 31, 2007, we had entered into 71 joint
ventures with respect to the ownership and operation of 60 home
nursing agency locations, five hospices and six long-term acute
care hospital locations. Our joint ventures are structured
either as equity joint ventures or agency leasing arrangements,
as permitted by applicable state laws and subject to business
considerations. As of December 31, 2007, we had 66 equity
joint ventures and five agency leasing arrangements. Of these 66
joint ventures, 53 are with hospitals, seven are with physicians
and six are with other parties. With respect to our seven joint
ventures with physicians, six are for the ownership and
operation of long-term acute care hospitals and one is for the
ownership of a home nursing agency.
Equity
Joint Ventures
As of December 31, 2007, we have entered into 66 equity
joint ventures for the ownership and operation of home nursing
agencies, hospices, outpatient rehabilitation clinics and
long-term acute care hospitals. Our equity joint ventures are
structured as limited liability companies in which we own a
majority equity interest and our partners own a minority equity
interest ranging from 1 to 49 percent. At the time of
formation, we and our partners each contribute capital to the
equity joint venture in the form of cash or property. We believe
that the amount contributed by each party to the equity joint
venture represents their pro rata portion of the fair market
value of the equity joint venture. None of our partners are
required to make or influence referrals to our equity joint
ventures. In fact, each of our hospital joint venture partners
must follow the same Medicare discharge planning regulations as
they would if they owned 100.0 percent of the home health
agency. For example, each of our hospital joint venture partners
must offer each Medicare patient a list of available
Medicare-certified home nursing agency options and must allow
the patient to make their own choice of provider.
Generally, we serve as the manager of our equity joint ventures
and oversee their day-to-day operations. In two of our equity
joint ventures with parties other than hospitals or physicians,
our partners provide business development services and, in one
case, administrative services. The management of our equity
joint ventures is typically governed by a management committee,
which is comparable to a board of directors. We generally
possess a majority of the total votes available to be cast by
the members of the management committee. However, in three of
these joint ventures where we have partnered with not-for-profit
hospitals, the hospital controls a majority of the total
management committee votes. In such instances we possess the
right to withdraw from the equity joint venture at any time upon
notice to our partner in exchange for the receipt of a payment
in an amount calculated in accordance with a predetermined fair
market value formula. Each member of all but one of our equity
joint ventures participates in profits and losses in proportion
to their
10
equity interests. We have one equity joint venture partner whose
participation in the quarterly losses of the ventures are
limited to three times the amount of rent paid monthly by the
joint venture companies to the parent companies of our joint
venture partners for space used in the operation of the joint
ventures. The amounts of these monthly rental payments are
currently $1,841 and $1,821 respectively. Distributions from our
equity joint ventures are not based on referrals made to the
equity joint venture by any of the members.
The 66 equity joint ventures individually contribute between
0.1 percent and 7.6 percent of our total net service
revenue and only two of these equity joint ventures account for
greater than 5 percent of our total net service revenue for
the 12 months ended December 31, 2007. One of these is
St. Landry Extended Care Hospital, a long-term acute care
hospital equity joint venture in which we own 98.7 percent
of the membership interests, with the remaining 1.3 percent
ownership divided among four individual physicians. Any party
may withdraw from this equity joint venture upon
90 days advance written notice. The second entity is
Extended Care Hospital of Lafayette, a long-term acute care
hospital in which we own 76.5 percent of the membership
interests, with the remaining 23.5 percent ownership
divided among 19 individual physicians. Any member may withdraw
from this equity joint venture upon 90 days advance
written notice.
In addition to these conversion rights, several of our equity
joint ventures grant a buy/sell option that would require us to
either purchase or our joint venture partner(s) to sell all of
the exercising members interests in the equity joint
venture within 30 days of the receipt of notice of the
exercise of the buy/sell option. The purchase price under these
buy/sell provisions is typically based on a multiple of the
historical or future earnings before income taxes, depreciation
and amortization of the equity joint venture at the time the
buy/sell option is exercised.
Agency
Leasing Arrangements
As of December 31, 2007, we have entered into two
agreements to lease, through our wholly-owned subsidiaries, the
right to use the home health licenses necessary to operate four
of our home nursing agency locations and one hospice. These
leases are entered into in instances where state law would
otherwise prohibit the alienation and sale of home nursing
agencies or where the local hospital is reluctant to sell its
home health agency due to state-imposed limits on the number of
certificates of need or permits of approval. The leasing fees
for one of these agency leasing arrangements is fixed at
$162,000 per year for the initial term and the other arrangement
is fixed at $5,000 per month for the initial term. Both of the
initial terms for our two leasing arrangements expire in 2017.
These leasing arrangements provide for ten-year terms with
optional renewal periods. In the both leasing arrangements, we
have a right of first refusal in the event that the lessor
intends to sell the leased agency to a third party.
Management
Services Agreements
As of December 31, 2007, we have five management services
agreements under which we manage the operations of four home
nursing agencies and one inpatient rehabilitation facility. We
currently have no ownership interest in the agencies and
facilities that are the subject of these management services
agreements. In four of these arrangements, we are responsible
for all direct and indirect costs associated with the operations
and receive a management fee equal to the amount of our direct
and indirect costs plus a percentage of the net income of those
operations. Under the remaining agreement, we receive a flat fee
for management. The term of these arrangements is typically five
years, with an option to renew for an additional five-year term.
The initial termination dates for our management services
agreements range from September 29, 2008 to July 31,
2010.
Competition
The home health care market is highly fragmented. According to
MedPac, there were approximately 8,813 Medicare-certified home
nursing agencies in the United States in 2006, of which
approximately 32 percent were hospital-based or
not-for-profit, freestanding agencies. MedPAC estimates that
37 percent of these home nursing agencies are located in
non-urban markets. Although there are a small number of public
home nursing companies with significant home nursing operations,
they generally do not compete with us in
11
the rural markets that we currently serve. As we expand into new
markets, we may encounter public companies that have greater
resources or greater access to capital. Competition in our
markets comes primarily from small local and regional providers,
many of which are undercapitalized. These providers include
facility- and hospital-based providers, visiting nurse
associations and nurse registries. We are unaware of any
competitor offering our breadth of services and focusing on the
needs of rural markets.
Although several public and private national and regional
companies own or manage long-term acute care hospitals, they
generally do not operate in the rural markets that we serve.
Generally, the competition in our markets comes from local
healthcare providers. We believe our principal competitive
advantages over these local providers are our diverse service
offerings, our collaborative approach to working with healthcare
providers, our focus on rural markets and our patient-oriented
operating model.
Compliance
and Quality Control
We have had a Compliance Committee since 1996. Our Compliance
Committee oversees a comprehensive company-wide compliance
program that provides for:
|
|
|
|
|
the appointment of a compliance officer and committee;
|
|
|
|
adoption of codes of business conduct and ethics;
|
|
|
|
employee education and training;
|
|
|
|
monitoring of an internal system, including a toll-free hotline,
for reporting concerns on a confidential, anonymous basis;
|
|
|
|
ongoing internal compliance auditing and monitoring programs;
|
|
|
|
means for enforcing the compliance programs
policies; and
|
|
|
|
a system to respond to and correct detected problems.
|
As part of our ongoing quality control, internal auditing and
monitoring programs, we conduct internal regulatory audits and
mock surveys at each of our agencies and facilities at least
once a year. If an agency or facility does not achieve a
satisfactory rating, we require that it prepares and implements
a plan of correction. We then perform a
follow-up
audit and survey to verify that all deficiencies identified in
the initial audit and survey have been corrected.
As required under the Medicare conditions of participation, we
have a continuous quality improvement program, which involves:
|
|
|
|
|
ongoing education of staff and quarterly continuous quality
improvement meetings at each of our agencies and facilities and
at our home office;
|
|
|
|
quarterly comprehensive audits of patient charts performed by
each of our agencies and facilities; and
|
|
|
|
at least annually, a comprehensive audit of patient charts
performed on each of our agencies and facilities by our home
office staff.
|
If an agency or facility fails to achieve a satisfactory rating
on a patient chart audit, we require that it prepares and
implements a plan of correction. We then conduct a
follow-up
patient chart audit to verify that appropriate action has been
taken to prevent future deficiencies.
The effectiveness of our compliance program is directly related
to the legal and ethical training that we provide to our
employees. Compliance education for new hires is initiated
immediately upon employment through corporate video training and
subsequently reinforced with a corporate orientation program at
which the Chief Compliance Officer conducts a comprehensive
compliance training seminar. In addition, all of our employees
are required to receive continuing compliance education and
training each year.
We continually expand and refine our compliance and quality
improvement programs. Specific written policies, procedures,
training and educational materials and programs, as well as
auditing and monitoring
12
activities, have been prepared and implemented to address the
functional and operational aspects of our business. Our programs
also address specific problem areas identified through
regulatory interpretation and enforcement activities.
Additionally, our policies, training, standardized documentation
requirements, reviews and audits specifically address our
financial arrangements with our referral sources, including
fraud and abuse laws and physician self-referral laws. We
believe our consistent focus on compliance and continuous
quality improvement programs provide us with a competitive
advantage in the market.
Technology
and Intellectual Property
Our Service Value Point system is a proprietary information
system that assists us in, among other things, monitoring use
and other cost factors, supporting our health care management
techniques, internal benchmarking, clinical analysis, outcomes
monitoring and claims generation, revenue cycle management and
revenue reporting. This proprietary home nursing clinical
resource and cost management system is a quantitative tool that
assigns a target level of resource units to each patient based
upon their initial assessment and estimated skilled nursing and
therapy needs. We designed this system to empower our direct
care employees to make appropriate day-to-day clinical care
decisions while also allowing us to manage the quality and
delivery of care across our system and to monitor the cost of
providing that care both on a patient-specific and
agency-specific basis.
In addition to our Service Value Point system, our business is
substantially dependent on other non-proprietary software. We
utilize a third-party software information system for our
long-term acute care hospitals. Our various home nursing agency
databases were fully consolidated into an enterprise-wide system
during the first half of 2005. These conversions have improved
the accuracy, reliability and efficiency of processing and
management reporting.
Further, we have two major patient billing systems that we use
across the enterprise: one system for our home-based services
and one for our facility-based services. Both of these systems
are fully automated and contain functionality that allows us to
calculate net service revenue at both the payor and patient
level.
The software we use is based on client-server technology and is
highly scalable. We believe our software and systems are
flexible, easy-to-use and allow us to accommodate growth without
difficulty. Technology plays a key role in our
organizations ability to expand operations and maintain
effective managerial control. We believe that building and
enhancing our information and software systems provides us with
a competitive advantage that will allow us to grow our business
in a more cost-efficient manner and will result in better
patient care.
Reimbursement
Medicare
The federal governments Medicare program, governed by the
Social Security Act of 1965, reimburses healthcare providers for
services furnished to Medicare beneficiaries. These
beneficiaries generally include persons age 65 and older
and those who are chronically disabled. The program is primarily
administered by the Department of Health and Human Services
(HHS) and CMS. Medicare payments accounted for
81.7 percent, 82.6 percent and 86.4 percent of
our net service revenue for the years ended December 31,
2007, 2006 and 2005, respectively. Medicare reimburses us based
upon the setting in which we provide our services or the
Medicare category in which those services fall.
Home Nursing. The Medicare home nursing
benefit is available to patients who need care following
discharge from a hospital, as well as patients who suffer from
chronic conditions that require ongoing but intermittent care.
The services received need not be rehabilitative or of a finite
duration; however, patients who require full-time skilled
nursing for an extended period of time generally do not qualify
for Medicare home nursing benefits. As a condition of coverage
under Medicare, beneficiaries must: (1) be homebound in
that they are unable to leave their home without considerable
effort; (2) require intermittent skilled nursing, physical
therapy, or speech therapy services that are covered by
Medicare; and (3) receive treatment under a plan of care
that is established and periodically reviewed by a physician.
Qualifying patients also may receive
13
reimbursement for occupational therapy, medical social services
and home health aide services if these additional services are
part of a plan of care prescribed by a physician.
We receive a standard prospective Medicare payment for
delivering care over a base
60-day
period, or episode of care. There is no limit to the number of
episodes a beneficiary may receive as long as he or she remains
eligible. Most patients complete treatment within one payment
episode. The base episode payment, established through federal
legislation, is a flat rate that is adjusted upward or downward
based upon differences in the expected resource needs of
individual patients as indicated by clinical severity,
functional severity and service utilization. The magnitude of
the adjustment is determined by each patients
categorization into one of 153 payment groups, known as home
health resource groups and the costliness of care for patients
in each group relative to the average patient. Our payment is
also adjusted for differences in local prices using the hospital
wage index. We bill and are reimbursed for services in two
stages: an initial request for advance payment when the episode
commences and a final claim when it is completed. We receive
60.0 percent of the estimated payment for a patients
initial episode up-front (after the initial assessment is
completed and upon initial billing) and the remaining
40.0 percent upon completion of the episode and after all
final treatment orders are signed by the physician. In the event
of subsequent episodes, reimbursement timing is
50.0 percent up-front and 50.0 percent upon completion
of the episode. Final payments may reflect one of five
retroactive adjustments to ensure the adequacy and effectiveness
of the total reimbursement: (1) an outlier payment if the
patients care was unusually costly; (2) a low
utilization adjustment if the number of visits was fewer than
five; (3) a partial payment if the patient transferred to
another provider before completing the episode; (4) a
change-in-condition
adjustment if the patients medical status changes
significantly, resulting in the need for more or less care; or
(5) a payment adjustment based upon the level of therapy
services required in the population base. Because the
applicability of a change is dependent upon the completion date
of the episode, changes in our reimbursement could impact our
financial results up to 60 days in advance of the effective
date and recognition of the change. We submit all Medicare
claims through five fiscal intermediaries for the federal
government.
We verify benefits at the time of admission and through this
verification process are able to determine the payor source and
eligibility for reimbursement for each patient. Accordingly, we
do not have any material reimbursement amounts that are pending
approval based on the eligibility of a patient to receive
reimbursement from the applicable payor program. Further, we
only provide limited services to patients who are ineligible for
reimbursement from a third party payor; therefore, we do not
have any material reimbursement from patients who are self-pay.
The base payment rate for Medicare home nursing in 2007 is
$2,339 per
60-day
episode. Since the inception of the prospective payment system
in October 2000, the base episode rate payment has varied due to
both the impact of annual market basket based increases and
Medicare-related legislation. Home health payment rates are
updated annually by either the full home health market basket
percentage, or by the home health market basket percentage as
adjusted by Congress. CMS establishes the home health market
basket index, which measures inflation in the prices of an
appropriate mix of goods and services included in home health
services.
On August 22, 2007, CMS released a final rule finalizing
certain updates and refinements to the basic case-mix adjustment
system. CMS instituted these changes to the home health payment
system to account for reported increases over the past several
years in the home health case-mix, which CMS believes have been
caused by changes in the coding practices and documentation by
Home Health Agencies (HHAs) not by the treatment of
more resource-intense patients. CMS thus designed the new
case-mix model to better predict the resource-intensity required
by home health beneficiaries over the
60-day
episode of care, which would, in turn, improve the accuracy of
Medicare reimbursement to HHAs. To effectuate these
improvements, the new model does the following: (1) enables
more precise coding for comorbidities and the differing health
characteristics of longer-stay patients; (2) accounts more
accurately for the impact of rehabilitation services on resource
use; and (3) lessens the risk of overutilization of therapy
services by replacing the single threshold (10 visits per
14
episode) with three thresholds (at 6, 14 and 20 visits), as well
as a graduated bonus system based on severity between each
threshold.
Also to address the increases in case-mix that CMS views as
unrelated to home health patients clinical conditions, the
final rule implemented a reduction in the national standardized
60-day
episode payment rate for four years. This 2.75 percent
reduction will begin in calendar year (CY) 2008 and continue for
three years, with a 2.71 percent reduction in the fourth
year. Also in the final rule, CMS finalized the market basket
increase of 3.0 percent, a 0.1 percent increase over
the proposed rule. When the market basket update is viewed in
conjunction with (1) the 2.75 percent
reduction in home health payment rates for 2008; (2) the
implementation of the new case-mix adjustment system;
(3) the changes in the wage index; and (4) the other
changes made in the final rule CMS predicts a
0.8 percent increase in payments for urban HHAs and a
1.77 percent decrease in payments for rural HHAs.
Collectively, these changes in the final rule (not including the
case-mix or wage index adjustments) decrease the national
60-day
episode payment rate for HHAs from the 2007 level of $2,339.00
to $2,270.32 for 2008.
The Office of Inspector General (OIG) of HHS has a
responsibility to report both to the Secretary of HHS and to
Congress any program and management problems related to programs
such as Medicare. The OIGs duties are carried out through
a nationwide network of audits, investigations and inspections.
The OIG has recently undertaken a study with respect to Medicare
reimbursement rates. No estimate can be made at this time
regarding the impact, if any, of the OIGs findings.
Hospice. In order for a Medicare beneficiary
to qualify for the Medicare hospice benefit, two physicians must
certify that, in the best judgment of the physician or medical
director, the beneficiary has less than six months to live,
assuming the beneficiarys disease runs its normal course.
In addition, the Medicare beneficiary must affirmatively elect
hospice care and waive any rights to other Medicare benefits
related to his or her terminal illness. For each benefit period,
a physician must recertify that the Medicare beneficiarys
life expectancy is six months or less in order for the
beneficiary to continue to qualify for and to receive the
Medicare hospice benefit. The first two benefit periods are
measured at
90-day
intervals and subsequent benefit periods are measured at
60-day
intervals. There is no limit on the number of periods that a
Medicare beneficiary may be recertified. A Medicare beneficiary
may revoke his or her election at any time and begin receiving
traditional Medicare benefits. There is no limit on how long a
Medicare beneficiary can receive hospice benefits and services,
provided that the beneficiary continues to meet Medicare hospice
eligibility criteria.
Medicare reimburses for hospice care using a prospective payment
system. Under that system, we receive one of four predetermined
daily or hourly rates based upon the level of care we furnish to
the beneficiary. These rates are subject to annual adjustments
based on inflation and geographic wage considerations. Our base
Medicare rates effective October 1, 2007 depend upon which
of the following four levels of care we provide:
|
|
|
|
|
Routine Home Care. The base rate is $135.11
per day for routine home care, adjusted by the hospice wage
index depending on the geographic location. We are paid the
routine home care rate for each day a patient is under our care
and not receiving one of the other categories of hospice care.
This rate is not adjusted for the volume or intensity of care
provided on a given day. This rate is also paid when a patient
is receiving hospital care for a condition unrelated to the
terminal condition.
|
|
|
|
General Inpatient Care. The base rate is
$601.02 per day for general inpatient care, adjusted by the
hospice wage index depending on the geographic location.
|
|
|
|
Continuous Home Care. The base rate is $788.55
per day for continuous home care, adjusted by the hospice wage
index depending on the geographic location. This daily
continuous home care rate is divided by 24 in order to arrive at
an hourly rate. The hourly rate is paid for every hour that
continuous home care is furnished, up to 24 hours in a
single day. A minimum of eight hours must be provided in a
single day to qualify for this rate.
|
|
|
|
Respite Care. The base rate is $139.76 per day
for respite care, adjusted by the hospice wage index depending
on the geographic location. Respite care is provided when the
family or caregiver of a patient requires temporary relief from
his or her care giving responsibilities for certain reasons. We
can
|
15
|
|
|
|
|
receive payment for respite care provided to a given patient for
up to five consecutive days. Our payment for any additional days
of respite care provided to the patient is limited to the
routine home care rate.
|
Medicare limits the reimbursement we may receive for inpatient
care services. Under the so-called
80-20
rule, if the number of inpatient care days furnished by us
to Medicare beneficiaries exceeds 20.0 percent of the total
days of hospice care furnished by us to Medicare beneficiaries,
Medicare payments to us for inpatient care days exceeding the
inpatient cap will be reduced to the routine home care rate.
This determination is made annually based on the
12-month
period beginning on November 1 each year. This limit is computed
on a
program-by-program
basis. None of our hospices have exceeded the cap on inpatient
care services during 2006 or 2005. We have not received
notification that any of our hospices have exceeded the cap on
inpatient care services during 2007.
Our Medicare hospice reimbursement is also subject to a cap
amount calculated by the Medicare fiscal intermediary at the end
of the hospice cap period, which runs from November 1 through
October 31st of the following year. Total Medicare
payments to us during this period are compared to the cap
amount for this period. Payments in excess of the cap
amount must be returned by us to Medicare. The cap amount is
calculated by multiplying the number of beneficiaries electing
hospice care during the period by a statutory amount that is
indexed for inflation annually. The cap amount for the
12-month
period ending October 31, 2007 was $21,410.04. The hospice
cap amount is computed on a
program-by-program
basis. None of our hospices have exceeded the cap on per
beneficiary limits during 2006 or 2005. We have not received
notification that any of our hospices have exceeded the cap on
per beneficiary limits during 2007.
We are required to file annual cost reports with HHS on each of
our hospices for informational purposes and to submit claims on
the basis of the location where we actually furnish the hospice
services. These requirements permit Medicare to adjust payment
rates for regional differences in wage costs.
Long-term Acute Care Hospitals. We are
reimbursed by Medicare for services provided by our long-term
acute care hospitals (LTACHs) under the LTACH prospective
payment system (PPS), which was implemented on October 1,
2002. Although CMS regulations allowed for a phase-in period, we
have elected to be paid solely on the basis of the long-term
care diagnosis-related groups (DRGs) established by the new
system. All of our eligible LTACHs have implemented the PPS.
Under the PPS, each patient discharged from our LTACHs is
assigned a long-term care DRG. CMS establishes these long-term
care DRGs by grouping diseases by diagnosis and each group
reflects the amount of resources needed to treat a given
disease. We are paid a pre-determined fixed amount applicable to
the particular long-term care DRG to which that patient is
assigned. This payment is intended to reflect the average cost
of treating a Medicare patient classified in that particular
long-term care DRG. For select patients, the amount may be
further adjusted based on length of stay and facility-specific
costs, as well as in instances where a patient is discharged and
subsequently readmitted, among other factors. Similar to other
Medicare PPSs, the rate is also adjusted for geographic wage
differences.
CMS has expressed its intention to develop LTACH
patient-specific criteria to refine the definition of such
facilities. To this end, CMS awarded a contract to Research
Triangle Institute (RTI) for the purpose of evaluating patient-
and facility-level characteristics for LTACHs in order to
differentiate the role of LTACHs from general acute care
hospitals. In January 2007, RTI released its study results,
recommending the development and use of facility and patient
criteria as a method of ensuring that patients admitted to
LTACHs are medically complex and have a good chance of
improvement. In December 2007, Congress passed the Medicare,
Medicaid and SCHIP Extension Act of 2007 (MMSEA) which, in line
with RTIs recommendations, established new facility and
medical review requirements (e.g., relating to patient screening
for admissions, physician involvement with patient care, regular
evaluation of patients) to ensure that patients receive
appropriate levels of care at facilities. The MMSEA also imposed
a limited moratorium on the development of new LTACHs, but
provided regulatory relief from certain payment policies (i.e.,
the very short-stay outlier policy, the one-time budget
neutrality adjustment and the 25 percent rule
with respect to certain LTACHs) for three years in order to
ensure continued access to current LTACH services. Further, the
MMSEA revised the standard federal rate for discharges occurring
in the last quarter of rate year (RY) 2008 to match the
16
standard federal rate for RY 2007 i.e., $38,086.04,
a reduction from the rate that otherwise would have applied
pursuant to the RY 2008 final rule ($38,356.45). Finally, the
MMSEA requires the Secretary of HHS to conduct a study on LTACH
facility and patient criteria.
In order to qualify for payment under the LTACH PPS, a facility
must be certified as a hospital by Medicare, have an average
Medicare inpatient length of stay of greater than 25 days
and meet all the new facility criteria established by the MMSEA.
Prior to qualifying under the LTACH PPS, facilities are
classified as short-term acute care hospitals and therefore
receive lower payments under the acute or inpatient
rehabilitation facility prospective payments systems. New LTACHs
continue to be paid under these systems for a minimum of six
months while they establish the required average length of stay
and meet certain additional Medicare LTACH requirements. All of
our LTACHs are currently qualified to receive full payment under
the LTACH PPS.
On January 22, 2008, CMS published a proposed rule
proposing to set the Medicare payment rates for LTACHs at
$39,076.28 for patient discharges taking place on or after
July 1, 2008 through September 30, 2009. (CMS proposed
a 15-month
rate year for 2009 in order to align the timing of the annual
update for the LTACH PPS with the annual update for the DRGs
used for LTACH patients.) CMS also proposed to set the cost
outlier fixed-loss threshold at $21,199. Further, CMS declined
to apply its one-time budget neutrality adjustment, in
accordance with the MMSEA, which prohibits the Secretary of HHS
from making this one-time prospective adjustment until
December 29, 2010. However, in the rule, CMS discussed a
methodology it had developed prior to the enactment of the MMSEA
for evaluating whether to propose this one-time adjustment and
it requested comments on its proposed methodology. CMS indicated
that, as December 29, 2010 approaches, it plans to use its
finalized methodology to evaluate whether to propose a one-time
budget neutrality adjustment at that time. (CMS also noted that,
had the MMSEA not been enacted, CMS would have proposed to use
the proposed methodology at this time and to make a one-time
adjustment of 3.75 percent to the standard federal rate.)
CMS indicated that other MMSEA LTACH provisions that were not
addressed in the proposed rule (i.e., provisions relating to the
25 percent rule, the short-stay outlier policy,
the establishment of new facilities and the expanded review of
medical necessity for admission and continued stay at LTACHs
would be the subject of future regulations.
LTACHs are typically operated either as stand-alone facilities
or as separate provider units within traditional acute care
hospitals. All but one of our LTACHs are located within host
hospitals. These hospitals within a hospital (HwHs) must satisfy
additional standards. An HwH must establish itself as a hospital
separate from its host by, among other things, obtaining
separate licensure and certification, not having common control
with its host hospital or a common parent organization and
having a separate chief executive officer, chief medical officer
and medical staff. Further, an HwH faces financial penalties if
it fails to limit the number of total Medicare patients
discharged from the host hospital and subsequently readmitted to
the HwH to no greater than 5.0 percent. None of our LTACHs
exceeded this 5.0 percent limitation through the year ended
December 31, 2007.
In August 2004, CMS announced final regulatory changes
applicable to LTACHs operated as HwHs. Effective for cost
reporting periods beginning on or after October 1, 2004,
LTACH HwHs would have to limit the number of Medicare admissions
from their co-located host hospital according to specified
thresholds. Medicare discharges over the specified threshold
would be paid at a reduced payment rate, specifically, the
inpatient PPS rate. This new policy was subject to a four year
phase-in period for existing LTACH HwHs, satellites and LTACHs
under formation. All of our LTACHs met the requirements for the
four year phase-in period. The first year of the phase-in period
(cost reporting periods beginning on or after October 1,
2004 and before October 1, 2005) was a hold
harmless year with no admission percentage threshold,
which was
17
scheduled to be followed by a percentage transition over the
three years beginning in fiscal year 2006 (October 1, 2005
to September 30, 2006) as set forth in the table below:
|
|
|
|
|
|
|
|
|
|
|
Allowable Admissions
|
|
|
|
from Host Hospital
|
|
|
|
Before Payment
|
|
|
|
Reduction
|
|
Cost Report Period Beginning
|
|
MSAs
|
|
|
Non-MSAs
|
|
|
Until September 30, 2005
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
October 1, 2005 September 30, 2006
|
|
|
75.0
|
%
|
|
|
75.0
|
%
|
October 1, 2006 September 30, 2007
|
|
|
50.0
|
%
|
|
|
50.0
|
%
|
October 1, 2007 and thereafter
|
|
|
25.0
|
%
|
|
|
50.0
|
%
|
The 2004 HwH rule specified that for HwHs located in rural or
non- metropolitan statistical area (MSA) locations, the final
year phase-in percentage would be 50 percent. For HwHs
located in an MSA, the final phase-in percentage would be
25 percent.
In a final rule released on May 1, 2007, CMS expanded the
policy to apply not only to LTACH HwHs and satellites but also
to freestanding LTACHs and grandfathered LTACHs as well as to
HwHs and satellites that admit Medicare patients from
non-co-located hospitals. While this policy change was supposed
to take effect for cost reporting periods beginning on or after
July 1, 2007, the MMSEA delayed the implementation of the
policy for three years with respect to freestanding LTACHs and
grandfathered LTACHs. Further, the MMSEA set the percentage
threshold at 50 percent for three years for HwHs and
satellites located in urban areas that would otherwise be
subject to a transition period and it established a
75 percent ceiling for HwHs and satellite facilities
located in rural areas and those that receive referrals from MSA
dominant hospitals or urban single hospitals.
We currently have a total of seven LTACHs. Six of our hospitals
are classified as HwHs and one as freestanding. Of the six HwH
facilities, four are located in rural or non-MSAs and are
therefore subject to a final admission percentage of
50 percent at the end of the phase-in period. Two of our
six HwH facilities are located in MSA or urban areas and will be
subject to a final admission percentage of 25 percent at
the end of the phase-in period. Of these six locations
classified as HwHs, two facilities are satellite locations of a
parent hospital located in an MSA and one is a satellite
location of a parent hospital located in a non-MSA. Based on our
discussions with CMS, we believe each of these satellite
locations will be viewed as being located in a non-MSA
regardless of the location of its parent hospital and will be
treated independently from its parent for purposes of
calculating its compliance with the admissions limitations. If
the 25 percent rule is extended, as planned, to
freestanding LTACHs after the three-year delay (established in
the MMSEA), our current freestanding facility would not be
affected because we currently do not receive more than
25 percent of our Medicare admissions from any single
referring hospital.
For the 12 months ended December 31, 2007, on an
individual basis, all of our LTACH locations admitted between
50.0 percent and 75.0 percent of their patients from
their host hospitals. These hospitals came under the proper
threshold as of September 30, 2007. Our remaining LTACH is
not an HwH; therefore, it is not subject to these limits on host
hospital referrals.
Outpatient Rehabilitation Services. Medicare
requires that outpatient therapy services be reimbursed on a fee
schedule, subject to annual limitations. Outpatient therapy
providers receive a fixed fee for each procedure performed,
adjusted by the geographical area in which the facility is
located. Medicare also imposes annual per Medicare beneficiary
caps. For 2007, these annual caps limited Medicare coverage to
$1,780 for outpatient rehabilitation services (including both
physical therapy and
speech-language
pathology services) and $1,780 for outpatient occupational
health services, including deductible and co-insurance amounts.
These caps were replaced for 2008 by annual cap amounts of
$1,810. Historically, Congress has acted to bypass the cap and
impose a moratorium on its operation. The Deficit Reduction Act
of 2005, the Tax Relief and Health Care Act of 2006 and the
MMSEA all provided for an exceptions process that
effectively prevents application of the caps. The exceptions
process ends June 30, 2008. We are unable to predict
whether Congress will extend
18
the exceptions process beyond June 30, 2008. We cannot be
assured that one or more of our outpatient rehabilitation
clinics will not exceed the caps in the future.
Historically, outpatient rehabilitation services have been
subject to scrutiny by the Medicare program for, among other
things, medical necessity, appropriate documentation,
supervision of therapy aides and students and billing for group
therapy. CMS has issued guidance to clarify that services
performed by a student are not reimbursable even if provided
under line of sight supervision of the therapist.
Likewise, CMS has reiterated that Medicare does not pay for
services provided by aides regardless of the level of
supervision. CMS also has issued instructions that outpatient
physical and occupational therapy services provided
simultaneously to two or more individuals by a practitioner
should be billed as group therapy services.
Inpatient Rehabilitation Facilities. Inpatient
rehabilitation facilities are paid under a PPS. Under this
system, each patient discharged from an inpatient rehabilitation
facility is assigned to a case-mix group containing patients
with similar clinical problems that are expected to require
comparable resources. An inpatient rehabilitation facility is
generally paid a predetermined, fixed amount applicable to the
assigned case-mix group (subject to certain case- and
facility-level adjustments). The PPS for inpatient
rehabilitation facilities also includes special payment policies
that adjust the payments for some patients based on length of
stay, facility costs, whether the patient was discharged and
subsequently readmitted and other factors. MMSEA provided
permanent relief from the so-called 75 percent
rule, which had restricted inpatient rehabilitation
facility admissions to certain categories of patients and set
the new compliance threshold permanently at 60.0 percent.
Medicaid
Medicaid is a joint federal and state funded health insurance
program for certain low-income individuals. Medicaid reimburses
health care providers using a number of different systems,
including cost-based, prospective payment and negotiated rate
systems. Rates are also subject to adjustment based on statutory
and regulatory changes, administrative rulings, interpretations
of policy by individual state agencies and certain government
funding limitations. Medicaid payments accounted for
5.5 percent, 5.7 percent and 4.9 percent of our
net service revenue for the years ended December 31, 2007,
2006 and 2005, respectively.
Non-Governmental
Payors
A portion of our net service revenue comes from private payor
sources. These sources include insurance companies,
workers compensation programs, health maintenance
organizations, preferred provider organizations, other managed
care companies and employers, as well as patients directly.
Patients are generally not responsible for any difference
between customary charges for our services and amounts paid by
Medicare and Medicaid programs and the non-governmental payors,
but are responsible for services not covered by these programs
or plans, as well as for deductibles and co-insurance
obligations of their coverage. The amount of these deductibles
and co-insurance obligations on patients has increased in recent
years. Collection of amounts due from individuals is typically
more difficult than collection of amounts due from government or
business payors. However, the majority of our billed services
are paid in full by Medicare, Medicaid or private insurance.
Accordingly, co-payments from patients do not represent a
material portion of our billed revenue and corresponding
accounts receivable. To further reduce their healthcare costs,
most insurance companies, health maintenance organizations,
preferred provider organizations and other managed care
companies have negotiated discounted fee structures or fixed
amounts for services performed, rather than paying healthcare
providers the amounts billed. Our results of operations may be
negatively affected if these organizations are successful in
negotiating further discounts. During 2007, we evaluated our
commercial, managed care and non PFFS Medicare Advantage
(Commercial) plan payor contracts associated with home health
services. We found these contracts to be unprofitable and
difficult to collect. In response to the challenges associated
with collecting from Commercial payors and the unprofitable
reimbursement rates paid by Commercial payors, we have
terminated all Commercial contracts associated with home health
services. These Commercial payors had reimbursement rates
averaging 26 percent below cost, representing approximately
8 percent of our home health revenue, 16 percent of
our home health admissions and 44 percent of our bad debt
write-offs against home health revenue in fiscal year 2007.
Payments from all non-governmental payors accounted for
12.8 percent,
19
11.7 percent and 8.7 percent of our net service
revenue for the years ended December 31, 2007, 2006 and
2005, respectively.
Government
Regulations
General
The healthcare industry is highly regulated and we are required
to comply with federal, state and local laws, which
significantly affect our business. These laws and regulations
are extremely complex and, in many instances, the industry does
not have the benefit of significant regulatory or judicial
interpretation. Regulations and policies frequently change and
we monitor these changes through trade and governmental
publications and associations. The significant areas of federal
and state regulatory laws that could affect our ability to
conduct our business include the following:
|
|
|
|
|
Medicare and Medicaid participation and reimbursement;
|
|
|
|
the federal Anti-Kickback Statute and similar state laws;
|
|
|
|
the federal Stark Law and similar state laws;
|
|
|
|
false and other improper claims;
|
|
|
|
the Health Insurance Portability and Accountability Act of 1996
(HIPAA);
|
|
|
|
civil monetary penalties;
|
|
|
|
environmental health and safety laws;
|
|
|
|
licensing; and
|
|
|
|
certificates of need and permits of approval.
|
If we fail to comply with these applicable laws and regulations,
we could suffer civil or criminal penalties, including the loss
of our licenses to operate and our ability to participate in
federal and state healthcare programs. Although we believe we
are in material compliance with all applicable laws, these laws
are complex and a review of our practices by a court or law
enforcement or regulatory authority could result in an adverse
determination that could harm our business. Furthermore, the
laws applicable to us are subject to change, interpretation and
amendment, which could adversely affect our ability to conduct
our business.
Medicare
Participation
During the year ended December 31, 2007, 2006 and 2005,
81.7 percent, 82.6 percent and 86.4 percent,
respectively, of our net service revenue was received from
Medicare. We expect to continue to receive the majority of our
net service revenue from serving Medicare beneficiaries.
Medicare is a federally funded and administered health insurance
program, primarily for individuals entitled to social security
benefits who are 65 or older or who are disabled. To participate
in the Medicare program and receive Medicare payments, our
agencies and facilities must comply with regulations promulgated
by CMS. Among other things, these requirements, known as
conditions of participation, relate to the type of
facility, its personnel and its standards of medical care.
Although we intend to continue to participate in the Medicare
reimbursement programs, we cannot assure you that our agencies
and programs will continue to qualify for participation.
Under Medicare rules, the designation provider-based
refers to circumstances in which a subordinate facility (e.g., a
separately-certified Medicare provider, a department of a
provider or a satellite facility) is treated as part of a
provider for Medicare payment purposes. In these cases, the
services of the subordinate facility are included in the
main providers cost report and overhead costs
of the main provider can be allocated to the subordinate
facility, to the extent that they are shared. We operate three
long-term acute care hospitals that are treated as
provider-based satellites of certain of our other facilities. We
also provide contract rehabilitation and management services to
hospital rehabilitation departments that may be treated as
provider-based. These facilities are required to satisfy certain
operational standards in order to retain their provider-based
status.
20
Anti-Kickback
Statute
Provisions of the Social Security Act of 1965, commonly referred
to as the Anti-Kickback Statute, prohibit the payment or receipt
of anything of value in return for the referral of patients or
arranging for the referral of patients, or in return for the
recommendation, arrangement, purchase, lease or order of items
or services that are covered by a federal health care program
such as Medicare and Medicaid. Violation of the Anti-Kickback
Statute is a felony and sanctions include imprisonment of up to
five years, criminal fines of up to $25,000, civil monetary
penalties of up to $50,000 per act plus three times the amount
claimed or three times the remuneration offered and exclusion
from federal healthcare programs (including the Medicare and
Medicaid programs). Many states have adopted similar
prohibitions against payments that are intended to induce
referrals of Medicaid and other third-party payor patients.
The OIG has published numerous safe harbors that
exempt some practices from enforcement action under the federal
Anti-Kickback Statute. These safe harbors exempt specified
activities, including bona-fide employment relationships,
contracts for the rental of space or equipment and personal
service arrangements and management contracts, so long as all of
the requirements of the safe harbor are met. The OIG has
recognized that the failure of an arrangement to satisfy all of
the requirements of a particular safe harbor does not
necessarily mean that the arrangement violates the Anti-Kickback
statute. Nonetheless, we cannot assure you that arrangements
that do not satisfy a safe harbor are not in violation of the
Anti-Kickback Statute.
We are required under the Medicare conditions of participation
and some state licensing laws to contract with numerous health
care providers and practitioners, including physicians,
hospitals and nursing homes and to arrange for these individuals
or entities to provide services to our patients. In addition, we
have contracts with other suppliers, including pharmacies,
ambulance services and medical equipment companies. We have also
entered into various joint ventures with hospitals and
physicians for the ownership and management of home nursing
agencies and long-term acute care hospitals. Some of these
individuals or entities may refer, or be in a position to refer,
patients to us and we may refer, or be in a position to refer,
patients to these individuals or entities. We attempt to
structure these arrangements in a manner which meets a safe
harbor. However, some of these arrangements may not meet all of
the requirements of a safe harbor. We believe that our contracts
and arrangements with providers, practitioners and suppliers do
not violate the Anti-Kickback Statute or similar state laws. We
cannot assure you, however, that these laws will ultimately be
interpreted in a manner consistent with our practices.
From time to time, various federal and state agencies, such as
HHS, issue pronouncements, including fraud alerts, that identify
practices that may be subject to heightened scrutiny. For
example, the OIGs 2007 Work Plan describes, among other
things, the governments intention to examine outlier
payments to home health agencies, accuracy of claims coding for
Medicare home health resources groups, payments to long-term
acute care hospitals and average lengths of stay at long-term
acute care hospitals.
In June 1995, the OIG issued a special fraud alert that focused
on the home nursing industry and identified some of the illegal
practices the OIG has uncovered. In March 1998, the OIG issued a
special fraud alert titled, Fraud and Abuse in Nursing Home
Arrangements with Hospices. This special fraud alert focused
on payments received by nursing homes from hospices. We believe,
but cannot assure you, that our operations comply with the
principles expressed by the OIG in these special fraud alerts.
We endeavor to conduct our operations in compliance with federal
and state healthcare fraud and abuse laws, including the
Anti-Kickback Statute. However, our practices may be challenged
in the future and the fraud and abuse laws may be interpreted in
a way that finds us in violation of these laws. If we are found
to be in violation of the Anti-Kickback Statute, we could be
subject to civil and criminal penalties and we could be excluded
from participating in federal health care programs such as
Medicare and Medicaid. The occurrence of any of these events
could significantly harm our business and financial condition.
Stark
Law
Congress also passed significant prohibitions against certain
physician referrals of patients for health care services. These
prohibitions are commonly known as the Stark Law. The Stark Law
prohibits a physician from
21
making referrals for particular health care services (called
designated health services) to entities with which the
physician, or an immediate family member of the physician, has a
financial relationship.
The term financial relationship is defined very
broadly to include most types of ownership or compensation
relationships. The Stark Law also prohibits the entity receiving
the referral from seeking payment under the Medicare and
Medicaid programs for services rendered pursuant to a prohibited
referral. If an entity is paid for services rendered pursuant to
a prohibited referral, it may incur civil penalties and could be
excluded from participating in the Medicare or Medicaid
programs. If an arrangement is covered by the Stark Law, the
requirements of a Stark Law exception must be met for the
physician to be able to make referrals to the entity for
designated health services and for the entity to be able to bill
for these services.
Designated health services under the Stark Law is
defined to include clinical laboratory services; physical
therapy services; occupational therapy services; radiology
services, including magnetic resonance imaging, computerized
axial tomography scans and ultrasound services; radiation
therapy services and supplies; durable medical equipment and
supplies; parenteral and enteral nutrients, equipment and
supplies; prosthetics, orthotics and prosthetic devices and
supplies; home health services; outpatient prescription drugs;
and inpatient and outpatient hospital services. The Stark Law
defines a financial relationship to include: (1) a
physicians ownership or investment interest in an entity
and (2) a compensation relationship between a physician and
an entity. Under the Stark Law, financial relationships include
both direct and indirect relationships.
Physicians refer patients to us for several Stark Law designated
health services, including home health services, inpatient and
outpatient hospital services and physical therapy services. We
have compensation arrangements with some of these physicians or
their professional practices in the form of medical director and
consulting agreements. We also have operations owned by joint
ventures in which physicians have an investment interest. In
addition, other physicians who refer patients to our agencies
and facilities may own our stock. As a result of these
relationships, we could be deemed to have a financial
relationship with physicians who refer patients to our
facilities and agencies for designated health services. If so,
the Stark Law would prohibit the physicians from making those
referrals and would prohibit us from billing for the services
unless a Stark Law exception applies.
The Stark Law contains exceptions for certain physician
ownership or investment interests in and certain physician
compensation arrangements with entities. If a compensation
arrangement or investment relationship between a physician, or a
physicians immediate family member, and an entity
satisfies all requirements for a Stark Law exception, the Stark
Law will not prohibit the physician from referring patients to
the entity for designated health services. The exceptions for
compensation arrangements cover employment relationships,
personal services contracts and space and equipment leases,
among others. The exceptions for a physician investment
relationship include ownership in an entire hospital and
ownership in rural providers. We believe our compensation
arrangements with referring physicians and our physician
investment relationships meet the requirements for an exception
under the Stark Law and that our operations comply with the
Stark Law.
The Stark Law also includes an exception for a physicians
ownership or investment interest in certain entities through the
ownership of stock. If a physician owns stock in an entity and
the stock is listed on a national exchange or is quoted on
NASDAQ and the ownership meets certain other requirements, the
Stark Law will not apply to prohibit the physician from
referring to the entity for designated health services. The
requirements for this Stark Law exception include a requirement
that the entity issuing the stock have at least
$75.0 million in stockholders equity at the end of
its most recent fiscal year or on average during the previous
three fiscal years. As of December 31, 2007, 2006 and 2005,
we have exceeded $75.0 million in stockholders equity.
If an entity violates the Stark Law, it could be subject to
civil penalties of up to $15,000 per prohibited claim and up to
$100,000 for knowingly entering into certain prohibited referral
schemes. The entity also may be excluded from participating in
federal health care programs (including Medicare and Medicaid).
If the Stark Law was found to apply to our relationships with
referring physicians and no exceptions under the Stark Law were
available, we would be required to restructure these
relationships or refuse to accept referrals for designated
health services from these physicians. If we were found to have
submitted claims to Medicare or
22
Medicaid for services provided pursuant to a referral prohibited
by the Stark Law, we would be required to repay any amounts we
received from Medicare for those services and could be subject
to civil monetary penalties. Further, we could be excluded from
participating in Medicare and Medicaid. If we were required to
repay any amounts to Medicare, subjected to fines, or excluded
from the Medicare and Medicaid Programs, our business and
financial condition would be harmed significantly.
Many states have physician relationship and referral statutes
that are similar to the Stark Law. These laws generally apply
regardless of payor. We believe that our operations are
structured to comply with applicable state laws with respect to
physician relationships and referrals. However, any finding that
we are not in compliance with these state laws could require us
to change our operations or could subject us to penalties. This,
in turn, could have a negative impact on our operations.
False
and Improper Claims
The submission of claims to a federal or state health care
program for items and services that are not provided as
claimed may lead to the imposition of civil monetary
penalties, criminal fines and imprisonment
and/or
exclusion from participation in state and federally funded
health care programs, including the Medicare and Medicaid
programs. These false claims statutes include the Federal False
Claims Act. Under the Federal False Claims Act, actions against
a provider can be initiated by the federal government or by a
private party on behalf of the federal government. These private
parties are often referred to as qui tam relators and relators
are entitled to share in any amounts recovered by the
government. Both direct enforcement activity by the government
and qui tam actions have increased significantly in recent
years. This development has increased the risk that a health
care company like us will have to defend a false claims action,
pay fines or be excluded from the Medicare and Medicaid programs
as a result of an investigation arising out of false claims
laws. Many states have enacted similar laws providing for the
imposition of civil and criminal penalties for the filing of
fraudulent claims. Because of the complexity of the government
regulations applicable to our industry, we cannot assure that we
will not be the subject of an action under the Federal False
Claims Act or similar state law.
Anti-fraud
Provisions of the HIPAA
In an effort to combat health care fraud, Congress included
several anti-fraud measures in HIPAA. Among other things, HIPAA
broadened the scope of certain fraud and abuse laws, extended
criminal penalties for Medicare and Medicaid fraud to other
federal health care programs and expanded the authority of the
OIG to exclude persons and entities from participating in the
Medicare and Medicaid programs. HIPAA also extended the Medicare
and Medicaid civil monetary penalty provisions to other federal
health care programs, increased the amounts of civil monetary
penalties and established a criminal health care fraud statute.
Federal health care offenses under HIPAA include health care
fraud and making false statements relating to health care
matters. Under HIPAA, among other things, any person or entity
that knowingly and willfully defrauds or attempts to defraud a
health care benefit program is subject to a fine, imprisonment
or both. Also under HIPAA, any person or entity that knowingly
and willfully falsifies or conceals or covers up a material fact
or makes any materially false or fraudulent statements in
connection with the delivery of or payment of health care
services by a health care benefit plan is subject to a fine,
imprisonment or both. HIPAA applies not only to governmental
plans but also to private payors.
Administrative
Simplification Provisions of HIPAA
HHSs final regulations governing electronic transactions
involving health information are part of the administrative
simplification provisions of HIPAA. These regulations are
commonly referred to as the Transaction Standards rule. The rule
establishes standards for eight of the most common health care
transactions by reference to technical standards promulgated by
recognized standards publishing organizations. Under the new
standards, any party transmitting or receiving health
transactions electronically must send and receive data in a
single format, rather than the large number of different data
formats currently used. This rule will apply to us in connection
with submitting and processing health claims. The Transaction
Standards rule
23
also applies to many of our payors and to our relationships with
those payors. Since many of our payors might not have been able
to accept transactions in the format required by the Transaction
Standards rule by the original compliance date, we filed a
timely compliance extension plan with HHS. We believe that our
operations materially comply with the Transaction Standards rule.
HHS also has final regulations implementing HIPAA that set forth
standards for the privacy of individually-identifiable health
information, referred to as protected health information. The
regulations cover health care providers, health care
clearinghouses and health plans. The privacy regulations require
companies covered by the regulations to use and disclose
protected health information only as allowed by the privacy
regulations. Specifically, the privacy regulations require
companies such as us to do the following, among other things:
|
|
|
|
|
obtain patient authorization prior to certain uses or
disclosures of protected health information;
|
|
|
|
provide notice of privacy practices to patients and obtain an
acknowledgement that the patient has received the notice;
|
|
|
|
respond to requests from patients for access to or to obtain a
copy of their protected health information;
|
|
|
|
respond to patient requests for amendments of their protected
health information;
|
|
|
|
provide an accounting to patients of certain disclosure of their
protected health information;
|
|
|
|
enter into agreements with the companies business
associates through which the business associates agree to use
and disclose protected health information only as permitted by
the agreement and the requirements of the privacy regulations;
|
|
|
|
train the companies workforce in privacy compliance;
|
|
|
|
designate a privacy officer;
|
|
|
|
use and disclose only the minimum necessary information to
accomplish a particular purpose; and
|
|
|
|
establish policies and procedures with respect to uses and
disclosures of protected health information.
|
These regulatory requirements impose significant administrative
and financial obligations on companies that use or disclose
individually identifiable health information relating to the
health of a patient. We have implemented new policies and
procedures to maintain patient privacy and comply with
HIPAAs privacy regulations. The privacy regulations are
extensive and we may need to change some of our practices to
comply with them as they are interpreted and as we deal with
issues that arise.
In February 2003, HHS published the final security regulations
implementing HIPAA that govern the security of health
information. The compliance date for the security regulations
was April 21, 2005. The security regulations require the
implementation of policies and procedures that establish
administrative, physical and technical safeguards for electronic
protected health information. Companies covered by the security
regulations are required to ensure the confidentiality,
integrity and availability of electronic protected health
information. Specifically, among others things, companies are
required to:
|
|
|
|
|
conduct a thorough assessment of the potential risks and
vulnerabilities to confidentiality, integrity and availability
of electronic protected health information and to reduce the
risks and vulnerabilities to a reasonable and appropriate level
as required by the security regulations;
|
|
|
|
designate a security officer;
|
|
|
|
establish policies relating to access by the companies
workforce to electronic protected health information;
|
|
|
|
enter into agreements with the companies business
associates whereby business associates agree to establish
administrative, physical and technical safeguards for electronic
protected health information received from or on behalf of the
companies;
|
24
|
|
|
|
|
create a disaster and contingency plan to ensure the
availability of electronic protected health information;
|
|
|
|
train the companies workforce in security compliance;
|
|
|
|
establish physical controls for electronic devices and media
containing or transmitting electronic protected health
information;
|
|
|
|
establish policies and procedures regarding the use of
workstations with access to electronic protected health
information; and
|
|
|
|
establish technical controls for the information systems
maintaining or transmitting electronic protected health
information.
|
These regulatory requirements impose significant administrative
and financial obligations on companies like us that use or
disclose electronic health information. Our operations are in
compliance with the security regulations.
Civil
Monetary Penalties
The Secretary of HHS may impose civil monetary penalties on any
person or entity that presents, or causes to be presented,
certain ineligible claims for medical items or services. The
amount of penalties varies depending on the offense, from $2,000
to $50,000 per violation, plus treble damages for the amount at
issue and exclusion from federal health care programs (including
Medicare and Medicaid).
HHS also can impose penalties on a person or entity who offers
inducements to beneficiaries for program services, who violates
rules regarding the assignment of payments or who knowingly
gives false or misleading information that could reasonably
influence the discharge of patients from a hospital. Persons who
have been excluded from a federal health care program and who
retain ownership in a participating entity and persons who
contract with excluded persons may be penalized.
HHS also can impose penalties for false or fraudulent claims and
those that include services not provided as claimed. In
addition, HHS may impose penalties on claims:
|
|
|
|
|
for physician services that the person or entity knew or should
have known were rendered by a person who was unlicensed, or
misrepresented either (1) his or her qualifications in
obtaining his or her license or (2) his or her
certification in a medical specialty;
|
|
|
|
for services furnished by a person who was, at the time the
claim was made, excluded from the program to which the claim was
made; or
|
|
|
|
that show a pattern of medically unnecessary items or services.
|
Penalties also are applicable in certain other cases, including
violations of the federal Anti-Kickback Statute, payments to
limit certain patient services and improper execution of
statements of medical necessity.
Environmental
Health and Safety Laws
We are subject to federal, state and local regulations governing
the storage, use and disposal of materials and waste products.
Although we believe that our safety procedures for storing,
handling and disposing of these hazardous materials comply with
the standards prescribed by law and regulation, we cannot
completely eliminate the risk of accidental contamination or
injury from those hazardous materials. In the event of an
accident, we could be held liable for any damages that result
and any liability could exceed the limits or fall outside the
coverage of our insurance. We may not be able to maintain
insurance on acceptable terms, or at all. We could incur
significant costs and the diversion of our managements
attention in order to comply with current or future
environmental laws and regulations. We do not have any
violations related to compliance with environmental, health and
safety laws through calendar year 2007.
25
Licensing
Our agencies and facilities are subject to state and local
licensing regulations ranging from the adequacy of medical care
to compliance with building codes and environmental protection
laws. In order to assure continued compliance with these various
regulations, governmental and other authorities periodically
inspect our agencies and facilities. Additionally, health care
professionals at our agencies and facilities are required to be
individually licensed or certified under applicable state law.
We take steps to ensure that our employees and agents possess
all necessary licenses and certifications.
The institutional pharmacy operations within our facility-based
services segment are subject to regulation by the various states
in which business is conducted as well as by the federal
government. The pharmacies are regulated under the Food, Drug
and Cosmetic Act and the Prescription Drug Marketing Act, which
are administered by the United States Food and Drug
Administration. Under the Comprehensive Drug Abuse Prevention
and Control Act of 1970, which is administered by the United
States Drug Enforcement Administration, dispensers of controlled
substances must register with the Drug Enforcement
Administration, file reports of inventories and transactions and
provide adequate security measures. Failure to comply with such
requirements could result in civil or criminal penalties. We do
not have any violations related to Comprehensive Drug Abuse
Prevention and Control Act of 1970 through calendar year 2007.
The JC is a nationwide commission that establishes standards
relating to the physical plant, administration, quality of
patient care and operation of medical staffs of hospitals.
Currently, JC accreditation of home nursing agencies is
voluntary. However, managed care organizations use JC
accreditation as a minimum standard for regional and state
contracts. As of December 31, 2007, the JC had accredited
36 of our home nursing agencies. Those not yet accredited are
working towards achieving this accreditation.
Certificate
of Need and Permit of Approval Laws
In addition to state licensing laws, some states require a
provider to obtain a certificate of need or permit of approval
prior to establishing or expanding certain health services or
facilities. States with certificate of need or permit of
approval laws place limits on both the construction and
acquisition of health care facilities and operations and the
expansion of existing facilities and services. In these states,
approvals are required for capital expenditures exceeding
certain amounts that involve certain facilities or services,
including home nursing agencies. The certificate of need or
permit of approval issued by the state determines the service
areas for the applicable agency or program. The states that
currently issue certificate of need or permits of approval are:
Alabama, Alaska, Arkansas, Georgia, Hawaii, Kentucky, Maryland,
Mississippi, Montana, New Jersey, New York, North Carolina,
South Carolina, Tennessee, Vermont, Washington, West Virginia
and the District of Columbia. In addition, the state of
Louisiana has imposed a moratorium on the issuance of new
licenses for home nursing agencies that is effective until
July 1, 2008.
State certificate of need and permit of approval laws generally
provide that, prior to the addition of new capacity, the
construction of new facilities or the introduction of new
services, a designated state health planning agency must
determine that a need exists for those beds, facilities or
services. The process is intended to promote comprehensive
health care planning, assist in providing high quality health
care at the lowest possible cost and avoid unnecessary
duplication by ensuring that only those health care facilities
and operations that are needed will be built and opened.
Employees
As of December 31, 2007 we had 4,498 employees, of
which 3,090 were full-time and 1,408 were part-time, and
approximately 925 independent contractors. None of our employees
are subject to a collective bargaining agreement. We consider
our relationships with our employees and independent contractors
to be good.
26
Insurance
We are subject to claims and legal actions in the ordinary
course of our business. To cover claims that may arise, we
maintain professional malpractice liability insurance, general
liability insurance, automobile liability insurance and
workers compensation/employers liability in amounts
that we believe are appropriate and sufficient for our
operations. We maintain professional malpractice and general
liability insurance that provide primary coverage on a
claims-made basis of $1.0 million per incident and
$3.0 million in annual aggregate amounts. We maintain
workers compensation insurance that meets state statutory
requirements with a primary employer liability limit of
$1.0 million for Louisiana, Mississippi, Alabama, Arkansas,
Texas, Tennessee, Georgia, Florida and Kentucky and $500,000 in
West Virginia. We maintain Automobile Liability for all owned,
hired and non-owned autos with a primary limit of
$2.0 million. In addition, we currently maintain multiple
layers of umbrella coverage in the aggregate amount of
$25.0 million that provides excess coverage for
professional malpractice, general liability, automobile
liability and employers liability. We also currently
maintain Directors and Officers liability insurance in the
aggregate amount of $15.0 million. The cost and
availability of such coverage has varied widely in recent years.
While we believe that our insurance policies and coverage are
adequate for a business enterprise of our type, we cannot assure
you that our insurance coverage is sufficient to cover all
future claims or that it will continue to be available in
adequate amounts or at a reasonable cost.
Available
Information
Our Annual Reports on
Form 10-K,
Quarterly Reports on
Form 10-Q,
Current Reports on
Form 8-K,
proxy statements and amendments to those reports are available
free of charge on our internet website (www.lhcgroup.com) as
soon as reasonably practicable after such reports are
electronically filed with or furnished to the Securities and
Exchange Commission (SEC). The SEC also maintains an internet
site (www.sec.gov) that contains reports, proxy and information
statements and other information regarding issuers that file
electronically with the SEC.
You should carefully consider the risks described below
before investing in the Company. The risks and uncertainties
described below are not the only ones we face. Other
risks and uncertainties that we have not predicted or assessed
may also adversely affect us.
If any of the following risks occurs, our earnings, financial
condition or business could be materially harmed and the trading
price of our common stock could decline, resulting in the loss
of all or part of your investment.
More
than 80 percent of our net service revenue is derived from
Medicare. If there are changes in Medicare rates or methods
governing Medicare payments for our services, or if we are
unable to control our costs, our net service revenue and net
income could decline materially.
For the years ended December 31, 2007, 2006 and 2005, we
received 81.7 percent, 82.6 percent and
86.4 percent, respectively, of our net service revenue from
Medicare. Reductions in Medicare rates or changes in the way
Medicare pays for services could cause our net service revenue
and net income to decline, perhaps materially. Reductions in
Medicare reimbursement could be caused by many factors,
including:
|
|
|
|
|
administrative or legislative changes to the base rates under
the applicable prospective payment systems;
|
|
|
|
the reduction or elimination of annual rate increases;
|
|
|
|
the imposition or increase by Medicare of mechanisms, such as
co-payments, shifting more responsibility for a portion of
payment to beneficiaries;
|
|
|
|
adjustments to the relative components of the wage index used in
determining reimbursement rates;
|
|
|
|
changes to case mix or therapy thresholds;
|
27
|
|
|
|
|
the reclassification of home health resource groups or long-term
care diagnosis-related groups; or
|
|
|
|
further limitations on referrals to long-term acute care
hospitals from host hospitals.
|
We generally receive fixed payments from Medicare for our
services based on the level of care provided to our patients.
Consequently, our profitability largely depends upon our ability
to manage the cost of providing these services. Medicare
currently provides for an annual adjustment of the various
payment rates, such as the base episode rate for our home
nursing services, based upon the increase or decrease of the
medical care expenditure category of the Consumer Price Index,
which may be less than actual inflation. This adjustment could
be eliminated or reduced in any given year. Our base episode
rate for home nursing services is also subject to an annual
market basket adjustment. For 2008, the home health market
basket percentage increase is 3.0 percent. Further,
Medicare routinely reclassifies home health resource groups and
long-term care diagnosis-related groups. As a result of those
reclassifications, we could receive lower reimbursement rates
depending on the case mix of the patients we service. If our
cost of providing services increases by more than the annual
Medicare price adjustment, or if these reclassifications result
in lower reimbursement rates, our net income could be adversely
impacted.
We are
subject to extensive government regulation. Any changes in the
laws governing our business, or the interpretation and
enforcement of those laws or regulations, could cause us to
modify our operations and could negatively impact our operating
results.
As a provider of health care services, we are subject to
extensive regulation on the federal, state and local levels,
including with regard to:
|
|
|
|
|
agency, facility and professional licensure and certificates of
need and permits of approval;
|
|
|
|
conduct of operations, including financial relationships among
health care providers, Medicare fraud and abuse and physician
self-referral;
|
|
|
|
maintenance and protection of records, including HIPAA;
|
|
|
|
environmental protection, health and safety;
|
|
|
|
certification of additional agencies or facilities by the
Medicare program; and
|
|
|
|
payment for services.
|
The laws and regulations governing our operations, along with
the terms of participation in various government programs,
regulate how we do business, the services we offer and our
interactions with patients and other providers. These laws and
regulations, and their interpretations, are subject to frequent
change. Changes in existing laws, regulations, their
interpretations or the enactment of new laws or regulations
could increase our costs of doing business and cause our net
income to decline. If we fail to comply with these applicable
laws and regulations, we could suffer civil or criminal
penalties, including the loss of our licenses to operate and our
ability to participate in federal and state reimbursement
programs.
We are subject to various routine and non-routine governmental
reviews, audits and investigations. In recent years federal and
state civil and criminal enforcement agencies have heightened
and coordinated their oversight efforts related to the health
care industry, including with respect to referral practices,
cost reporting, billing practices, joint ventures and other
financial relationships among health care providers. A violation
or change in the interpretation of the laws governing our
operations, or changes in the interpretation of those laws,
could result in the imposition of fines, civil or criminal
penalties, the termination of our rights to participate in
federal and state-sponsored programs or the suspension or
revocation of our licenses to operate. If we become subject to
material fines or if other sanctions or other corrective actions
are imposed upon us, we may suffer a substantial reduction in
net income.
28
If any
of our agencies or facilities fail to comply with the conditions
of participation in the Medicare program, that agency or
facility could be terminated from Medicare, which would
adversely affect our net service revenue and net
income.
Our agencies and facilities must comply with the extensive
conditions of participation in the Medicare program. These
conditions of participation vary depending on the type of agency
or facility, but in general require our agencies and facilities
to meet specified standards relating to personnel, patient
rights, patient care, patient records, administrative reporting
and legal compliance. If an agency or facility fails to meet any
of the Medicare conditions of participation, that agency or
facility may receive a notice of deficiency from the applicable
state surveyor. If that agency or facility then fails to
institute and comply with a plan of correction to correct the
deficiency within the time period provided by the state
surveyor, that agency or facility could be terminated from the
Medicare program. We respond in the ordinary course to
deficiency notices issued by state surveyors and none of our
facilities or agencies have ever been terminated from the
Medicare program for failure to comply with the conditions of
participation. Any termination of one or more of our agencies or
facilities from the Medicare program for failure to satisfy the
Medicare conditions of participation would adversely affect our
net service revenue and net income.
In addition, if our long-term acute care hospitals fail to meet
or maintain the standards for Medicare certification as
long-term acute care hospitals, such as for average minimum
length of patient stay, they will receive reimbursement under
the prospective payment system applicable to general acute care
hospitals rather than the system applicable to long-term acute
care hospitals. Payments at rates applicable to general acute
care hospitals would likely result in our long-term acute care
hospitals receiving less Medicare reimbursement than they
currently receive for their patient services. Moreover, all of
our long-term acute care hospitals are subject to additional
Medicare criteria because they operate as separate hospitals
located in space leased from and located in, a general acute
care hospital, known as a host hospital. This is known as a
hospital within a hospital model. These additional
criteria include requirements concerning financial and
operational separateness from the host hospital. If several of
our long-term acute care hospitals were subject to payment as
general acute care hospitals or fail to comply with the
separateness requirements, our net service revenue and net
income would decline.
CMS
has adopted regulations that could materially and adversely
impact the revenue and net income of our long-term acute care
hospitals.
In a final rule released on May 1, 2007, CMS expanded the
policy to apply not only to LTACH HwHs and satellites but also
to freestanding LTACHs and grandfathered LTACHs as well as to
HwHs and satellites that admit Medicare patients from
non-co-located hospitals. While this policy change was supposed
to take effect for cost reporting periods beginning on or after
July 1, 2007, the MMSEA delayed the implementation of the
policy for three years with respect to freestanding LTACHs and
grandfathered LTACHs. Further, the MMSEA set the percentage
threshold at 50 percent for three years for HwHs and
satellites located in urban areas that would otherwise be
subject to a transition period and it established a
75 percent ceiling for HwHs and satellite facilities
located in rural areas and those that receive referrals from MSA
dominant hospitals or urban single hospitals.
We currently have a total of seven LTACHs. Six of our hospitals
are classified as HwHs and one as freestanding. Of the six HwH
facilities, four are located in rural or non-MSAs and are
therefore subject to a final admission percentage of
50 percent at the end of the phase-in period. Two of our
six HwH facilities are located in MSA or urban areas and will be
subject to a final admission percentage of 25 percent at
the end of the phase-in period. Of these six locations
classified as HwHs, two facilities are satellite locations of a
parent hospital located in an MSA and one is a satellite
location of a parent hospital located in a non-MSA. Based on our
discussions with CMS, we believe each of these satellite
locations will be viewed as being located in a non-MSA
regardless of the location of its parent hospital and will be
treated independently from its parent for purposes of
calculating its compliance with the admissions limitations. If
the 25 percent rule is extended, as planned, to
freestanding LTACHs after the three-year delay (established in
the MMSEA), our current freestanding facility would not be
affected because we currently do not receive more than
25 percent of our Medicare admissions from any single
referring hospital.
29
For the 12 months ended December 31, 2007, on an
individual basis, all of our LTACH locations admitted between
50.0 percent and 75.0 percent of their patients from
their host hospitals. These hospitals came under the proper
threshold as of September 30, 2007. Our remaining LTACH is
not an HwH; therefore, it is not subject to these limits on host
hospital referrals.
Our ability to quantify the potential reduction in our
reimbursement rates resulting from the implementation of these
new regulations is contingent upon a variety of factors, such as
our ability to reduce the percentage of admissions that are
derived from our host hospitals and, if necessary, our ability
to relocate our existing long-term acute care hospitals to
freestanding locations. We may not be able to successfully
restructure or relocate these operations without incurring
significant expense or in a manner that avoids reimbursement
reductions. If these new regulations result in lower
reimbursement rates, our net service revenue and net income
could decline. As a result of these new rules, we do not intend
to expand the number of hospital within a hospital long-term
acute care hospitals that we operate.
We are reimbursed by Medicare for services we provide in our
long-term acute care hospitals based on the long-term care
diagnosis-related group assigned to each patient. CMS
establishes these long-term care diagnosis-related groups by
grouping diseases by diagnosis, which group reflects the amount
of resources needed to treat a given disease. These new rules
reclassify certain long-term care diagnosis-related groups,
which could result in a decrease in reimbursement rates.
Further, the new rules kept in place the financial penalties
associated with the failure to limit the total number of
Medicare patients discharged from a host hospital and
subsequently readmitted to a long-term acute care hospital
located within the host hospital to no greater than
5.0 percent. If we fail to comply with these readmission
rates or if our reimbursement rates decline due to the
reclassification of certain long-term care diagnosis-related
groups, our net service revenue and net income could decline.
Legislative
initiatives could negatively impact our operations and financial
results.
In recent years, an increasing number of legislative initiatives
have been introduced or proposed in Congress and in state
legislatures that would result in major changes in the health
care system, either at the national or state level. Many of
these proposals have been introduced in an effort to reduce
costs. For example, the Medicare Modernization Act of 2003 (MMA)
allocated significant additional funds to Medicare managed care
providers in order to promote greater participation in those
plans by Medicare beneficiaries. If these increased funding
levels achieve their intended result, the rate of growth in the
Medicare fee-for-service market could decline. For the years
ended December 31, 2007, 2006 and 2005, we received
81.7 percent, 82.6 percent and 86.4 percent,
respectively, of our net service revenue from the Medicare
fee-for-service market. Among other proposals that have been
introduced are insurance market reforms to increase the
availability of group health insurance to small businesses,
requirements that all businesses offer health insurance coverage
to their employees and the creation of government health
insurance or plans that would cover all citizens and increase
payments by beneficiaries. We cannot predict whether any of the
above proposals, or any other future proposals, will be adopted.
If adopted, we could be forced to expend considerable resources
to comply with and implement such reforms.
More
than 50 percent of our net service revenue is currently
generated in Louisiana, making us particularly sensitive to
economic and other conditions in that state.
Our Louisiana agencies and facilities accounted for
approximately 50.9 percent, 64.1 percent and
78.6 percent of net service revenue during the years ended
December 31, 2007, 2006 and 2005, respectively. Any
material change in the current economic or competitive
conditions in Louisiana could have a disproportionate effect on
our overall business results.
Hurricanes
or other adverse weather events could negatively affect our
local economies or disrupt our operations, which could have an
adverse effect on our business or results of
operations.
Our market areas in the southern United States are particularly
susceptible to hurricanes. Such weather events can disrupt our
operations, result in damage to our properties and negatively
affect the local economies
30
in which we operate. In late summer 2005, Hurricane Katrina and
Hurricane Rita struck the Gulf Coast region of the United States
and caused extensive and catastrophic physical damage to those
areas. While we believe we have recovered from the effects of
Hurricane Katrina and Hurricane Rita, future hurricanes could
affect our operations or the economies in those market areas and
result in damage to certain of our facilities, the equipment
located at such facilities or equipment rented to customers in
those areas. Our business or results of operations may be
adversely affected by these and other negative effects of future
hurricanes.
If we
are unable to maintain relationships with existing referral
sources or establish new referral sources, our growth and net
income could be adversely affected.
Our success depends significantly on referrals from physicians,
hospitals and other health care providers in the communities in
which we deliver our services. Our referral sources are not
obligated to refer business to us and may refer business to
other health care providers. We believe many of our referral
sources refer business to us as a result of the quality of
patient service provided by our local employees in the
communities in which our agencies and facilities are located. If
we are unable to retain these employees, our referral sources
may refer business to other health care providers. Our loss of,
or failure to maintain, existing relationships or our failure to
develop new relationships could affect adversely our ability to
expand our operations and operate profitably.
Delays
in reimbursement may cause liquidity problems.
Our business is characterized by delays in reimbursement from
the time we request payment for our services to the time we
receive reimbursement or payment. A portion of our estimated
reimbursement (60.0 percent for an initial episode of care
and 50.0 percent for subsequent episodes of care) for each
Medicare episode is billed at the commencement of the episode
and we typically receive payment within approximately
12 days. The remaining reimbursement is billed upon
completion of the episode and is typically paid within 14 to
17 days from the billing date. If we have information
system problems or issues arise with Medicare or other payors,
we may encounter further delays in our payment cycle. For
example, in the past we have experienced delays resulting from
problems arising out of the implementation by Medicare of new or
modified reimbursement methodologies or as a result of natural
disasters, such as hurricanes. We have also experienced delays
in reimbursement resulting from our implementation of new
information systems related to our accounts receivable and
billing functions. Any future timing delay may cause working
capital shortages. As a result, working capital management,
including prompt and diligent billing and collection, is an
important factor in our consolidated results of operations and
liquidity. Our working capital management procedures may not
successfully negate this risk. Significant delays in payment or
reimbursement could have an adverse impact on our liquidity and
financial condition.
The
termination of a large number of managed care contracts in the
fourth quarter of 2007 may lead to a decrease in
revenues.
In response to the challenges associated with collecting from
Commercial payors and the unprofitable reimbursement rates paid
by many Commercial payors, the Company terminated or sent notice
of termination to 285 Commercial payors for home health
services in the fourth quarter of 2007. These 285 Commercial
payors had reimbursement rates averaging 26 percent below
cost, representing approximately 8 percent of the
Companys home health revenue, 16 percent of the
Companys home health admissions and 44 percent of the
Companys bad debt write-offs against home health revenue
in 2007. The termination of these contracts may cause a decrease
in our revenues.
Our
allowance for contractual adjustments and doubtful accounts may
not be sufficient to cover uncollectible amounts.
On an ongoing basis, we estimate the amount of Medicare,
Medicaid and private insurance receivables that we will not be
able to collect. This allows us to calculate the expected loss
on our receivables for the
31
period we are reporting. Our allowance for contractual
adjustments and doubtful accounts may underestimate actual
unpaid receivables for various reasons, including:
|
|
|
|
|
adverse changes in our estimates as a result of changes in payor
mix and related collection rates;
|
|
|
|
inability to collect funds due to missed filing deadlines or
inability to prove that timely filings were made;
|
|
|
|
adverse changes in the economy generally exceeding our
expectations; or
|
|
|
|
unanticipated changes in reimbursement from Medicare, Medicaid
and private insurance companies.
|
If our allowance for contractual adjustments and doubtful
accounts is insufficient to cover losses on our receivables, our
business, financial position or results of operations could be
materially adversely affected.
Possible
changes in the case mix of patients, as well as payor mix and
payment methodologies, may have a material adverse effect on our
results of operations.
The sources and amounts of our patient revenue are determined by
a number of factors, including the mix of patients and the rates
of reimbursement among payors. Changes in the case mix of the
patients, payment methodologies or payor mix among private pay,
Medicare and Medicaid may significantly affect our results of
operations.
The
agreement governing our credit facility contains, and future
debt agreements may contain, various covenants that limit our
discretion in the operation of our business.
The agreement and instruments governing our outstanding credit
facility, and the agreements and instruments governing future
debt agreements may contain various restrictive covenants that,
among other things, require us to comply with or maintain
certain financial tests and ratios that may restrict our ability
to:
|
|
|
|
|
incur more debt;
|
|
|
|
redeem or repurchase stock, pay dividends or make other
distributions;
|
|
|
|
make certain investments;
|
|
|
|
create liens;
|
|
|
|
enter into transactions with affiliates;
|
|
|
|
make unapproved acquisitions;
|
|
|
|
merge or consolidate;
|
|
|
|
transfer or sell assets; and
|
|
|
|
make fundamental changes in our corporate existence and
principal business.
|
In addition, events beyond our control could affect our ability
to comply with and maintain these financial tests and ratios.
Any failure by us to comply with or maintain all applicable
financial tests and ratios and to comply with all applicable
covenants could result in an event of default with respect to
our credit facility or any other future debt agreements. This
could lead to the acceleration of the maturity of any
outstanding loans and the termination of the commitments to make
further extensions of credit. Even if we are able to comply with
all applicable covenants, the restrictions on our ability to
operate our business at our sole discretion could harm our
business by, among other things, limiting our ability to take
advantage of financing, mergers, acquisitions and other
corporate opportunities.
If the
structures or operations of our joint ventures are found to
violate the law, our financial condition and consolidated
results of operations could be materially adversely
impacted.
As of December 31, 2007, we had entered into 71 joint
ventures with respect to the ownership and operation of 60 home
nursing agency locations, five hospices and six long-term acute
care hospital locations.
32
Our joint ventures are structured either as equity joint
ventures or agency leasing arrangements, as permitted by
applicable state laws and subject to business considerations. As
of December 31, 2007, we had 66 equity joint ventures and
five agency leasing arrangements. Of these 66 joint ventures, 53
are with hospitals, seven are with physicians and six are with
other parties. With respect to our seven joint ventures with
physicians, six are for the ownership and operation of long-term
acute care hospitals and one is for the ownership of a home
nursing agency.
Our joint ventures with hospitals and physicians are governed by
the Anti-Kickback Statute and similar state laws. These
anti-kickback statutes prohibit the payment or receipt of
anything of value in return for referrals of patients or
services covered by governmental health care programs, such as
Medicare. The OIG has published numerous safe harbors that
exempt qualifying arrangements from enforcement under the
Anti-Kickback Statute. We have sought to satisfy as many safe
harbor requirements as possible in structuring these joint
ventures. For example, each of our equity joint ventures with
hospitals and physicians is structured in accordance with the
following principles:
|
|
|
|
|
the investment interest offered is not based upon actual or
expected referrals by the hospital or physician;
|
|
|
|
our joint venture partners are not required to make or influence
referrals to the joint venture;
|
|
|
|
at the time the joint venture is formed, each hospital or
physician joint venture partner is required to make an actual
capital contribution to the joint venture equal to the fair
market value of its investment interest and is at risk to lose
its investment;
|
|
|
|
neither we nor the joint venture entity lends funds to or
guarantees a loan to acquire interests in the joint venture for
a hospital or physician; and
|
|
|
|
distributions to our joint venture partners are based solely on
their equity interests and not affected by referrals from the
hospital or physician.
|
Although we have sought to satisfy as many safe harbor
requirements as possible, our joint ventures may not satisfy all
elements of the safe harbor requirements.
Our seven joint ventures with physicians are also governed by
the Stark Law and similar state laws, which restrict physicians
from making referrals for particular health care services to
entities with which the physicians or their families have a
financial relationship. We also believe we have structured our
physician joint ventures in a way that meets applicable
exceptions under the Stark Law and similar state physician
referral laws. For example, we believe our one physician
joint venture for a home nursing agency comply with the
rural provider exception to the Stark Law and that our six
physician joint ventures for long-term acute care
hospitals comply with the whole hospital exception to the Stark
Law.
If any of our joint ventures were found to be in violation of
federal or state anti-kickback or physician referral laws, we
could be required to restructure them or refuse to accept
referrals from the physicians or hospitals with which we have
entered into a joint venture. We also could be required to repay
to Medicare amounts we have received pursuant to any prohibited
referrals and we could suffer civil or criminal penalties,
including the loss of our licenses to operate and our ability to
participate in federal and state health care programs. If any of
our joint ventures were subject to any of these penalties, our
business could be damaged. In addition, our growth strategy is,
in part, based on the continued development of new joint
ventures with rural hospitals for the ownership and operation of
home nursing agencies. If the structure of any of these joint
ventures were found to violate federal or state anti-kickback
statutes or physician referral laws, we may be unable to
implement our growth strategy, which could have an adverse
impact on our future net income and consolidated results of
operations.
If we
are required to either repurchase or sell a substantial portion
of the equity interests in our joint ventures, our capital
resources and financial condition could be materially, adversely
impacted.
Upon the occurrence of fundamental changes to the laws and
regulations applicable to our joint ventures, or if a
substantial number of our joint venture partners were to
exercise the buy/sell provisions contained in
33
many of our joint venture agreements, we may be obligated to
purchase or sell the equity interests held by us or our joint
venture partners. The purchase price under these buy/sell
provisions is typically based on a multiple of the historical or
projected earnings before income taxes, depreciation and
amortization of the joint venture at the time the buy/sell
option is exercised. In the event the buy/sell provisions are
exercised and we lack sufficient capital to purchase the
interest of our joint venture partners, we may be obligated to
sell our equity interest in these joint ventures. If we are
forced to sell our equity interest, we will lose the benefit of
those particular joint venture operations. If these buy/sell
provisions are exercised and we choose to purchase the interest
of our joint venture partners, we may be obligated to expend
significant capital in order to complete such acquisitions. If
either of these events occurs, our net service revenue and net
income could decline or we may not have sufficient capital
necessary to implement our growth strategy.
Shortages
in qualified nurses and other health care professionals could
increase our operating costs significantly or constrain our
ability to grow.
We rely on our ability to attract and retain qualified nurses
and other health care professionals. The availability of
qualified nurses nationwide has declined in recent years and
competition for these and other health care professionals has
increased. Salary and benefit costs have risen accordingly. Our
ability to attract and retain these nurses and other health care
professionals depends on several factors, including our ability
to provide desirable assignments and competitive benefits and
salaries. We may not be able to attract and retain qualified
nurses or other health care professionals in the future. In
addition, the cost of attracting and retaining these
professionals and providing them with attractive benefit
packages may be higher than anticipated which could cause our
net income to decline. Moreover, if we are unable to attract and
retain qualified professionals, the quality of services offered
to our patients may decline or our ability to grow may be
constrained.
The
loss of certain senior management could have a material adverse
effect on our operations and financial
performance.
Our success depends upon the continued employment of certain
members of our senior management, including our co-founder,
Chief Executive Officer and Chairman, Keith G. Myers, our Senior
Vice President, Chief Financial Officer and Treasurer, Peter J.
Roman, and our President, Chief Operating Officer, Secretary and
Director, John L. Indest. We have entered into an employment
agreement with each of these officers in an effort to further
secure their employment. The loss of service of any of these
officers could have a material adverse effect on our operations
if we were unable to find a suitable replacement.
If we
are subject to substantial malpractice or other similar claims,
our net income could be materially, adversely
impacted.
The services we offer have an inherent risk of professional
liability and related, substantial damage awards. We, and the
nurses and other health care professionals who provide services
on our behalf, may be the subject of medical malpractice claims.
These nurses and other health care professionals could be
considered our agents and, as a result, we could be held liable
for their medical negligence. We cannot predict the effect that
any claims of this nature, regardless of their ultimate outcome,
could have on our business or reputation or on our ability to
attract and retain patients and employees. We maintain
malpractice liability insurance that provides primary coverage
on a claims-made basis of $1.0 million per incident and
$3.0 million in annual aggregate amounts. In addition, we
maintain multiple layers of umbrella coverage in the aggregate
amount of $25.0 million that provide excess coverage for
professional malpractice and other liabilities. We are
responsible for deductibles and amounts in excess of the limits
of our coverage. Claims that could be made in the future in
excess of the limits of such insurance, if successful, could
materially, adversely affect our ability to conduct business or
manage our assets. In addition, our insurance coverage may not
continue to be available to us at commercially reasonable rates,
in adequate amounts or on satisfactory terms.
34
The
application of state certificate of need and permit of approval
regulations and compliance with federal and state licensing
requirements could substantially limit our ability to operate
and grow our business.
Our ability to expand operations in a state will depend on our
ability to obtain a state license to operate. States may have a
limit on the number of licenses they issue. For example, as of
December 31, 2007 we operated 42 home nursing agencies in
Louisiana. Louisiana currently has a moratorium on the issuance
of new home nursing agency licenses through July 1, 2008.
We cannot predict whether this moratorium will be extended
beyond this date or whether any other states in which we
currently operate, or may wish to operate in the future, may
adopt a similar moratorium.
In addition to the moratorium imposed by the state of Louisiana,
nine of the states in which we currently operate, or plan to
operate in the future, require health care providers to obtain
prior approval, known as a certificate of need or a permit of
approval, for the purchase, construction or expansion of health
care facilities, to make certain capital expenditures or to make
changes in services or bed capacity. The states that currently
issue certificate of need or permits of approval are: Alabama,
Alaska, Arkansas, Georgia, Hawaii, Kentucky, Maryland,
Mississippi, Montana, New Jersey, New York, North Carolina,
South Carolina, Tennessee, Vermont, Washington, West Virginia
and the District of Columbia. In granting approval, these states
consider the need in the service area for additional or expanded
health care facilities or services. The failure to obtain any
requested certificate of need, permit of approval or other
license could impair our ability to operate or expand our
business.
We
face competition, including from competitors with greater
resources, which may make it difficult for us to compete
effectively as a provider of post-acute health care
services.
We compete with local and regional home nursing and hospice
companies, hospitals and other businesses that provide
post-acute health care services, some of which are large
established companies that have significantly greater resources
than we do. Our primary competition comes from local operators
in each of our markets. We expect our competitors to develop
joint ventures with providers, referral sources and payors,
which could result in increased competition. The introduction by
our competitors of new and enhanced service offerings, in
combination with industry consolidation and the development of
competitive joint ventures, could cause a decline in net service
revenue, loss of market acceptance of our services or make our
services less attractive. Future increases in competition from
existing competitors or new entrants may limit our ability to
maintain or increase our market share. We may not be able to
compete successfully against current or future competitors and
competitive pressures may have a material, adverse impact on our
business, financial condition or consolidated results of
operations.
If we
are unable to protect the proprietary nature of our software
systems and methodologies, our business and financial condition
could be harmed.
We have developed a proprietary software system, which we refer
to as our Service Value Point system, that allows us to collect
assessment data, establish treatment plans, monitor patient
treatment and evaluate our clinical and financial performance.
In addition, we rely on other proprietary methodologies or
information to which others may obtain access or independently
develop. To protect our proprietary information, we require
certain employees, consultants, financial advisors and strategic
partners to enter into confidentiality and non-disclosure
agreements. These agreements may not ultimately provide
meaningful protection for our proprietary information in the
event of any unauthorized use, misappropriation or disclosure.
If our competitors were able to replicate our Service Value
Point system, it could allow them to improve their operations
and thereby compete more effectively in the markets in which we
provide our services. If we are unable to protect the
proprietary nature of our Service Value Point system or our
other proprietary information or methodologies, our business and
financial performance could be harmed.
35
Failure
of, or problems with, our critical software or information
systems could harm our business and operating
results.
In addition to our Service Value Point system, our business is
substantially dependent on other non-proprietary software. We
utilize a third-party software information system for our
long-term acute care hospitals. Our various home nursing agency
databases were fully consolidated into an enterprise-wide system
during the first half of 2005. Problems with, or the failure of,
these systems could negatively impact our clinical performance
and our management and reporting capabilities. Any such problems
or failure could materially and adversely affect our operations
and reputation, result in significant costs to us, cause delays
in our ability to bill Medicare or other payors for our
services, or impair our ability to provide our services in the
future. The costs incurred in correcting any errors or problems
with regard to our proprietary and non-proprietary software may
be substantial and could adversely affect our net income.
Our information systems are networked via public network
infrastructure and standards based encryption tools that meet
regulatory requirements for transmission of protected health
care information over such networks. However, threats from
computer viruses, instability of the public network on which our
data transit relies, or other instances that might render those
networks unstable or disabled would create operational
difficulties for us, including the ability to effectively
transmit claims and maintain efficient clinical oversight of our
patients as well as the disruption of revenue reporting and
billing and collections management, which could adversely affect
our business or operations.
Future
acquisitions may be unsuccessful and could expose us to
unforeseen liabilities.
Our growth strategy involves the acquisition of home nursing
agencies in rural markets. These acquisitions involve
significant risks and uncertainties, including difficulties
integrating acquired personnel and other corporate cultures into
our business, the potential loss of key employees or patients of
acquired agencies and the assumption of liabilities and exposure
to unforeseen liabilities of acquired agencies. We may not be
able to fully integrate the operations of the acquired
businesses with our current business structure in an efficient
and cost-effective manner. The failure to effectively integrate
any of these businesses could have a material adverse effect on
our operations.
We generally structure our acquisitions as asset purchase
transactions in which we expressly state that we are not
assuming any pre-existing liabilities of the seller and obtain
indemnification rights from the previous owners for acts or
omissions arising prior to the date of such acquisitions.
However, the allocation of liability arising from such acts or
omissions between the parties could involve the expenditure of a
significant amount of time, manpower and capital. Further, the
former owners of the agencies and facilities we acquire may not
have the financial resources necessary to satisfy our
indemnification claims relating to pre-existing liabilities. If
we were unsuccessful in a claim for indemnification from a
seller, the liability imposed could materially, adversely affect
our operations.
Our
acquisition and internal development activity may impose strains
on our existing resources.
We have grown significantly over the past four years. As we
continue to expand our markets, our growth could strain our
resources, including management, information and accounting
systems, regulatory compliance, logistics and other internal
controls. Our resources may not keep pace with our anticipated
growth. If we do not manage our expected growth effectively, our
future prospects could be affected adversely.
We may
face increased competition for attractive acquisition and joint
venture candidates.
We intend to continue growing through the acquisition of
additional home nursing agencies and the formation of joint
ventures with rural hospitals for the operation of home nursing
agencies. We face competition for acquisition and joint venture
candidates, which may limit the number of acquisition and joint
venture opportunities available to us or lead to the payment of
higher prices for our acquisitions and joint ventures. Recently,
we have observed an increase in the acquisition prices for
select home nursing agencies. We cannot assure you that we will
be able to identify suitable acquisition or joint venture
opportunities in the future or that any such opportunities, if
identified, will be consummated on favorable terms, if at all.
Without
36
successful acquisitions or joint ventures, our future growth
rate could decline. In addition, we cannot assure you that any
future acquisitions or joint ventures, if consummated, will
result in further growth.
We may
be unable to secure the additional capital necessary to
implement our growth strategy.
As of December 31, 2007, we had $1.2 million in cash.
Based on our current plan of operations, including acquisitions,
we believe this amount, when combined with a revolving line of
credit totaling $37.5 million available under our credit
facility, which, subject to certain conditions, may be increased
to $50.0 million, will be sufficient to fund our growth
strategy and to meet our currently anticipated operating
expenses, capital expenditures and debt service obligations for
at least the next 12 months. If our future net service
revenue or cash flow from operations is less than we currently
anticipate, we may not have sufficient funds to implement our
growth strategy. Further, we cannot readily predict the timing,
size and success of our acquisition and internal development
efforts and the associated capital commitments. If we do not
have sufficient cash resources, our growth could be limited
unless we are able to obtain additional equity or debt financing.
We are
a holding company with no operations of our own.
We are a holding company with no operations of our own.
Accordingly, our ability to service our debt and pay dividends,
if any, is dependent upon the earnings from the business
conducted by our subsidiaries. The distributions of those
earnings or advances or other distributions of funds by these
subsidiaries to us are contingent upon the subsidiaries
earnings and are subject to various business considerations. In
addition, distributions by subsidiaries could be subject to
statutory restrictions, including state laws requiring that the
subsidiary be solvent, or contractual restrictions. If our
subsidiaries are unable to make sufficient distributions or
advances to us, we may not have the cash resources necessary to
service our debt or pay dividends.
Our
executive officers and directors and their affiliates hold a
substantial portion of our stock and could exercise significant
influence over matters requiring stockholder approval,
regardless of the wishes of other stockholders.
Our executive officers and directors and individuals or entities
affiliated with them, beneficially own an aggregate of
approximately 18.5 percent of our outstanding common stock
as of December 31, 2007. The interests of these
stockholders may differ from your interests. If they were to act
together, these stockholders would be able to significantly
influence all matters that our stockholders vote upon, including
the election of directors, business combinations, the amendment
of our certificate of incorporation and other significant
corporate actions.
Certain
provisions of our charter, bylaws Delaware law and our
stockholders rights plan may delay or prevent a change in
control of our company.
Delaware law and our corporate documents contain provisions that
may enable our board of directors to resist a change in control
of our company. These provisions include:
|
|
|
|
|
a staggered board of directors;
|
|
|
|
limitations on persons authorized to call a special meeting of
stockholders;
|
|
|
|
the authorization of undesignated preferred stock, the terms of
which may be established and shares of which may be issued
without stockholder approval
|
|
|
|
advance notice procedures required for stockholders to nominate
candidates for election as directors or to bring matters before
an annual meeting of stockholders; and
|
|
|
|
a stockholders rights plan that includes a 20 percent
threshold for triggering events, a three-year term for
directors, an independent director evaluation provision
(commonly known as a TIDE provision) and a
stockholder redemption feature allowing stockholders to vote at
a special meeting that would be called to consider qualified
takeover offers.
|
37
These anti-takeover defenses could discourage, delay or prevent
a transaction involving a change in control of our company.
These provisions could also discourage proxy contests and make
it more difficult for you and other stockholders to elect
directors of your choosing or cause us to take other corporate
actions you desire.
Our
stock price may be volatile and your investment in our common
stock could suffer a decline in value.
The price at which our common stock will trade may be volatile.
The stock market has from time to time experienced significant
price and volume fluctuations that have affected the market
prices of securities, particularly securities of health care
companies. The market price of our common stock may be
influenced by many factors, including:
|
|
|
|
|
our operating and financial performance;
|
|
|
|
variances in our quarterly financial results compared to
research analyst expectations;
|
|
|
|
the depth and liquidity of the market for our common stock;
|
|
|
|
future sales of our common stock or the perception that sales
could occur;
|
|
|
|
investor perception of our business, acquisitions and our
prospects;
|
|
|
|
developments relating to litigation or governmental
investigations;
|
|
|
|
changes or proposed changes in health care laws or regulations
or enforcement of these laws and regulations, or announcements
relating to these matters; or
|
|
|
|
general economic and stock market conditions.
|
In addition, the stock market, and the NASDAQ Global Select
Market, or NASDAQ, in particular, has experienced price and
volume fluctuations that have often been unrelated or
disproportionate to the operating performance of health care
provider companies. These broad market and industry factors may
materially reduce the market price of our common stock,
regardless of our operating performance. In the past, securities
class-action
litigation has often been brought against companies following
periods of volatility in the market price of their respective
securities. We may become involved in this type of litigation in
the future. Litigation of this type is often expensive to defend
and may divert the attention of our senior management as well as
resources from the operation of our business.
We
currently do not intend to pay dividends on our common stock
and, consequently, your only opportunity to achieve a return on
your investment is if the price of our common stock appreciates
and you sell your shares.
We do not plan to declare dividends on shares of our common
stock in the foreseeable future. Consequently, your only
opportunity to achieve a return on your investment in our common
stock will be if the market price of our common stock
appreciates and you sell your shares at a profit. There is no
guarantee that the price of our common stock will ever exceed
the price that you pay.
We
incur costs as a result of being a public company.
As a public company, we incur significant legal, accounting and
other expenses associated with our public company reporting
requirements and corporate governance requirements, including
requirements under the Sarbanes-Oxley Act of 2002
(Sarbanes-Oxley) and the rules of the SEC and NASDAQ. We expect
these requirements to continue increasing our legal and
financial compliance costs and to make some activities more
time-consuming and costly. For example, we expect to continue
incurring significant costs in connection with the assessment of
our internal controls. We also expect these rules and
regulations may make it more expensive for us to obtain director
and officer liability insurance. We are currently evaluating and
monitoring developments with respect to these new rules and we
cannot predict or estimate the amount of additional costs we may
incur or the timing of such costs.
38
If we
identify deficiencies in our internal control over financial
reporting, our business and our stock price could be adversely
affected.
Beginning with our annual report for the year ending
December 31, 2006, we are required to report on the
effectiveness of our internal control over financial reporting
as required by Section 404 of Sarbanes-Oxley. Under
Section 404, we are required to assess the effectiveness of
our internal control over financial reporting and report our
conclusion in our annual report. Our auditor is also required to
report its conclusion regarding the effectiveness of our
internal control over financial reporting. The existence of one
or more material weaknesses would require us and our auditor to
conclude that our internal control over financial reporting is
not effective. If there are identified deficiencies in our
internal control over financial reporting, we could be subject
to regulatory scrutiny and a loss of public confidence in our
financial reporting, which could have an adverse effect on our
business and our stock price. We reported a material weakness at
December 31, 2007, and our auditor reported our internal
control over financial reporting was ineffective at
December 31, 2007.
|
|
Item 1B.
|
Unresolved
Staff Comments
|
Not applicable.
As of December 31, 2007 we owned or managed 58 locations in
Louisiana, 27 in Mississippi, 22 in Kentucky, 14 in Arkansas, 11
in Alabama, 11 in West Virginia, eight in Texas, eight in
Tennessee, seven in Florida, five in Georgia and one in Ohio.
Our home office is located in Lafayette, Louisiana in
19,159 square feet of leased office space under a lease
that commenced on March 1, 2004 and expires
February 28, 2014. Typically, our home nursing agencies are
located in leased facilities. Generally, the leases for our home
nursing agencies have initial terms of one year, but range from
one to five years. Most of the leases either contain multiple
options to extend the lease period in one-year increments or
convert to a month-to-month lease upon the expiration of the
initial term. Six of our long-term acute care hospitals
locations are hospitals within a hospital, meaning we have a
lease or sublease for space with the host hospital. Generally,
our leases or subleases for long-term acute care hospitals have
initial terms of five years, but range from three to ten years.
Most of our leases and subleases for our long-term acute care
hospitals contain multiple options to extend the term in
one-year increments.
|
|
Item 3.
|
Legal
Proceedings
|
We are involved in litigation and proceedings in the ordinary
course of our business. We do not believe that the outcome of
any of the matters in which we are currently involved,
individually or in the aggregate, will have a material adverse
effect upon our business, financial condition or results of
operations.
|
|
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
No matters were submitted to a vote of the Companys
stockholders during the fourth quarter of 2007.
PART II
|
|
Item 5.
|
Market
for Registrants Common Equity and Related Stockholder
Matters and Issuer Purchases of Equity Securities
|
Holders
The Companys common stock trades on the NASDAQ Global
Select Market under the symbol LHCG. As of
March 5, 2008, there were approximately 142 registered
holders of record of the Companys common stock and the
Company believes there are approximately 13,500 beneficial
holders.
39
Dividend
Policy
The Company has not paid any dividends on its common stock since
the initial public offering in 2005 and does not anticipate
paying dividends in the foreseeable future. We currently intend
to retain future earnings, if any, to support the development
and growth of our business. Payment of future dividends, if any,
will be at the discretion of our board of directors.
Price
Range of Common Stock
The following table provides the high and low prices of the
Companys Common Stock during 2007 and 2006 as quoted by
NASDAQ Global Select Market.
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
2007
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
26.17
|
|
|
$
|
20.28
|
|
Third Quarter
|
|
|
27.06
|
|
|
|
18.58
|
|
Second Quarter
|
|
|
33.14
|
|
|
|
24.52
|
|
First Quarter
|
|
|
33.00
|
|
|
|
24.15
|
|
|
|
|
|
|
|
|
|
|
|
|
High
|
|
|
Low
|
|
|
2006
|
|
|
|
|
|
|
|
|
Fourth Quarter
|
|
$
|
29.67
|
|
|
$
|
22.23
|
|
Third Quarter
|
|
|
24.78
|
|
|
|
18.70
|
|
Second Quarter
|
|
|
21.35
|
|
|
|
15.73
|
|
First Quarter
|
|
|
18.39
|
|
|
|
13.70
|
|
|
|
|
|
|
The closing price of our common stock as reported by NASDAQ on
March 5, 2008 was $17.01 |
Performance
Graph
This item is incorporated by reference to our annual report to
stockholders for the fiscal year ended December 31, 2007.
40
|
|
Item 6.
|
Selected
Financial Data
|
The selected consolidated financial data presented below is
derived from our audited consolidated financial statements for
each of the years ended December 31, 2003 through
December 31, 2007. The financial data for the years ended
December 31, 2007, 2006 and 2005 should be read together
with our consolidated financial statements and related notes and
Managements Discussion and Analysis of Financial
Condition and Consolidated Results of Operations included
herein.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
|
(In thousands except share and per share data)
|
|
|
Consolidated Statements of Income Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
298,031
|
|
|
$
|
218,535
|
|
|
$
|
155,687
|
|
|
$
|
116,090
|
|
|
$
|
68,515
|
|
Cost of service revenue
|
|
|
152,577
|
|
|
|
112,095
|
|
|
|
82,996
|
|
|
|
57,672
|
|
|
|
34,455
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
145,454
|
|
|
|
106,440
|
|
|
|
72,691
|
|
|
|
58,418
|
|
|
|
34,060
|
|
General and administrative expenses
|
|
|
106,795
|
|
|
|
71,115
|
|
|
|
46,519
|
|
|
|
35,168
|
|
|
|
23,411
|
|
Impairment loss
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31
|
|
Equity-based compensation expense(1)
|
|
|
|
|
|
|
|
|
|
|
3,856
|
|
|
|
1,788
|
|
|
|
864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
38,659
|
|
|
|
35,325
|
|
|
|
22,316
|
|
|
|
21,462
|
|
|
|
9,754
|
|
Interest expense
|
|
|
376
|
|
|
|
325
|
|
|
|
1,067
|
|
|
|
1,328
|
|
|
|
1,223
|
|
Non-operating (income) loss, including gain on sale of assets
|
|
|
(1,073
|
)
|
|
|
(2,033
|
)
|
|
|
(574
|
)
|
|
|
13
|
|
|
|
(106
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
minority interest and cooperative endeavor allocations
|
|
|
39,356
|
|
|
|
37,033
|
|
|
|
21,823
|
|
|
|
20,121
|
|
|
|
8,637
|
|
Income tax expense
|
|
|
12,147
|
|
|
|
10,817
|
|
|
|
6,052
|
|
|
|
6,111
|
|
|
|
2,400
|
|
Minority interest and cooperative endeavor allocations
|
|
|
5,984
|
|
|
|
4,795
|
|
|
|
4,545
|
|
|
|
4,158
|
|
|
|
2,837
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
21,225
|
|
|
|
21,421
|
|
|
|
11,226
|
|
|
|
9,852
|
|
|
|
3,400
|
|
Loss from discontinued operations, net
|
|
|
(1,667
|
)
|
|
|
(1,464
|
)
|
|
|
(1,124
|
)
|
|
|
(851
|
)
|
|
|
(557
|
)
|
Gain on sale of discontinued operations, net
|
|
|
31
|
|
|
|
637
|
|
|
|
|
|
|
|
312
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
19,589
|
|
|
|
20,594
|
|
|
|
10,102
|
|
|
|
9,313
|
|
|
|
2,843
|
|
Change in the redemption value of redeemable minority interests
|
|
|
193
|
|
|
|
1,163
|
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common stockholders
|
|
$
|
19,782
|
|
|
$
|
21,757
|
|
|
$
|
8,626
|
|
|
$
|
9,313
|
|
|
$
|
2,843
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share-basic(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.19
|
|
|
$
|
1.25
|
|
|
$
|
0.77
|
|
|
$
|
0.82
|
|
|
$
|
0.28
|
|
Loss from discontinued operations
|
|
|
(0.09
|
)
|
|
|
(0.09
|
)
|
|
|
(0.08
|
)
|
|
|
(0.07
|
)
|
|
|
(0.04
|
)
|
Gain on sale of discontinued operations, net
|
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.10
|
|
|
|
1.20
|
|
|
|
0.69
|
|
|
|
0.77
|
|
|
|
0.24
|
|
Change in the redemption value of redeemable minority interests
|
|
|
0.01
|
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common stockholders
|
|
$
|
1.11
|
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.77
|
|
|
$
|
0.24
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share-diluted(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.19
|
|
|
$
|
1.25
|
|
|
$
|
0.77
|
|
|
$
|
0.81
|
|
|
$
|
0.27
|
|
Loss from discontinued operations
|
|
|
(0.09
|
)
|
|
|
(0.09
|
)
|
|
|
(0.08
|
)
|
|
|
(0.07
|
)
|
|
|
(0.04
|
)
|
Gain on sale of discontinued operations, net
|
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.10
|
|
|
|
1.20
|
|
|
|
0.69
|
|
|
|
0.76
|
|
|
|
0.23
|
|
Change in the redemption value of redeemable minority interests
|
|
|
0.01
|
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common stockholders
|
|
$
|
1.11
|
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
$
|
0.76
|
|
|
$
|
0.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding(2):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
17,760,432
|
|
|
|
17,090,583
|
|
|
|
14,628,737
|
|
|
|
12,085,154
|
|
|
|
12,085,154
|
|
Diluted
|
|
|
17,827,444
|
|
|
|
17,104,660
|
|
|
|
14,684,639
|
|
|
|
12,145,150
|
|
|
|
12,114,675
|
|
Cash dividends declared per common share
|
|
|
|
|
|
|
|
|
|
|
.009
|
|
|
|
.039
|
|
|
|
.016
|
|
41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
2004
|
|
|
2003
|
|
|
|
(In thousands)
|
|
|
Consolidated Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
1,155
|
|
|
$
|
26,877
|
|
|
$
|
17,398
|
|
|
$
|
2,911
|
|
|
$
|
1,725
|
|
Total assets
|
|
|
174,985
|
|
|
|
152,694
|
|
|
|
104,418
|
|
|
|
47,519
|
|
|
|
27,915
|
|
Total debt
|
|
|
3,431
|
|
|
|
3,837
|
|
|
|
5,427
|
|
|
|
18,275
|
|
|
|
12,277
|
|
Total stockholders equity
|
|
|
143,371
|
|
|
|
121,889
|
|
|
|
78,444
|
|
|
|
16,351
|
|
|
|
6,909
|
|
|
|
|
(1) |
|
Equity-based compensation expense is allocated as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
2007
|
|
2006
|
|
2005
|
|
2004
|
|
2003
|
|
|
(In thousands)
|
|
Cost of service revenue
|
|
$
|
|
|
|
$
|
|
|
|
$
|
565
|
|
|
$
|
58
|
|
|
$
|
5
|
|
General and administrative expenses
|
|
|
|
|
|
|
|
|
|
|
3,291
|
|
|
|
1,730
|
|
|
|
859
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity-based compensation expense
|
|
$
|
|
|
|
$
|
|
|
|
$
|
3,856
|
|
|
$
|
1,788
|
|
|
$
|
864
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
All references to shares and per share amounts have been
retroactively restated to reflect our incorporation in the State
of Delaware and to give effect to a three-for-two stock split
with respect to our common stock as if such events occurred as
of the beginning of the earliest period presented. See
Note 1 to our consolidated financial statements. |
|
|
Item 7.
|
Managements
Discussion and Analysis of Financial Condition and Results of
Operations
|
The following discussion and analysis contains
forward-looking statements about our plans and expectations of
what may happen in the future. Forward-looking statements are
based on a number of assumptions and estimates that are
inherently subject to significant risks and uncertainties and
our results could differ materially from the results anticipated
by our forward-looking statements as a result of many known or
unknown factors, including, but not limited to, those factors
discussed on pages 27 to 39 under the heading Risk
Factors. Also, please read the cautionary notice regarding
forward-looking statements set forth at the beginning of this
annual report.
Please read the following discussion in conjunction with our
consolidated financial statements and the related notes
contained elsewhere in this annual report on
Form 10-K.
Overview
We provide post-acute health care services primarily to Medicare
beneficiaries in non-urban markets in the United States. We
provide these post-acute health care services through our home
nursing agencies, hospices, long-term acute care hospitals and
outpatient rehabilitation clinic. Since our founders began
operations in 1994 with one home nursing agency in Palmetto,
Louisiana, we have grown to 172 locations in Louisiana,
Mississippi, Kentucky, Arkansas, Alabama, West Virginia, Texas,
Tennessee, Florida, Georgia and Ohio as of December 31,
2007.
Segments
We operate in two segments for financial reporting purposes:
home-based services and facility-based services. We derived
81.9 percent, 75.4 percent and 67.8 percent of
our net service revenue during the year ended December 31,
2007, 2006 and 2005, respectively, from our home-based services
segment and derived the balance of our net service revenue from
our facility-based services segment.
Through our home-based services segment we offer a wide range of
services, including skilled nursing, private duty nursing,
physical, occupational and speech therapy, medically-oriented
social services and hospice care. As of December 31, 2007,
we owned and operated 144 home nursing locations, nine hospices,
a diabetes
42
management company and a private duty location. Of our 155
home-based services locations, 90 are wholly-owned by us, 60 are
majority-owned or controlled by us through joint ventures and
five are controlled by us through license lease arrangements. We
also manage the operations of four home nursing agencies in
which we have no ownership interest. We intend to increase the
number of home nursing agencies that we operate through
continued acquisition and development, primarily in underserved
non-urban markets, as we implement our growth strategy. As we
acquire and develop home nursing agencies, we anticipate the
percentage of our net service revenue and operating income
derived from our home-based services segment will increase.
We provide facility-based services principally through our
long-term acute care hospitals and outpatient rehabilitation
clinics. As of December 31, 2007, we owned and operated
four long-term acute care hospitals with seven locations, of
which all but one are located within host hospitals. We also
owned and operated an outpatient rehabilitation clinic, a
pharmacy, two medical equipment companies, a health and fitness
center and we provided contract rehabilitation services to third
parties. Of these 12 facility-based services locations, six are
wholly-owned by us and six are majority-owned or controlled by
us through joint ventures. We also manage the operations of one
inpatient rehabilitation facility in which we have no ownership
interest. Due to our emphasis on expansion through the
acquisition and development of home nursing agencies, we
anticipate that the percentage of our net service revenue and
operating income derived from our facility-based segment will
decline.
Development
Activities
From January 1, 2002 through December 31, 2007, we
acquired all or a majority of the economic interests in 84 home
nursing agencies for a total of approximately
$62.9 million: 16 in Kentucky, 14 in Mississippi, ten in
Louisiana, ten in Alabama, eight in West Virginia, seven in
Florida, seven in Tennessee, six in Texas, three in Arkansas and
three in Georgia. During this same period, we also internally
developed 39 home nursing agencies: 16 in Mississippi, 11 in
Louisiana, four in Arkansas, three in Kentucky, three in
Georgia, one in Texas and one in West Virginia. Also from
January 1, 2002 through December 31, 2007, we acquired
all or a majority of the economic interests in nine hospices for
approximately $2.1 million: four in Louisiana, two in
Arkansas, two in West Virginia and one in Tennessee.
From January 1, 2002 through December 31, 2007, we
acquired all or a majority of the economic interests in two
long-term acute care hospital locations and three outpatient
rehabilitation clinics located in Louisiana for approximately
$3.6 million. During this same period, we internally
developed four long-term acute care hospital locations, one
short-term acute care hospital, two inpatient rehabilitation
facilities and two outpatient rehabilitation clinics located in
Louisiana. During 2005, we converted the short-term acute care
hospital and inpatient rehabilitation facilities to long-term
acute care hospitals. Since January 2002, we have expanded the
number of licensed beds at our long-term acute care hospital
locations facilities from 22 beds to 156 beds as of
December 31, 2007.
In February 2004, we sold three hospices, two in Louisiana and
one in Mississippi and one home nursing agency in Louisiana for
$500,000. Also in February 2004, we sold one inpatient
rehabilitation facility located in Louisiana for $129,000 and
closed one outpatient rehabilitation clinic and one long-term
acute care hospital, both located in Louisiana. In October 2004,
we closed one home nursing agency and one outpatient
rehabilitation clinic. In December 2004, we closed one home
nursing agency.
In March 2006, we sold one home nursing agency in Louisiana for
$240,000. In April 2006, we sold one outpatient rehabilitation
clinic for a promissory note totaling $946,000 and closed
another. Both were located in Louisiana. In May 2006, we sold
one long-term acute care hospital located in Louisiana for
$1.2 million. Typically, we sold or closed these locations
because they were not performing according to our expectations.
In July 2007, the Company sold its critical access hospital for
$180,000 and recognized a gain of $31,000, net of tax of
$20,000, on the sale of this hospital. The critical access
hospital was located in Louisiana. Additionally, the Company
closed an Alabama home health pharmacy in September 2007.
The following table is a summary of our acquisitions,
divestitures and internal development activities from
January 1, 2002 through December 31, 2007. This table
does not include the five management services
43
agreements under which we manage the operations of four home
nursing agencies and one inpatient rehabilitation facility.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Acute Care
|
|
|
|
|
|
|
|
|
|
|
|
|
Hospitals, Critical
|
|
|
Specialty and
|
|
|
|
|
|
|
|
|
|
Access Hospitals
|
|
|
Outpatient
|
|
|
|
Home Nursing
|
|
|
|
|
|
and Inpatient
|
|
|
Rehabilitation
|
|
Year
|
|
Agencies
|
|
|
Hospices
|
|
|
Rehabilitation Facilities
|
|
|
Clinics
|
|
|
Total at January 1, 2002
|
|
|
26
|
|
|
|
3
|
|
|
|
1
|
|
|
|
1
|
|
Developed
|
|
|
1
|
|
|
|
|
|
|
|
2
|
|
|
|
|
|
Acquired
|
|
|
7
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2002
|
|
|
34
|
|
|
|
4
|
|
|
|
3
|
|
|
|
1
|
|
Developed
|
|
|
7
|
|
|
|
1
|
|
|
|
2
|
|
|
|
2
|
|
Acquired
|
|
|
2
|
|
|
|
1
|
|
|
|
2
|
|
|
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2003
|
|
|
43
|
|
|
|
6
|
|
|
|
7
|
|
|
|
4
|
|
Developed
|
|
|
7
|
|
|
|
|
|
|
|
2
|
|
|
|
2
|
|
Acquired
|
|
|
6
|
|
|
|
|
|
|
|
|
|
|
|
3
|
|
Divested/Closed
|
|
|
(3
|
)
|
|
|
(3
|
)
|
|
|
(2
|
)
|
|
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2004
|
|
|
53
|
|
|
|
3
|
|
|
|
7
|
|
|
|
7
|
|
Converted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1
|
)
|
Developed
|
|
|
2
|
|
|
|
|
|
|
|
1
|
|
|
|
|
|
Acquired
|
|
|
16
|
|
|
|
1
|
|
|
|
1
|
|
|
|
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2005
|
|
|
71
|
|
|
|
4
|
|
|
|
9
|
|
|
|
8
|
|
Developed
|
|
|
5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired
|
|
|
31
|
|
|
|
2
|
|
|
|
|
|
|
|
1
|
|
Divested/Closed
|
|
|
(1
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2006
|
|
|
106
|
|
|
|
6
|
|
|
|
8
|
|
|
|
6
|
|
Developed
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Acquired
|
|
|
22
|
|
|
|
3
|
|
|
|
|
|
|
|
1
|
|
Divested/Closed
|
|
|
(1
|
)
|
|
|
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total at December 31, 2007
|
|
|
144
|
|
|
|
9
|
|
|
|
7
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recent
Developments
Medicare
Home-Based Services. The base payment rate for
Medicare home nursing in 2007 is $2,339 per
60-day
episode. Since the inception of the prospective payment system
in October 2000, the base episode rate payment has varied due to
both the impact of annual market basket based increases and
Medicare-related legislation. Home health payment rates are
updated annually by either the full home health market basket
percentage, or by the home health market basket percentage as
adjusted by Congress. CMS establishes the home health market
basket index, which measures inflation in the prices of an
appropriate mix of goods and services included in home health
services.
On August 22, 2007, CMS released a final rule finalizing
certain updates and refinements to the basic case-mix adjustment
system. CMS instituted these changes to the home health payment
system to account for reported increases over the past several
years in the home health case-mix, which CMS believes have been
caused by HHAs changes in coding practices and
documentation not by the treatment of more
resource-intense patients. CMS thus designed the new case-mix
model to better predict the resource-intensity required by home
health beneficiaries over the
60-day
episode of care, which would, in turn, improve the accuracy of
44
Medicare reimbursement to HHAs. To effectuate these
improvements, the new model does the following: (1) enables
more precise coding for comorbidities and the differing health
characteristics of longer-stay patients; (2) accounts more
accurately for the impact of rehabilitation services on resource
use; and (3) lessens the risk of overutilization of therapy
services by replacing the single threshold (10 visits per
episode) with three thresholds (at 6, 14 and 20 visits), as well
as a graduated bonus system based on severity between each
threshold.
Also to address the increases in case-mix that CMS views as
unrelated to home health patients clinical conditions, the
final rule released in 2007 implemented a reduction in the
national standardized
60-day
episode payment rate for four years. This 2.75% reduction will
begin in CY 2008 and continue for three years, with a
2.71 percent reduction in the fourth year. Also in the
final rule, CMS finalized the market basket increase of
3.0 percent, a 0.1 percent increase from the proposed
rule. When the market basket update is viewed in conjunction
with (1) the 2.75 percent reduction in
home health payment rates for 2008; (2) the implementation
of the new case-mix adjustment system; (3) the changes in
the wage index; and (4) the other changes made in the final
rule CMS predicts a 0.8 percent increase in
payments for urban HHAs and a 1.77 percent decrease in
payments for rural HHAs. Collectively, these changes in the
final rule (not including the case-mix or wage index
adjustments) decrease the national
60-day
episode payment rate for HHAs from the 2007 level of $2,339.00
to $2,270.32 for 2008.
In June 2007, CMS announced the payment rates for hospice care
furnished from October 1, 2007 through September 30,
2008. These rates are 3.3 percent higher than the rates for
the previous year. In addition, CMS announced that the hospice
cap amount for the year ending October 31, 2007 is
$21,410.04.
Facility-Based Services. We are reimbursed by
Medicare for services provided by our LTACHs under the LTACH
PPS, which was implemented on October 1, 2002. Although CMS
regulations allowed for a phase-in period, we have elected to be
paid solely on the basis of the long-term care DRGs established
by the new system. All of our eligible LTACHs have implemented
the PPS.
On January 22, 2008, CMS published a proposed rule
proposing to set the Medicare payment rates for LTACHs at
$39,076.28 for patient discharges taking place on or after
July 1, 2008 through September 30, 2009. (CMS proposed
in this rule to have a
15-month
rate year for 2009 in order to bring into alignment the timing
of the annual update for the LTACH PPS and the annual update for
the DRGs used for LTACH patients.) CMS also proposed to set the
cost outlier fixed-loss threshold at $21,199. Further, CMS
declined to apply its one-time budget neutrality adjustment, in
accordance with the MMSEA, which prohibits the Secretary of HHS
from making this one-time prospective adjustment until
December 29, 2010. However, in the rule CMS discussed
a methodology it had developed prior to the enactment of the
MMSEA for evaluating whether to propose this one-time adjustment
and it requested comments on its proposed methodology. CMS
indicated that as December 29, 2010 approaches, it plans to
use its finalized methodology to evaluate whether to propose a
one-time budget neutrality adjustment at that time. (CMS also
noted that, had the MMSEA not been enacted, CMS would have
proposed to use the proposed methodology at this time and to
make a one-time adjustment of 3.75 percent to the standard
federal rate.) CMS indicated that other MMSEA LTACH provisions
that were not addressed in the proposed rule (i.e., provisions
relating to the 25 percent rule, the short-stay
outlier policy, the establishment of new facilities and the
expanded review of medical necessity for admission and continued
stay at LTACHs) would be the subject of future regulations.
Medicare requires that outpatient therapy services be reimbursed
on a fee schedule, subject to annual limitations. Outpatient
therapy providers receive a fixed fee for each procedure
performed, adjusted by the geographical area in which the
facility is located. Medicare also imposes annual per Medicare
beneficiary caps. For 2007, these annual caps limited Medicare
coverage to $1,780 for outpatient rehabilitation services
(including both physical therapy and
speech-language
pathology services) and $1,780 for outpatient occupational
health services, including deductible and co-insurance amounts.
These caps were replaced for 2008 by annual cap amounts of
$1,810. Historically, Congress has acted to bypass the cap and
impose a moratorium on its operation. The Deficit Reduction Act
of 2005, the Tax Relief and Health Care Act of 2006 and the
MMSEA all provided for an exceptions process that
effectively prevents application of the caps. The exceptions
process ends June 30, 2008. We are unable to predict
whether Congress will extend the exceptions
45
process beyond June 30, 2008. We cannot be assured that one
or more of our outpatient rehabilitation clinics will not exceed
the caps in the future.
Office
of Inspector General
OIG has a responsibility to report any program and management
problems related to programs such as Medicare to the Secretary
of HHS and Congress. The OIGs duties are carried out
through a nationwide network of audits, investigations and
inspections. Each year, the OIG outlines areas it intends to
study relating to a wide range of providers. In fiscal year
2007, the OIG indicated its intent to study topics relating to,
among others, home health, hospice, long-term care hospitals and
certain outpatient rehabilitation services. No estimate can be
made at this time regarding the impact, if any, of the
OIGs findings.
Components
of Expenses
Cost
of Service Revenue
Our cost of service revenue consists primarily of the following
expenses incurred by our clinical and clerical personnel in our
agencies and facilities:
|
|
|
|
|
salaries and related benefits;
|
|
|
|
transportation, primarily mileage reimbursement; and
|
|
|
|
supplies and services, including payments to contract therapists.
|
General
and Administrative Expenses
Our general and administrative expenses consist primarily of the
following expenses incurred by our home office and
administrative field personnel:
|
|
|
|
|
home office, including salaries and related benefits, insurance,
costs associated with advertising and other marketing
activities, and rent and utilities;
|
|
|
|
supplies and services, including accounting, legal and other
professional services, and office supplies;
|
|
|
|
depreciation; and
|
|
|
|
provision for bad debts.
|
46
2007 and
2006 Operational Data
The following table sets forth, for the period indicated, data
regarding admissions and Medicare admissions to our home-based
segment and patient days and outpatient visits for our
facility-based segment. Certain historical data has been
reclassified in order to present a more comparative analysis of
the statistical data.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Year Ended
|
|
|
|
March 31, 2007
|
|
|
June 30, 2007
|
|
|
September 30, 2007
|
|
|
December 31, 2007
|
|
|
December 31, 2007
|
|
|
Home-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average census
|
|
|
15,712
|
|
|
|
16,283
|
|
|
|
16,862
|
|
|
|
17,914
|
|
|
|
16,635
|
|
Average Medicare census
|
|
|
11,642
|
|
|
|
12,222
|
|
|
|
12,767
|
|
|
|
13,734
|
|
|
|
12,560
|
|
Admissions
|
|
|
10,615
|
|
|
|
10,825
|
|
|
|
11,216
|
|
|
|
11,080
|
|
|
|
43,736
|
|
Medicare admissions
|
|
|
7,333
|
|
|
|
7,500
|
|
|
|
7,819
|
|
|
|
8,099
|
|
|
|
30,751
|
|
Facility-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days
|
|
|
11,674
|
|
|
|
11,453
|
|
|
|
11,202
|
|
|
|
11,489
|
|
|
|
45,818
|
|
Outpatient visits
|
|
|
2,617
|
|
|
|
2,301
|
|
|
|
2,684
|
|
|
|
2,518
|
|
|
|
10,120
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
Three Months
|
|
|
|
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Ended
|
|
|
Year Ended
|
|
|
|
March 31, 2006
|
|
|
June 30, 2006
|
|
|
September 30, 2006
|
|
|
December 31, 2006
|
|
|
December 31, 2006
|
|
|
Home-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average census
|
|
|
9,138
|
|
|
|
9,807
|
|
|
|
13,029
|
|
|
|
14,073
|
|
|
|
12,982
|
|
Average Medicare census
|
|
|
7,251
|
|
|
|
7,944
|
|
|
|
9,537
|
|
|
|
10,429
|
|
|
|
9,573
|
|
Admissions
|
|
|
5,570
|
|
|
|
5,852
|
|
|
|
7,377
|
|
|
|
8,173
|
|
|
|
26,972
|
|
Medicare admissions
|
|
|
4,018
|
|
|
|
4,210
|
|
|
|
5,225
|
|
|
|
5,685
|
|
|
|
19,138
|
|
Facility-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patient days
|
|
|
11,699
|
|
|
|
11,110
|
|
|
|
11,674
|
|
|
|
10,978
|
|
|
|
45,461
|
|
Outpatient visits
|
|
|
8,775
|
|
|
|
5,157
|
|
|
|
4,287
|
|
|
|
2,907
|
|
|
|
21,126
|
|
47
Consolidated
Results of Operations
The following table sets forth, for the periods indicated,
certain items included in our consolidated statement of income
as a percentage of our net service revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Net service revenue
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
Cost of service revenue
|
|
|
51.2
|
|
|
|
51.3
|
|
|
|
53.3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
48.8
|
|
|
|
48.7
|
|
|
|
46.7
|
|
General and administrative expenses
|
|
|
35.8
|
|
|
|
32.5
|
|
|
|
29.9
|
|
Equity-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
2.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
13.0
|
|
|
|
16.2
|
|
|
|
14.3
|
|
Interest expense
|
|
|
0.1
|
|
|
|
0.2
|
|
|
|
0.7
|
|
Non-operating income, including gain on sales of assets
|
|
|
(0.3
|
)
|
|
|
(0.9
|
)
|
|
|
(0.4
|
)
|
Income tax expense
|
|
|
4.1
|
|
|
|
4.9
|
|
|
|
3.9
|
|
Minority interest and cooperative endeavor allocations
|
|
|
2.0
|
|
|
|
2.2
|
|
|
|
2.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
7.1
|
%
|
|
|
9.8
|
%
|
|
|
7.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth, for the periods indicated, net
service revenue, cost of service revenue, general and
administrative expenses, equity-based compensation expense and
operating income by segment. The table also includes data
regarding total admissions and total Medicare admissions for our
home-based services segment and patient days and outpatient
visits for our facility-based services segment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands, except for admissions, patient day and
outpatient visit data)
|
|
|
Home-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
244,107
|
|
|
$
|
164,701
|
|
|
$
|
105,588
|
|
Cost of service revenue
|
|
|
118,451
|
|
|
|
79,070
|
|
|
|
51,255
|
|
General and administrative expenses
|
|
|
88,532
|
|
|
|
55,700
|
|
|
|
33,650
|
|
Equity-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
2,699
|
|
Operating income
|
|
|
37,124
|
|
|
|
29,931
|
|
|
|
17,984
|
|
Average census
|
|
|
16,635
|
|
|
|
12,982
|
|
|
|
7,515
|
|
Average Medicare census
|
|
|
12,560
|
|
|
|
9,573
|
|
|
|
6,177
|
|
Total admissions
|
|
|
43,736
|
|
|
|
26,972
|
|
|
|
16,954
|
|
Total Medicare admissions
|
|
|
30,751
|
|
|
|
19,138
|
|
|
|
12,645
|
|
Facility-Based Services Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net service revenue
|
|
$
|
53,924
|
|
|
$
|
53,834
|
|
|
$
|
50,099
|
|
Cost of service revenue
|
|
|
34,126
|
|
|
|
33,025
|
|
|
|
31,741
|
|
General and administrative expenses
|
|
|
18,263
|
|
|
|
15,415
|
|
|
|
12,869
|
|
Equity-based compensation expense
|
|
|
|
|
|
|
|
|
|
|
1,157
|
|
Operating income
|
|
|
1,535
|
|
|
|
5,394
|
|
|
|
4,332
|
|
Patient days
|
|
|
45,818
|
|
|
|
45,461
|
|
|
|
44,685
|
|
Outpatient visits
|
|
|
10,120
|
|
|
|
21,126
|
|
|
|
41,877
|
|
48
Year
Ended December 31, 2007 Compared to Year Ended
December 31, 2006
Net
Service Revenue
Net service revenue for the year ended December 31, 2007,
increased 36.4 percent to $298.0 million compared with
$218.5 million in 2006. For the year ended
December 31, 2007 and 2006, 81.7 percent and
82.6 percent, respectively, of net service revenue was
derived from Medicare. For the year ended December 31,
2007, home-based services accounted for 81.9 percent of
revenue and facility-based services were 18.1 percent of
revenue compared with 75.4 percent and 24.6 percent,
respectively, for the comparable prior year quarter.
Home-Based Services. Net service revenue from
the home-based services for the year ended December 31,
2007 was $244.1 million, an increase of $79.4 million,
or 48.6 percent, from $164.7 million for the year
ended December 31, 2006. Organic growth in this service
sector was approximately $59.1 million, or
35.9 percent, during the period. Total admissions increased
62.2 percent to 43,736 during the period, versus 26,972 for
the same period in 2006. Organic growth in admissions was
37.9 percent. Average home-based patient census for the
year ended December 31, 2007, increased 28.1 percent
to 16,635 patients as compared with 12,982 patients
for the year ended December 31, 2006. Organic growth in
home-based patient census was 12.3 percent. Approximately
$23.0 million of the increase in net service revenue was
attributable to acquisition or internal development activity
during 2007. An additional $56.4 million increase in net
service revenue was attributable to acquisition or internal
development activity during 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
Organic
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
Total
|
|
|
|
Organic(1)
|
|
|
Growth %
|
|
|
Same Store(2)
|
|
|
De Novo(3)
|
|
|
Acquired(4)
|
|
|
Total
|
|
|
Growth %
|
|
|
Revenue
|
|
$
|
223,828
|
|
|
|
35.9
|
%
|
|
$
|
221,154
|
|
|
$
|
2,674
|
|
|
$
|
20,280
|
|
|
$
|
244,107
|
|
|
|
48.2
|
%
|
Average Census
|
|
|
14,582
|
|
|
|
12.3
|
%
|
|
|
14,285
|
|
|
|
297
|
|
|
|
2,053
|
|
|
|
16,635
|
|
|
|
28.1
|
%
|
Average Medicare Census
|
|
|
10,869
|
|
|
|
13.5
|
%
|
|
|
10,645
|
|
|
|
224
|
|
|
|
1,691
|
|
|
|
12,560
|
|
|
|
31.2
|
%
|
Admissions
|
|
|
37,187
|
|
|
|
37.9
|
%
|
|
|
36,490
|
|
|
|
697
|
|
|
|
6,549
|
|
|
|
43,736
|
|
|
|
62.2
|
%
|
Medicare Admissions
|
|
|
25,901
|
|
|
|
35.3
|
%
|
|
|
25,378
|
|
|
|
523
|
|
|
|
4,850
|
|
|
|
30,751
|
|
|
|
60.7
|
%
|
Episodes
|
|
|
75,790
|
|
|
|
43.5
|
%
|
|
|
75,305
|
|
|
|
485
|
|
|
|
3,872
|
|
|
|
79,662
|
|
|
|
50.8
|
%
|
|
|
|
(1) |
|
Organic combination of same store and de novo. |
|
(2) |
|
Same store location that has been in service with
the Company for at greater than 12 months. |
|
(3) |
|
De Novo internally developed location that has been
in service with the Company for 12 months or less. |
|
(4) |
|
Acquired purchased location that has been in service
with the Company for 12 months or less. |
Facility-Based Services. Net service revenue
from the facility-based services for the year ended
December 31, 2007, increased $100,000, or 0.2 percent,
to $53.9 million compared with $53.8 million for the
year ended December 31, 2006. Organic growth made up the
total growth in this service sector during the period. The
increase in net service revenue was due in part to an increase
in patient days of 0.8 percent to 45,818 in the year ended
December 31, 2007, from 45,461 in the year ended
December 31, 2006.
Cost
of Service Revenue
Cost of service revenue for the year ended December 31,
2007 was $152.6 million, an increase of $40.5 million,
or 36.1 percent, from $112.1 million for the year
ended December 31, 2006. Cost of service revenue
represented approximately 51.2 percent and
51.3 percent of our net service revenue for the years ended
December 31, 2007 and 2006, respectively.
Home-Based Services. Cost of service revenue
from the home-based services for the year ended
December 31, 2007 was $118.5 million, an increase of
$39.4 million, or 49.8 percent, from
$79.1 million for the year ended December 31, 2006.
Approximately $33.5 million of this increase resulted from
an increase in salaries and benefits, of which
$26.9 million was incurred as a result of acquisition or
development activity during 2006 and $13.2 million was
incurred as a result of acquisition or development activity
during 2007. The growth in salaries and benefits expense due to
acquisitions and developments is offset by a decrease in
49
the salaries and benefits expense in the same store
locations by approximately $6.6 million. The remaining
increase in cost of service revenue was attributable to
increases in supplies and services expense and transportation
expense. Supplies and service expense increased approximately
$2.8 million in 2007 as compared to 2006. Supplies and
services expense increased $2.0 million related to
acquisitions and developments that occurred in 2006 and
$1.3 million related to acquisitions and developments that
occurred in 2007. The growth in supplies and services expense
due to acquisitions and developments is offset by a decrease in
the supplies and services expense in the same store
locations by approximately $495,000. Transportation expense
increased approximately $3.0 million in 2007 as compared to
2006. Transportation expense increased $2.4 million related
to acquisitions and developments that occurred in 2006 and
$1.1 million related to acquisitions and developments that
occurred in 2007. The growth in transportation expense due to
acquisitions and developments is offset by a decrease in the
transportation expense in the same store locations
by approximately $531,000.
Cost of service revenue in the home-based segment for the year
ended December 31, 2007 represented 48.5 percent of
our net service revenue compared to 48.0 percent during the
year ended December 31, 2006.
Facility-Based Services. Cost of service
revenue from the facility-based services for the year ended
December 31, 2007 was $34.1 million, an increase of
$1.1 million, or 3.3 percent, from $33.0 million
for the year ended December 31, 2006. The entire increase
in cost of service revenue from facility-based services was due
primarily to an increase in supplies and services resulting from
an increase in patient days.
Cost of service revenue in the facility-based segment for the
year ended December 31, 2007 represented 63.3 percent
of our net service revenue compared to 61.3 percent during
the year ended December 31, 2006.
General
and Administrative Expenses
General and administrative expenses for the year ended
December 31, 2007 were $106.8 million, an increase of
$35.7 million, or 50.2 percent, from
$71.1 million for the year ended December 31, 2006.
General and administrative expenses represented approximately
35.8 percent and 32.5 percent of our net service
revenue for the years ended December 31, 2007 and 2006,
respectively.
Home-Based Services. General and
administrative expenses from the home-based services for the
year ended December 31, 2007 were $88.5 million, an
increase of $32.8 million, or 58.9 percent, from
$55.7 million for the year ended December 31, 2006.
Approximately $20.2 million of the increase in general and
administrative expenses was due to acquisitions that occurred in
2006 and approximately $9.6 million of the increase in
general and administrative expenses was due to acquisitions that
occurred in 2007. General and administrative expenses in the
same store locations decreased by $2.4 million
and were offset by an increase in the provision for bad debts of
$6.4 million in 2007 as compared to 2006.
General and administrative expenses in the home-based segment
for the year ended December 31, 2007 represented
36.3 percent of our net service revenue compared to
33.8 percent during the year ended December 31, 2006.
Facility-Based Services. General and
administrative expenses from the facility-based services for the
year ended December 31, 2007 were $18.3 million, an
increase of $2.8 million, or 18.5 percent, from
$15.4 million for the year ended December 31, 2006.
Provision for bad debts increased $1.8 million in 2007 as
compared to 2006.
General and administrative expenses in the facility-based
segment for the year ended December 31, 2007 represented
33.9 percent of our net service revenue compared to
28.6 percent during the year ended December 31, 2006.
Non-operating
income
Non-operating income for the year ended December 31, 2007
was $1.1 million, a decrease of approximately $900,000 from
$2.0 million for the year ended December 31, 2006.
Non-operating income in
50
2006 includes $1.0 million in proceeds received from the
life insurance policy on our former CFO who died in a plane
crash after retiring from the Company.
Income
Tax Expense
The effective tax rates for the years ended December 31,
2007 and 2006 were 36.4 percent and 33.6 percent,
respectively. The effective tax rate for the year ended
December 31, 2007 is higher due to a lower credit related
to the Gulf Opportunity Act in 2007 than in 2006 and the effect
of income from insurance proceeds in 2006, which are not taxable.
Minority
Interest and Cooperative Endeavor Allocations
The minority interest and cooperative endeavor allocations
expense for the year ended December 31, 2007 was
$6.0 million, an increase of $1.2 million, compared to
$4.8 million for the year ended December 31, 2006.
Minority interest and cooperative endeavor expense varies
depending on the operations of each joint venture.
Discontinued
Operations
Revenue from discontinued operations for the year ended
December 31, 2007 and 2006 was $3.0 million and
$5.3 million, respectively. Costs, expenses and minority
interest and cooperative endeavor allocations were
$5.4 million and $7.6 million, respectively, for the
year ended December 31, 2007 and 2006. For the year ended
December 31, 2007, the loss from discontinued operations
was $1.7 million as compared to a loss from discontinued
operations of $1.5 million for the same period in 2006. In
2007, we placed a home health pharmacy and a critical access
hospital into discontinued operations and recorded a valuation
allowance of $504,000 in the deferred tax asset generated by the
tax net operating loss carry forward of the pharmacy. The home
health pharmacy was closed on September 30, 2007 and the
sale of the hospital was completed on July 1, 2007.
Year
Ended December 31, 2006 Compared to Year Ended
December 31, 2005
Net
Service Revenue
Net service revenue for the year ended December 31, 2006
was $218.5 million, an increase of $62.8 million, or
40.4 percent, from $155.7 million in 2005. For the
year ended December 31, 2006 and 2005, 82.6 percent
and 86.4 percent, respectively, of net service revenue was
derived from Medicare. For the year ended December 31,
2006, home-based services accounted for 75.4 percent of
revenue and facility-based services was 24.6 percent of
revenue compared with 67.8 percent and 32.2 percent,
respectively, for the comparable prior year period.
Home-Based Services. Net service revenue from
the home-based services for the year ended December 31,
2006 was $164.7 million, an increase of $59.1 million,
or 56.0 percent, from $105.6 million for the year
ended December 31, 2005. Organic growth in this service
sector was approximately $30.1 million, or
29.3 percent, during the period. Total admissions increased
59.1 percent to 26,972 during the period, versus 16,954 for
the same period in 2005. Organic growth in admissions was
10.6 percent. Average home-based patient census for the
year ended December 31, 2006, increased 72.7 percent
to 12,982 patients as compared with 7,515 patients for
the year ended December 31, 2005. Organic growth in
home-based patient census was 26.4 percent. Approximately
$26.2 million of the increase in net service revenue was
attributable to acquisition or internal development activity
during 2005. An additional $24.0 million increase in net
service revenue was attributable to acquisition or internal
development activity during 2006. The remaining increase of
approximately $8.9 million reflects our internal growth.
The increase in net service revenue from internal growth
resulted in part from a 26.4 percent increase in organic
census in the year ended December 31, 2006 as compared to
2005. Improvements in case mix and an increase in therapy
utilization within our home health episodes also contributed to
the increase.
51
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2006
|
|
|
Organic
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
Total
|
|
|
|
Organic(1)
|
|
|
Growth %
|
|
|
Same Store(2)
|
|
|
De Novo(3)
|
|
|
Acquired(4)
|
|
|
Total
|
|
|
Growth %
|
|
|
Revenue
|
|
$
|
136,508
|
|
|
|
29.3
|
%
|
|
$
|
131,945
|
|
|
$
|
4,563
|
|
|
$
|
28,193
|
|
|
$
|
164,701
|
|
|
|
56.0
|
%
|
Average Census
|
|
|
9,497
|
|
|
|
26.4
|
%
|
|
|
9,248
|
|
|
|
249
|
|
|
|
3,485
|
|
|
|
12,982
|
|
|
|
72.7
|
%
|
Average Medicare Census
|
|
|
7,386
|
|
|
|
19.6
|
%
|
|
|
7,176
|
|
|
|
210
|
|
|
|
2,187
|
|
|
|
9,573
|
|
|
|
55.0
|
%
|
Admissions
|
|
|
18,755
|
|
|
|
10.6
|
%
|
|
|
17,765
|
|
|
|
990
|
|
|
|
8,217
|
|
|
|
26,972
|
|
|
|
59.1
|
%
|
Medicare Admissions
|
|
|
14,089
|
|
|
|
11.4
|
%
|
|
|
13,364
|
|
|
|
725
|
|
|
|
5,049
|
|
|
|
19,138
|
|
|
|
51.3
|
%
|
Episodes
|
|
|
46,969
|
|
|
|
24.2
|
%
|
|
|
45,589
|
|
|
|
1,380
|
|
|
|
5,844
|
|
|
|
52,813
|
|
|
|
39.7
|
%
|
|
|
|
(1) |
|
Organic combination of same store and de novo. |
|
(2) |
|
Same store location that has been in service with
the Company for greater than 12 months. |
|
(3) |
|
De Novo internally developed location that has been
in service with the Company for 12 months or less. |
|
(4) |
|
Acquired purchased location that has been in service
with the Company for 12 months or less. |
Facility-Based Services. Net service revenue
from the facility-based services for the year ended
December 31, 2006, increased $3.7 million, or
7.5 percent, to $53.8 million compared with
$50.1 million for the year ended December 31, 2005.
Organic growth made up the total growth in this service sector
during the period. The increase in net service revenue was due
in part to an increase in patient days of 1.7 percent to
45,461 in the year ended December 31, 2006, from 44,685 in
the year ended December 31, 2005. Outpatient visits
decreased 50.0 percent to 21,126 at December 31, 2006,
compared with 41,877 for the year ended December 31, 2005,
due to the sale of one of our outpatient clinics and the closure
of another clinic on April 1, 2006. Approximately
$2.1 million of the increase in net service revenue was
attributable to acquisition activity during 2005. The remaining
increase of approximately $1.6 million reflects our
internal growth.
Cost
of Service Revenue
Cost of service revenue for the year ended December 31,
2006 was $112.1 million, an increase of $29.1 million,
or 35.1 percent, from $83.0 million for the year ended
December 31, 2005. Cost of service revenue represented
approximately 51.3 percent and 53.3 percent of our net
service revenue for the years ended December 31, 2006 and
2005, respectively.
Home-Based Services. Cost of service revenue
from the home-based services for the year ended
December 31, 2006 was $79.0 million, an increase of
$27.8 million, or 54.3 percent, from
$51.3 million for the year ended December 31, 2005.
Approximately $23.0 million of this increase resulted from
an increase in salaries and benefits, of which
$12.0 million was incurred as a result of acquisition or
development activity during 2005 and $12.5 million was
incurred as a result of acquisition or development activity
during 2006. Salaries and benefits expense decreased
approximately $1.5 million due to internal growth. Supplies
and services expense and transportation expense contributed
$2.7 million and $2.1 million, respectively, to the
increase in cost of service revenue.
Cost of service revenue in the home-based segment for the year
ended December 31, 2006 represented 48.0 percent of
our net service revenue compared to 48.5 percent during the
year ended December 31, 2005.
Facility-Based Services. Cost of service
revenue from the facility-based services for the year ended
December 31, 2006 was $33.0 million, an increase of
$1.3 million, or 4.0 percent, from $31.7 million
for the year ended December 31, 2005. Approximately
$1.0 million of this increase resulted from an increase in
salaries and benefits. The $600,000 increase in salaries and
benefits expense resulted from internal growth within our
facility-based services segment. Supplies and services expense
contributed approximately $300,000 of the increase in cost of
service revenue.
52
Cost of service revenue in the facility-based segment for the
year ended December 31, 2006 represented 61.3 percent
of our net service revenue compared to 63.4 percent during
the year ended December 31, 2005.
General
and Administrative Expenses
General and administrative expenses for the year ended
December 31, 2006 were $71.1 million, an increase of
$24.6 million, or 52.9 percent, from
$46.5 million for the year ended December 31, 2005.
General and administrative expenses represented approximately
32.5 percent and 29.9 percent of our net service
revenue for the years ended December 31, 2006 and 2005,
respectively.
Home-Based Services. General and
administrative expenses from the home-based services for the
year ended December 31, 2006 were $55.7 million, an
increase of $22.0 million, or 65.5 percent, from
$33.7 million for the year ended December 31, 2005.
Approximately $10.3 million of this increase was
attributable to acquisition or internal development activity
during 2005. Internal growth accounted for approximately
$4.4 million of the increase in general and administrative
expense and the remaining $7.3 million was due to
acquisition and internal development activity during the 2006
period. Included in these increases is an increase to bad debt
expense of $800,000 related to receivables acquired in business
combinations in late 2005 and 2006.
General and administrative expenses in the home-based segment
for the year ended December 31, 2006 represented
33.8 percent of our net service revenue compared to
31.9 percent during the year ended December 31, 2005.
Facility-Based Services. General and
administrative expenses from the facility-based services for the
year ended December 31, 2006 were $15.4 million, an
increase of $2.5 million, or 19.8 percent, from
$12.9 million for the year ended December 31, 2005.
Approximately $1.7 million of the increase was attributable
to the increased acquisition and internal development activity
during the 2005 period and the remaining $800,000 increase is
due to internal growth.
General and administrative expenses in the facility-based
segment for the year ended December 31, 2006 represented
28.6 percent of our net service revenue compared to
25.7 percent during the year ended December 31, 2005.
Equity-Based
Compensation Expense
Equity-based compensation expense for the year ended
December 31, 2005 was $3.9 million. This was related
to the mark-to-market valuation adjustment for the KEEP Units in
conjunction with the initial public offering. Of the
$3.9 million expense we incurred in the year ended
December 31, 2005, approximately $565,000 was attributable
to cost of service revenue and $3.3 million attributable to
general and administrative expenses. There was no equity-based
compensation expense for the year ended December 31, 2006.
Non-operating
income
Non-operating income for the year ended December 31, 2006
was $2.0 million, an increase of $1.4 million from
$600,000 for the year ended December 31, 2005. The increase
in non-operating income is due primarily to $1.0 million in
proceeds received from the life insurance policy on our former
CFO who died in a plane crash after retiring from the Company.
Income
Tax Expense
The effective tax rates for the years ended December 31,
2006 and 2005 were 33.6 percent and 35.0 percent,
respectively. The effective tax rate for the year ended
December 31, 2006 decreased due to $1.0 million credit
related to the Gulf Opportunity Act. The effective tax rate for
the year ended December 31, 2005 was effected by an income
tax benefit of $342,000 related to a $900,000 equity-based
compensation charge stemming from shares issued by one of the
Companys principal shareholders to an officer of the
Company in 2001. At the time, the Company did not believe it
would be able to deduct the equity-based compensation charge for
income tax purposes. In conjunction with the initial public
offering, the Company
53
determined that it would be able to deduct the $900,000
equity-based compensation charge, and as a result, recognized an
income tax benefit associated with that charge of $342,000 in
2005.
Minority
Interest and Cooperative Endeavor Allocations
The minority interest and cooperative endeavor allocations
expense for the year ended December 31, 2006 was
$4.8 million, an increase of $300,000, compared to
$4.5 million for the year ended December 31, 2005.
Minority interest and cooperative endeavor expense varies
depending on the operations of each joint venture.
Liquidity
and Capital Resources
Our principal source of liquidity for our operating activities
is the collection of our accounts receivable, most of which are
collected from governmental and third-party commercial payors.
Our reported cash flows from operating activities are impacted
by various external and internal factors, including the
following:
|
|
|
|
|
Operating Results Our net income has a
significant impact on our operating cash flows. Any significant
increase or decrease in our net income could have a material
impact on our operating cash flows.
|
|
|
|
Start Up Costs Following the completion of an
acquisition, we suspend billing Medicare and Medicaid claims
until we receive the change of ownership and electronic funds
transfer approvals. We also generally incur substantial start up
costs in order to implement our business strategy. There is
generally a delay between our expenditure of these start up
costs and the increase in net service revenue and subsequent
cash collections, which adversely affects our cash flows from
operating activities.
|
|
|
|
Timing of Payroll Our employees are paid
bi-weekly on Fridays; therefore, operating cash flows decline in
reporting periods that end on a Friday. Conversely, for those
reporting periods ending on a day other than Friday, our cash
flows are higher because we have not yet paid our payroll.
|
|
|
|
Medical Insurance Plan Funding We are
self-funded for medical insurance purposes. Any significant
changes in the amount of insurance claims submitted could have a
direct impact on our operating cash flows.
|
|
|
|
Medical Supplies A significant expense
associated with our business is the cost of medical supplies.
Any increase in the cost of medical supplies, or in the use of
medical supplies by our patients, could have a material impact
on our operating cash flows.
|
Cash used in investing activities is primarily for acquisitions
of home nursing agencies, while cash provided by financing
activities is derived from the proceeds from our issuance of
common stock.
Operating activities during the year ended December 31,
2007 provided $12.1 million in cash compared to
$21.8 million for year ended December 31, 2005. Net
income provided cash of $19.6 million. Non-cash items such
as depreciation and amortization, provision for bad debts,
directors restricted stock expense, minority interest in
earnings of subsidiaries, deferred income taxes and gain on sale
of assets totaled $23.5 million. The decrease in operating
cash from 2006 to 2007 is due primarily to an increase in
accounts receivable stemming from an increase in net service
revenue.
Days sales outstanding (DSO) for the year ended
December 31, 2007, was 73 days compared to
68 days for the same period in 2006. DSO, when adjusted for
acquisitions and unbilled accounts receivables, was
63 days. The adjustment takes into account
$8.8 million of unbilled receivables that the Company is
delayed in billing due to the lag time in receiving the change
of ownership after acquiring companies. For the comparable
period in 2006, adjusted DSO was 60 days, taking into
account $5.8 million in unbilled accounts receivable.
Investing activities used $32.3 million and
$27.5 million in cash for the year ended December 31,
2007 and 2006, respectively. Of the $32.3 million used in
investing activities in 2007, $29.0 million was used in the
54
costs of acquisitions. Of the $27.5 million used in
investing activities in 2006 $25.0 million was used in the
cost of acquisitions.
Financing activities used $5.6 million in cash in the year
ended December 31, 2007 and provided $15.2 million in
cash in the year ended December 31, 2006. Cash used in
financing activities in 2007 was due primarily to minority
interest distributions. Cash provided by financing activities in
2006 included $21.0 million in proceeds from the follow-on
public offering. This increase was offset by cash used in
financing activities in the year ended December 31, 2006
which included net principal payments on debt and capital leases
of $1.6 million, offering costs incurred of $300,000 and
minority interest distributions of $4.2 million.
At December 31, 2007, we had working capital of
$61.0 million compared to $68.5 million at
December 31, 2006, a decrease of $7.5 million. The
decrease in working capital was due primarily to a decrease in
cash primarily resulting from growth in receivables.
Indebtedness
Our total long-term indebtedness was $3.4 million at
December 31, 2007 and $3.8 million at
December 31, 2006, including the current portions of
$521,000 and $639,000.
On February 20, 2008, the Company terminated the credit
facility agreement with GMAC (Former Credit Facility) and
entered into a new credit facility agreement with Capital One,
National Association (New Credit Facility). Under the terms of
the Former Credit Facility, which was in effect at
December 31, 2007, the Company was able to be advanced
funds up to a defined limit of eligible accounts receivable not
to exceed the borrowing limit. At December 31, 2007 the
borrowing limit was $22,500,000 and no amounts were outstanding.
Interest accrues on any outstanding amounts at a varying rate
and was based on the Wells Fargo Bank, N.A. prime rate plus
1.5 percent (9.02 percent at December 31, 2007).
The annual facility fee was 0.5 percent of the total
availability. The Former Credit Facility was due to expire on
April 15, 2010. As a result of terminating the Former
Credit Facility, the Company paid a termination fee of $225,000.
On February 20, 2008, the Company entered into the New
Credit Facility, which was amended on March 6, 2008 to
include an additional lender, First Tennessee Bank, N.A.,
increase the line of credit and amend the Eurodollar Margin for
each Eurodollar Loan (as those terms are defined in the New
Credit Facility) issued under the New Credit Facility. The New
Credit Facility is unsecured, has a term of two years and
provides for a line of credit of $37.5 million (with a
letter of credit sub-limit equal to $2.0 million). Upon
written notice by the Company to the Agent, the Agent will
endeavor to obtain additional lending commitments from other
financial institutions to increase the line of credit to
$50.0 million. The annual facility fee is
0.125 percent of the total availability. The interest rate
for borrowings under the New Credit Agreement is a function of
the prime rate (Base Rate) or the eurodollar rate (Eurodollar),
as elected by the Company, plus the applicable margin as set
forth below:
|
|
|
|
|
|
|
|
|
|
|
Eurodollar
|
|
|
Base Rate
|
|
Leverage Ratio
|
|
Margin
|
|
|
Margin
|
|
|
< 1.00:1.00
|
|
|
1.75
|
%
|
|
|
(0.25
|
)%
|
³1.00:1.00
< 1.50:100
|
|
|
2.00
|
%
|
|
|
0
|
%
|
³1.50:1.00
< 2.00:1.00
|
|
|
2.25
|
%
|
|
|
0
|
%
|
³2.00:1.00
|
|
|
2.50
|
%
|
|
|
0
|
%
|
Our credit facility contains customary affirmative, negative and
financial covenants. For example, we are restricted in incurring
additional debt, disposing of assets, making investments and
allowing fundamental changes to our business or organization.
Under the New Credit Facility we are also required to meet
certain financial covenants with respect to fixed charge
coverage, leverage, working capital and liabilities to tangible
net worth ratios.
Our credit facility also contains customary events of default.
These include bankruptcy and other insolvency events,
cross-defaults to other debt agreements, a change in control
involving us or any subsidiary guarantor (other than due to this
offering) and the failure to comply with certain covenants.
55
The New Credit Facility is to be guaranteed by all of the
Companys wholly-owned subsidiaries. The New Credit
Facility shall be guaranteed by certain non-wholly owned
subsidiaries of the Company within 60 days following the
date of the New Credit Facility. In the event that any
non-wholly owned subsidiary of the Company does not guaranty the
New Credit Facility, the Company will pledge its interest in
such subsidiary to Capital One, National Association, as agent,
as security for the New Credit Facility.
Contingent
Convertible Minority Interests
During 2004, in conjunction with the acquisition/sale of joint
venture interests, the Company entered into agreements with
minority interest holders in three of its majority owned
subsidiaries that allowed these minority interest holders to put
their minority interests to the Company. Only one of these
agreements remains as of December 31, 2007. The put option
allows the minority interest holder to exchange their minority
interest for cash based on EBITDA and the Companys stock
price. As of March 5, 2008, approximately 76.5 percent
of the minority interest holders have converted their minority
interests to cash.
The above put/redemption options and exchange agreements have
been presented in the historical financial statements under the
guidance in Accounting Series Release (ASR) No. 268
and Emerging Issues Task Force (EITF) Topic D-98, which
generally require a public companys stock subject to
redemption requirements that are outside the control of the
issuer to be excluded from the caption stockholders
equity and presented separately in the issuers
balance sheet. Under EITF Topic D-98, once it becomes probable
that the minority interest would become redeemable; the minority
interest should be adjusted to its current redemption amount,
marked to market.
In connection with the partial redemption of certain minority
interest in the year ended December 31, 2006, the Company
decreased minority interest by approximately $1,039,000 and
increased retained earnings by the same amount. Simultaneously,
the Company recorded goodwill of $979,000 to represent the value
of the minority interest redeemed. Also for the year ended
December 31, 2006, the Company recorded a mark to market
benefit of $124,000.
There were no redemptions in the year ended December 31,
2007. In the year ended December 31, 2007, the Company
recorded a mark-to-market benefit of $194,000 for these
redeemable minority interests. Included in minority interests
subject to exchange contracts
and/or put
options liability at December 30, 2007 and 2006 is $121,000
and $317,000, respectively, related to these redeemable minority
interests.
Commitments
The following table discloses aggregate information about our
contractual obligations (excludes interest cost) and the periods
in which payments are due as of December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payment due by period
|
|
|
|
|
|
|
Less Than
|
|
|
|
|
|
|
|
|
More Than
|
|
Contractual Cash Obligation
|
|
Total
|
|
|
1 Year
|
|
|
1-3 Years
|
|
|
3-5 Years
|
|
|
5 Years
|
|
|
|
(In thousands)
|
|
|
Long-term debt (includes line of credit)
|
|
$
|
3,280
|
|
|
$
|
433
|
|
|
$
|
717
|
|
|
$
|
494
|
|
|
$
|
1,636
|
|
Capital lease obligations
|
|
|
151
|
|
|
|
88
|
|
|
|
63
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
|
15,634
|
|
|
|
6,519
|
|
|
|
5,425
|
|
|
|
2,074
|
|
|
|
1,616
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total contractual cash obligations
|
|
$
|
19,065
|
|
|
$
|
7,040
|
|
|
$
|
6,205
|
|
|
$
|
2,568
|
|
|
$
|
3,252
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On February 20, 2008, the Company entered into a Loan
Agreement with Capital One, National Association for a term note
in the amount of $5,050,000 for the purchase of a 1999 Cessna
560 aircraft. The term note is payable in 84 monthly
installments of principal plus interest commencing on
March 6, 2008 and ending with the final payment on
February 6, 2015. The term note will bear the interest at
the LIBOR Rate (adjusted monthly) plus the Applicable Margin of
1.9 percent.
56
Off-Balance
Sheet Arrangements
We do not currently have any off-balance sheet arrangements with
unconsolidated entities, financial partnerships or entities
often referred to as structured finance or special purpose
entities, which would have been established for the purpose of
facilitating off-balance sheet arrangements or other
contractually narrow or limited purposes. In addition, we do not
engage in trading activities involving non-exchange traded
contracts. As such, we are not materially exposed to any
financing, liquidity, market or credit risk that could arise if
we had engaged in these relationships.
Critical
Accounting Policies
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements and the reported revenue and expenses
during the reported period. Actual results could differ from
those estimates. Changes in the accounting estimates are
reasonably likely to occur from period to period. Accordingly,
actual results could differ materially from our estimates. To
the extent that there are material differences between these
estimates and actual results, our financial condition or results
of operations will be affected. We base our estimates on past
experience and other assumptions that we believe are reasonable
under the circumstances and we evaluate these estimates on an
ongoing basis. We refer to accounting estimates of this type as
critical accounting policies and estimates, which we discuss
further below.
Principles
of Consolidation
Our consolidated financial statements include all subsidiaries
and entities controlled by us. We define control as
ownership of a majority of the voting interest of an entity. Our
consolidated financial statements also include entities in which
we absorb a majority of the entitys expected losses,
receive a majority of the entitys expected residual
returns, or both, as a result of ownership, contractual or other
financial interests in the entity.
The decision to consolidate or not consolidate an entity would
not impact our earnings, as we would include our portion of
these entities profits and losses either through
consolidation or the equity method of accounting if we did not
consolidate.
All significant intercompany accounts and transactions have been
eliminated in consolidation. Business combinations accounted for
as purchases have been included in the consolidated financial
statements from the respective dates of acquisition.
The following table summarizes the percentage of net service
revenue earned by type of ownership or relationship we had with
the operating entity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Wholly owned subsidiaries
|
|
|
46.4
|
%
|
|
|
41.7
|
%
|
|
|
36.0
|
%
|
Equity joint ventures
|
|
|
43.7
|
|
|
|
46.3
|
|
|
|
49.7
|
|
License leasing arrangements
|
|
|
7.8
|
|
|
|
9.5
|
|
|
|
11.3
|
|
Management services
|
|
|
2.1
|
|
|
|
2.5
|
|
|
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following discussion sets forth our consolidation policy
with respect to our equity joint ventures, cooperative
endeavors, license leasing arrangements and management services
agreements.
Equity
Joint Ventures
Our equity joint ventures are structured as limited liability
companies in which we typically own a majority equity interest
ranging from 51.0 to 99.0 percent. Each member of all but
one of our equity joint ventures participates in profits and
losses in proportion to their equity interests. We have one
equity joint
57
venture partner whose participation in losses is limited. We
consolidate these entities, as we absorb a majority of the
entities expected losses, receive a majority of the
entities expected residual returns and generally have
voting control.
License
Leasing Arrangements
We lease, through our wholly owned subsidiaries, home health
licenses necessary to operate certain of our home nursing
agencies. As with our wholly owned subsidiaries, we own
100.0 percent of the equity interests of these entities and
consolidate them based on such ownership, as well as our right
to receive a majority of the entities expected residual
returns and our obligation to absorb a majority of the
entities expected losses.
Management
Services
We have various management services agreements under which we
manage certain operations of agencies and facilities. We do not
consolidate these agencies or facilities, as we do not have an
equity interest and do not have a right to receive a majority of
the agencies or facilities expected residual returns
or an obligation to absorb a majority of the agencies or
facilities expected losses.
Revenue
Recognition
We report net service revenue at the estimated net realizable
amount due from Medicare, Medicaid, commercial insurance,
managed care payors, patients and others for services rendered.
Under Medicare, our home nursing patients are classified into a
home health resource group prior to the receipt of services.
Based on this home health resource group we are entitled to
receive a prospective Medicare payment for delivering care over
a 60 day period. Medicare adjusts these prospective
payments based on a variety of factors, such as low utilization,
patient transfers, changes in condition and the level of
services provided. In calculating our reported net service
revenue from our home nursing services, we adjust the
prospective Medicare payments by an estimate of the adjustments.
We calculate the adjustments based on a rolling average of these
types of adjustments for claims paid during the preceding three
months. Historically we have not made any material revisions to
reflect differences between our estimate of the Medicare
adjustments and the actual Medicare adjustments. For our home
nursing services, we recognize revenue based on the number of
days elapsed during the episode of care.
Under Medicare, patients in our long-term acute care facilities
are classified into long-term care diagnosis-related groups.
Based on this classification, we are then entitled to receive a
fixed payment from Medicare. This fixed payment is also subject
to adjustment by Medicare due to factors such as short stays. In
calculating our reported net service revenue for services
provided in our long-term acute care hospitals, we reduce the
prospective payment amounts by an estimate of the adjustments.
We calculate the adjustment based on a historical average of
these types of adjustments for claims paid during the preceding
three months. For our long-term acute care hospitals we
recognize revenue as services are provided.
For hospice services we are paid by Medicare under a prospective
payment system. We receive one of four predetermined daily or
hourly rates based upon the level of care we furnish. We record
net service revenue from our hospice services based on the daily
or hourly rate. We recognize revenue for hospice as services are
provided.
Under Medicare we are reimbursed for our rehabilitation services
based on a fee schedule for services provided adjusted by the
geographical area in which the facility is located. We recognize
revenue as these services are provided.
Our Medicaid reimbursement is based on a predetermined fee
schedule applied to each service we provide. Therefore, we
recognize revenue for Medicaid services as services are provided
based on this fee schedule. Our managed care payors reimburse us
in a manner similar to either Medicare or Medicaid. Accordingly,
we recognize revenue from our managed care payors in the same
manner as we recognize revenue from Medicare or Medicaid.
58
We record management services revenue as services are provided
in accordance with the various management services agreements to
which we are a party. The agreements generally call for us to
provide billing, management and other consulting services suited
to and designed for the efficient operation of the applicable
home nursing agency or inpatient rehabilitation facility. We are
responsible for the costs associated with the locations and
personnel required for the provision of the services. We are
generally compensated based on a percentage of net billings or
an established base fee. In addition, for certain of the
management agreements, we may earn incentive compensation.
Accounts
Receivable and Allowances for Uncollectible
Accounts
We report accounts receivable net of estimated allowances for
uncollectible accounts and adjustments. Accounts receivable are
uncollateralized and primarily consist of amounts due from
third-party payors and patients who receive final bills once all
documentation is completed. Using detailed accounts receivable
aging reports produced by our billing system, our collections
department monitors and pursues payment. We have adopted a
charity care policy that provides the criteria a patient must
meet in order to be considered indigent and his or her balance
considered for charity write-off. All other accounts that are
deemed uncollectible are turned over to an outside collection
agency for further collection efforts. To provide for accounts
receivable that could become uncollectible in the future, we
establish an allowance for uncollectible accounts to reduce the
carrying amount of such receivables to their estimated net
realizable value. The credit risk for concentrations of
receivables is limited due to the significance of Medicare as
the primary payor. The amount of the provision for bad debts is
based upon our assessment of historical and expected net
collections, aging of receivables, business and economic
conditions, trends in government reimbursement and other
collection indicators.
A portion of the estimated Medicare prospective payment system
reimbursement from each submitted home nursing episode is
received in the form of a request for accelerated payment (RAP)
before all services are rendered. The estimated episodic payment
is billed at the commencement of the episode. We receive a RAP
for 60.0 percent of the estimated reimbursement at the
initial billing for the initial episode of care per patient and
the remaining reimbursement is received upon completion of the
episode. For any subsequent episodes of care contiguous with the
first episode of care for a patient we receive a RAP for
50.0 percent of the estimated reimbursement at initial
billing. The remaining 50.0 percent reimbursement is
received upon completion of the episode. We have earned net
service revenue in excess of billings rendered to Medicare. Only
a nominal portion of the amounts due to the Medicare program
represent cash collected in advance of providing services.
Our Medicare population is paid at a prospectively set amount
that can be determined at the time services are rendered. Our
Medicaid reimbursement is based on a predetermined fee schedule
applied to each individual service we provide. Our managed care
contracts are structured similar to either the Medicare or
Medicaid payment methodologies. Because of our payor mix, we are
able to calculate our actual amount due at the patient level and
adjust the gross charges down to the actual amount at the time
of billing. This negates the need for an estimated contractual
allowance to be booked at the time we report net service revenue
for each reporting period.
At December 31, 2007, our allowance for uncollectible
accounts, as a percentage of patient accounts receivable, was
approximately 11.3 percent. For the year ended
December 31, 2007, the provision for doubtful accounts
increased to 4.1 percent of net service revenue compared to
1.9 percent of net service revenue for the same period in
2006. Adverse changes in general economic conditions, billing
operations, payor mix, or trends in federal or state
governmental coverage could affect our collection of accounts
receivable, cash flows and results of operations.
59
The following table sets forth our aging of accounts receivable
(based on the billing date) as of December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payor
|
|
0-30
|
|
|
31-60
|
|
|
61-90
|
|
|
91-120
|
|
|
121-150
|
|
|
151-180
|
|
|
181-240
|
|
|
241+
|
|
|
Total
|
|
|
Medicare
|
|
$
|
20,326
|
|
|
$
|
4,904
|
|
|
$
|
4,678
|
|
|
$
|
3,751
|
|
|
$
|
2,915
|
|
|
$
|
3,722
|
|
|
$
|
861
|
|
|
$
|
3,629
|
|
|
$
|
44,786
|
|
Medicaid
|
|
|
7,292
|
|
|
|
1,111
|
|
|
|
938
|
|
|
|
840
|
|
|
|
958
|
|
|
|
1,040
|
|
|
|
309
|
|
|
|
3,083
|
|
|
|
15,571
|
|
Other
|
|
|
3,228
|
|
|
|
2,799
|
|
|
|
2,321
|
|
|
|
1,012
|
|
|
|
1,151
|
|
|
|
1,113
|
|
|
|
1,051
|
|
|
|
5,954
|
|
|
|
18,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
30,846
|
|
|
$
|
8,814
|
|
|
$
|
7,937
|
|
|
$
|
5,603
|
|
|
$
|
5,024
|
|
|
$
|
5,875
|
|
|
$
|
2,221
|
|
|
$
|
12,666
|
|
|
$
|
78,986
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Goodwill
and Intangible Assets
Goodwill and other intangible assets with indefinite lives are
reviewed annually, or more frequently if circumstances indicate
impairment may have occurred.
The Company estimates the fair value of its identified reporting
units and compares those estimates against the related carrying
value. For each of the reporting units, the estimated fair value
is determined based on a multiple of earnings before interest,
taxes, depreciation and amortization or on the estimated fair
value of assets in situations when it is readily determinable.
Included in intangible assets are other intangible assets such
as licenses to operate home-based
and/or
facility-based services and trade names. The Company has valued
these intangible assets separately from goodwill for each
acquisition completed during the year ended December 31,
2007. The Company has concluded that these licenses and trade
names have indefinite lives, as management has determined that
there are no legal, regulatory, contractual, economic or other
factors that would limit the useful life of these intangible
assets and the Company intends to renew and operate the licenses
and uses these trade names indefinitely. Prior to
January 1, 2006, the Company elected to recognize the fair
value of indefinite-lived licenses and trade names together with
goodwill as a single asset for financial reporting purposes.
Components of the Companys home nursing operating segment
are generally represented by individual subsidiaries or joint
ventures with individual licenses to conduct specific operations
within geographic markets as limited by the terms of each
license. Components of the Companys facility-based
services are represented by individual operating entities.
Effective January 1, 2004, management began aggregating the
components of these two segments into two reporting units for
purposes of evaluating impairment. Prior to January 1,
2004, management evaluated each operating entity separately for
impairment. Modifications to the Companys management of
the segments and reporting provided management with a basis to
change the reporting unit structure.
Recently
Issued Accounting Pronouncements
In September 2006, the Financial Accounting Standards Board
(FASB) issued SFAS No. 157, Fair Value
Measurements (SFAS 157), which defines fair value and
establishes a framework for measuring fair value in generally
accepted accounting principles and expands disclosure
requirements about fair value measurements. SFAS 157 is
effective for fiscal years beginning after November 15,
2007. The adoption of SFAS No. 157 is not expected to
have a material effect on the Companys consolidated
financial position or results of operations.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option for Financial Assets and Financial
Liabilities, Including an Amendment to SFAS 115
(SFAS 159). SFAS 159 allows the measurement of many
financial instruments and certain other assets and liabilities
at fair value on an
instrument-by-instrument
basis under a fair value option. SFAS 159 is effective for
fiscal years that begin after November 15, 2007. The
adoption of SFAS No. 159 is not expected to have a
material effect on the Companys consolidated financial
position or results of operations.
In December 2007, the FASB issued SFAS No. 141
(Revised 2007), Business Combinations (SFAS 141R).
SFAS 141R changes the accounting for business combinations.
Under SFAS 141R, an acquiring entity will be required to
recognize all the assets acquired and liabilities assumed in a
transaction at the acquisition-date fair value with limited
exceptions. SFAS 141R will change the accounting treatment
and disclosure for certain
60
specific items in a business combination. For instance,
acquisition-related costs, with the exception of debt or equity
issuance costs, are to be recorded in the period that the costs
are incurred and the services are received. SFAS 141R
applies prospectively to business combinations for which the
acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15,
2008. Accordingly, any business combinations we engage in will
be recorded and disclosed following existing GAAP until
January 1, 2009. We expect SFAS 141R will have an
impact on accounting for business combinations once adopted but
the effect is dependent upon acquisitions at that time.
In December 2007, the FASB issued SFAS No. 160,
Noncontrolling Interests in Consolidated Financial
Statements An Amendment of ARB No. 51
(SFAS 160). SFAS 160 establishes new accounting
and reporting standards for the noncontrolling interest in a
subsidiary and for the deconsolidation of a subsidiary.
SFAS 160 is effective for fiscal years beginning on or
after December 15, 2008. We have not completed our
evaluation of the potential impact, if any, of the adoption of
SFAS 160 on our consolidated financial position, results of
operations and cash flows.
|
|
Item 7A.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
As of December 31, 2007, we had $1.2 million in cash.
Cash in excess of requirements are deposited in highly liquid
money market instruments with maturities less than 90 days.
Because of the short maturities of these instruments, a sudden
change in market interest rates would not be expected to have a
material impact on the fair value of the portfolio. We would not
expect our operating results or cash flows to be materially
affected by the effect of a sudden change in market interest
rates on our portfolio. At times, cash in banks is in excess of
the Federal Insurance Deposit Corporation (FDIC) insurance
limit. The Company has not experienced any loss as a result of
those deposits and does not expect any in the future.
Our exposure to market risk relates to changes in interest rates
for borrowings under the new credit facility we entered into in
February 2008. A hypothetical 100 basis point adverse move
(increase) in interest rates would not have materially affected
the interest expense for the year ended December 31, 2007
since there were no amounts outstanding under our former, senior
secured credit agreement that was in place during this period.
|
|
Item 8.
|
Financial
Statements and Supplementary Data
|
The consolidated financial statements and financial statement
schedules in Part IV, Item 15 of this report are
incorporated by reference into this Item 8.
|
|
Item 9.
|
Changes
In and Disagreements with Accountants on Accounting and
Financial Disclosure
|
None.
|
|
Item 9A.
|
Controls
and Procedures
|
Evaluation
of Disclosure Control and Procedures
As reported in the Companys quarterly report on
Form 10-Q
for the quarter ended June 30, 2007, the Company identified
a material weakness related to the controls over the recording
of contractual adjustments on commercial contract claims in its
Long-Term Acute Care Hospital (LTACH) business. As a result of
this material weakness, the Companys management, including
the Companys principal executive and principal financial
officers, concluded that the Companys disclosure controls
and procedures were not effective as of June 30, 2007.
To address this material weakness, the Company implemented
additional manual controls and procedures over the recording of
contractual adjustments related to commercial contracts in the
LTACHs. The Company has also continued to work with outside
consultants to identify and implement appropriate methods of
ensuring these controls and procedures remain effective.
61
The Companys remediation efforts with respect to the
material weakness related to the controls over the recording of
contractual adjustments were completed prior to
December 31, 2007. We believe that the corrective actions
remedied the identified material weakness described above.
Under the supervision and with the participation of the
Companys management, including the Chief Executive Officer
and its Chief Financial Officer, management evaluated the
effectiveness of the Companys disclosure controls and
procedures (as such term is defined under
Rule 13a-15(e)
promulgated under the Securities Exchange Act of 1934, as
amended) as of December 31, 2007. Disclosure controls and
procedures include, without limitation, controls and procedures
designed to ensure that information required to be disclosed by
a company in the reports that it files or submits under the
Securities Exchange Act is accumulated and communicated to the
companys management, including its principal executive and
principal financial officers, as appropriate to allow timely
decisions regarding required disclosure. Based on that
evaluation, the Companys Chief Executive Officer and its
Chief Financial Officer concluded that the Companys
disclosure controls and procedures were not effective at the
reasonable assurance level as of December 31, 2007 because
of the material weakness discussed below in Managements
Report on Internal Control Over Financial Reporting.
Managements
Report on Internal Control Over Financial Reporting
The Companys management is responsible for establishing
and maintaining adequate internal control over financial
reporting, as that term is defined in Exchange Act
Rule 13a-15(f).
Under the supervision and with the participation of the
Companys management, including the principal executive
officer and principal financial officer, the Company conducted
an evaluation of its internal control over financial reporting
as of December 31, 2007 based on the framework in
Internal Control Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway
Commission. Because of its inherent limitations, internal
control over financial reporting may not prevent or detect
misstatements. Also, projections of any evaluation of
effectiveness to future periods are subject to the risk that
controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures
may deteriorate.
A material weakness is a deficiency, or combination of
deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material
misstatement of the Companys annual or interim financial
statements will not be prevented or detected on a timely basis.
During its evaluation, management determined that a material
weakness existed with respect to its process of estimating the
allowance for uncollectible accounts at December 31, 2007.
The Companys process for determining its allowance for
uncollectible accounts focused primarily on evaluating the
appropriate percentage of gross revenues to record during a
particular period. However, as of December 31, 2007, the
Company did not have processes or controls in place that would
enable management to appropriately evaluate, document and review
the adequacy of the allowance for uncollectible accounts as of a
particular period-end. As a result, the Company recorded
adjustments during the 2007 fourth quarter and as of
December 31, 2007 that were identified in connection with
its year-end audit that decreased 2007 income and increased the
allowance for uncollectible accounts by $3.9 million,
including: $2.8 million, primarily related to home health
commercial, managed care, and non-PFFS Medicare Advantage plan
payors; and $1.1 million, primarily related to hospice
claims.
Because of this material weakness, management has concluded that
the Company did not maintain effective internal control over
financial reporting as of December 31, 2007.
Ernst & Young LLP, the independent registered public
accounting firm that audited the Companys consolidated
financial statements, has issued an attestation report on the
Companys internal control over financial reporting as of
December 31, 2007, which is included below in this
Item 9A of this
Form 10-K.
Changes
in Internal Control Over Financial Reporting
Except as otherwise discussed below, there have not been any
changes in the Companys internal control over financial
reporting, as such term is defined in
Rule 13a-15(f)
under the Exchange Act, during the
62
Companys fiscal quarter ended December 31, 2007 that
have materially affected, or are reasonably likely to materially
affect, the Companys internal control over financial
reporting.
Subsequent to December 31, 2007, management has implemented
two primary measures to address the material weakness described
above. First, we have enhanced our controls and processes for
calculating the allowance for uncollectible accounts. These
enhancements include estimating and documenting the
collectibility of receivables at the end of a period based on
their aging categories and timely review of that documentation
by senior management and our outside consultants, Simione
Consultants. Second, we have engaged outside consultants,
Simione Consultants, to oversee the Companys billing and
collection efforts with regards to commercial, managed care, and
non PFFS Medicare Advantage plan payors beginning in February
2008. We expect their oversight to improve collection efforts
and provide an additional evaluation of the collectability of
the accounts.
63
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
INTERNAL CONTROL OVER FINANCIAL REPORTING
THE BOARD OF DIRECTORS AND STOCKHOLDERS OF
LHC GROUP, INC.
We have audited LHC Group, Inc. and subsidiaries internal
control over financial reporting as of December 31, 2007,
based on criteria established in Internal Control
Integrated Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission (the COSO criteria).
LHC Group, Inc.s management is responsible for maintaining
effective internal control over financial reporting, and for its
assessment of the effectiveness of internal control over
financial reporting included in the accompanying
Managements Report on Internal Control Over Financial
Reporting. Our responsibility is to express an opinion on the
companys internal control over financial reporting based
on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, assessing the risk
that a material weakness exists, testing and evaluating the
design and operating effectiveness of internal control based on
the assessed risk, and performing such other procedures as we
considered necessary in the circumstances. We believe that our
audit provides a reasonable basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
A material weakness is a deficiency, or combination of
deficiencies, in internal control over financial reporting, such
that there is a reasonable possibility that a material
misstatement of the companys annual or interim financial
statements will not be prevented or detected on a timely basis.
The following material weakness has been identified and included
in managements assessment. Management has identified a
material weakness in controls related to the Companys
process of estimating the allowance for uncollectible accounts.
This material weakness was considered in determining the nature,
timing, and extent of audit tests applied in our audit of the
2007 financial statements, and this report does not affect our
report dated March 14, 2008 on those financial statements.
In our opinion, because of the effect of the material weakness
described above on the achievement of the objectives of the
control criteria, LHC Group, Inc. and subsidiaries has not
maintained effective internal control over financial reporting
as of December 31, 2007, based on the COSO criteria.
/s/ Ernst & Young LLP
New Orleans, Louisiana
March 14, 2008
64
|
|
Item 9B.
|
Other
Information
|
None.
PART III
|
|
Item 10.
|
Directors,
Executive Officers and Corporate Governance
|
Executive
Officers and Directors
The information required by this Item is incorporated by
reference to the sections entitled Directors and Executive
Officers in the definitive Proxy Statement relating to the
Companys 2008 Annual Meeting of Stockholders.
Compliance
with Section 16(a) of the Exchange Act
The information required by this Item is incorporated by
reference to the sections entitled Directors and Executive
Officers in the definitive Proxy Statement relating to the
Companys 2008 Annual Meeting of Stockholders.
Code of
Conduct and Ethics
We have adopted a code of ethics that applies to all of our
directors, officers and employees. This code is publicly
available in the investor relations area of our website
(www.lhcgroup.com). This code of ethics is not incorporated in
this report by reference. Copies of our code of ethics may also
be requested in print by writing to Investor Relations at LHC
Group, Inc., 420 West Pinhook Road, Suite A,
Lafayette, Louisiana, 70503.
|
|
Item 11.
|
Executive
Compensation
|
The information required by this Item is incorporated by
reference to the sections entitled Executive
Compensation in the definitive Proxy Statement relating to
the Companys 2007 Annual Meeting of Stockholders.
|
|
Item 12.
|
Security
Ownership of Certain Beneficial Owners and Management and
Related Stockholder Matters
|
With the exception of the equity plan information table set
forth below, the information required by this Item is
incorporated by reference to the sections entitled
Security Ownership of Certain Beneficial Owners and
Management in the definitive Proxy Statement relating to
the Companys 2008 Annual Meeting of Stockholders.
Equity
Compensation Plan Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
(c)
|
|
|
|
|
|
|
|
|
|
Number of Shares
|
|
|
|
Number of Shares to
|
|
|
|
|
|
Remaining Available
|
|
|
|
be Issued Upon
|
|
|
Weighted-Average
|
|
|
for Future Issuance
|
|
|
|
Exercise of
|
|
|
Exercise Price of
|
|
|
Under Equity
|
|
|
|
Outstanding
|
|
|
Outstanding Price
|
|
|
Compensation Plans
|
|
|
|
Options, Warrants,
|
|
|
of Outstanding
|
|
|
(Excluding Securities
|
|
Plan Category
|
|
and Rights
|
|
|
Rights
|
|
|
Reflected in Column(a))
|
|
|
Equity compensation plans approved by Stockholders:
|
|
|
19,000
|
|
|
$
|
17.20
|
|
|
|
933,910
|
(1)
|
Equity compensation plans not approved by Stockholders:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
19,000
|
|
|
$
|
17.20
|
|
|
|
933,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65
|
|
|
(1) |
|
707,899 of these shares are reserved under the LHC Group, Inc.
2005 Long-Term Incentive Plan and are available for issuance
pursuant to the exercise or grant of stock options, stock
appreciation rights, restricted stock, restricted stock units,
performance shares or unrestricted stock. 226,011 of these
shares are reserved and available for issuance under the 2006
LHC Group, Inc. Employee Stock Purchase Plan. |
|
|
Item 13.
|
Certain
Relationships and Related Transactions, and Director
Independence
|
The information required by this Item is incorporated by
reference to the sections entitled Certain Relationships
and Related Transactions in the definitive Proxy Statement
relating to the Companys 2008 Annual Meeting of
Stockholders.
|
|
Item 14.
|
Principal
Accounting Fees and Services
|
The information required by this Item is incorporated by
reference to the sections entitled Principal Accounting
Fees and Services in the definitive Proxy Statement
relating to the Companys 2008 Annual Meeting of
Stockholders.
66
PART IV
|
|
Item 15.
|
Exhibits,
Financial Statement Schedules
|
(a) Documents to be filed with
Form 10-K:
(1) Financial Statements
|
|
|
|
|
|
|
|
F-1
|
|
|
|
|
F-2
|
|
For each of the three years in the period ended
December 31, 2007, 2006 and 2005:
|
|
|
|
|
|
|
|
F-3
|
|
|
|
|
F-4
|
|
|
|
|
F-5
|
|
|
|
|
F-6
|
|
(2) Financial Statement Schedules
There are no financial statement schedules included in this
report.
(3) Exhibits
The Exhibits are listed in the Index of Exhibits Required
by Item 601 of
Regulation S-K
included herewith, which is incorporated by reference.
67
REPORT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders of LHC Group, Inc.
We have audited the accompanying consolidated balance sheets of
LHC Group Inc. and subsidiaries as of December 31, 2007 and
2006, and the related consolidated statements of income,
shareholders equity, and cash flows for each of the three
years in the period ended December 31, 2007. These
financial statements are the responsibility of the
Companys management. Our responsibility is to express an
opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the consolidated
financial position of LHC Group, Inc. and subsidiaries at
December 31, 2007 and 2006, and the consolidated results of
their operations and their cash flows for each of the three
years in the period ended December 31, 2007, in conformity
with U.S. generally accepted accounting principles.
As discussed in Note 2 to the consolidated financial
statements, effective January 1, 2007 the Company adopted
FASB Interpretation No. 48, Accounting for Uncertainty
in Income Taxes an Interpretation of FASB Statement
No. 109, and effective January 1, 2006, the
Company adopted Statement of Financial Accounting Standards No.
123 (revised 2004), Share-Based Payment.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), LHC
Group, Inc. and subsidiaries internal control over
financial reporting as of December 31, 2007, based on
criteria established in Internal Control-Integrated
Framework issued by the Committee of Sponsoring
Organizations of the Treadway Commission and our report dated
March 14, 2008 expressed an adverse opinion thereon.
/s/ Ernst & Young LLP
New Orleans, Louisiana
March 14, 2008
F-1
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
BALANCE SHEETS
(Amounts
in thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
As of December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
ASSETS
|
Current assets:
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
1,155
|
|
|
$
|
26,877
|
|
Receivables:
|
|
|
|
|
|
|
|
|
Patient accounts receivable, less allowance for uncollectible
accounts of $8,953 and $5,769 at December 31, 2007 and
2006, respectively
|
|
|
70,033
|
|
|
|
50,029
|
|
Other receivables
|
|
|
2,425
|
|
|
|
3,401
|
|
Amounts due from governmental entities
|
|
|
1,459
|
|
|
|
2,518
|
|
|
|
|
|
|
|
|
|
|
|
|
|
73,917
|
|
|
|
55,948
|
|
Deferred income taxes
|
|
|
2,946
|
|
|
|
1,935
|
|
Prepaid expenses and other current assets
|
|
|
4,423
|
|
|
|
4,120
|
|
Assets held for sale
|
|
|
556
|
|
|
|
1,171
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
82,997
|
|
|
|
90,051
|
|
Property, building and equipment, net
|
|
|
12,523
|
|
|
|
11,705
|
|
Goodwill
|
|
|
62,227
|
|
|
|
39,681
|
|
Intangible assets, net
|
|
|
14,055
|
|
|
|
8,262
|
|
Other assets
|
|
|
3,183
|
|
|
|
2,995
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$
|
174,985
|
|
|
$
|
152,694
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable and other accrued liabilities
|
|
$
|
6,103
|
|
|
$
|
5,903
|
|
Salaries, wages and benefits payable
|
|
|
11,303
|
|
|
|
10,572
|
|
Amounts due to governmental entities
|
|
|
3,162
|
|
|
|
3,223
|
|
Income taxes payable
|
|
|
863
|
|
|
|
1,219
|
|
Current portion of capital lease obligations
|
|
|
88
|
|
|
|
211
|
|
Current portion of long-term debt
|
|
|
433
|
|
|
|
428
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
21,952
|
|
|
|
21,556
|
|
Deferred income taxes
|
|
|
3,243
|
|
|
|
2,104
|
|
Capital lease obligations, less current portion
|
|
|
63
|
|
|
|
147
|
|
Long-term debt, less current portion
|
|
|
2,847
|
|
|
|
3,051
|
|
Minority interests subject to exchange contracts and/or put
options
|
|
|
121
|
|
|
|
317
|
|
Other minority interests
|
|
|
3,388
|
|
|
|
3,630
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Common stock $0.01 par value:
40,000,000 shares authorized; 20,725,713 and
20,682,317 shares issued and 17,775,284 and
17,732,258 shares outstanding at December 31, 2007 and
2006, respectively
|
|
|
177
|
|
|
|
177
|
|
Treasury stock 2,950,429 and 2,950,059 shares
at cost at December 31, 2007 and 2006, respectively
|
|
|
(2,866
|
)
|
|
|
(2,856
|
)
|
Additional paid-in capital
|
|
|
81,983
|
|
|
|
80,273
|
|
Retained earnings
|
|
|
64,077
|
|
|
|
44,295
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
143,371
|
|
|
|
121,889
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity
|
|
$
|
174,985
|
|
|
$
|
152,694
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
F-2
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF INCOME
(Amounts in thousands, except share and per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Net service revenue
|
|
$
|
298,031
|
|
|
$
|
218,535
|
|
|
$
|
155,687
|
|
Cost of service revenue
|
|
|
152,577
|
|
|
|
112,095
|
|
|
|
82,996
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross margin
|
|
|
145,454
|
|
|
|
106,440
|
|
|
|
72,691
|
|
General and administrative expenses
|
|
|
106,795
|
|
|
|
71,115
|
|
|
|
46,519
|
|
Equity-based compensation expense(1)
|
|
|
|
|
|
|
|
|
|
|
3,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
38,659
|
|
|
|
35,325
|
|
|
|
22,316
|
|
Interest expense
|
|
|
376
|
|
|
|
325
|
|
|
|
1,067
|
|
Non-operating (income) loss, including gain or loss on sales of
assets
|
|
|
(1,073
|
)
|
|
|
(2,033
|
)
|
|
|
(574
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations before income taxes and
minority interest and cooperative endeavor allocations
|
|
|
39,356
|
|
|
|
37,033
|
|
|
|
21,823
|
|
Income tax expense
|
|
|
12,147
|
|
|
|
10,817
|
|
|
|
6,052
|
|
Minority interest and cooperative endeavor allocations
|
|
|
5,984
|
|
|
|
4,795
|
|
|
|
4,545
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
|
21,225
|
|
|
|
21,421
|
|
|
|
11,226
|
|
Loss from discontinued operations (net of income tax benefit of
$239, $897 and $688 in 2007, 2006 and 2005, respectively)
|
|
|
(1,667
|
)
|
|
|
(1,464
|
)
|
|
|
(1,124
|
)
|
Gain on sale of discontinued operations (net of income taxes of
$20 and $390 in 2007 and 2006, respectively)
|
|
|
31
|
|
|
|
637
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
19,589
|
|
|
|
20,594
|
|
|
|
10,102
|
|
Change in the redemption value of redeemable minority interests
|
|
|
193
|
|
|
|
1,163
|
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common stockholders
|
|
$
|
19,782
|
|
|
$
|
21,757
|
|
|
$
|
8,626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.19
|
|
|
$
|
1.25
|
|
|
$
|
0.77
|
|
Loss from discontinued operations, net
|
|
|
(0.09
|
)
|
|
|
(0.09
|
)
|
|
|
(0.08
|
)
|
Gain on sale of discontinued operations, net
|
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.10
|
|
|
|
1.20
|
|
|
|
0.69
|
|
Change in the redemption value of redeemable minority interests
|
|
|
0.01
|
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
1.11
|
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations
|
|
$
|
1.19
|
|
|
$
|
1.25
|
|
|
$
|
0.77
|
|
Loss from discontinued operations, net
|
|
|
(0.09
|
)
|
|
|
(0.09
|
)
|
|
|
(0.08
|
)
|
Gain on sale of discontinued operations, net
|
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
|
1.10
|
|
|
|
1.20
|
|
|
|
0.69
|
|
Change in the redemption value of redeemable minority interests
|
|
|
0.01
|
|
|
|
0.07
|
|
|
|
(0.10
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income available to common shareholders
|
|
$
|
1.11
|
|
|
$
|
1.27
|
|
|
$
|
0.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
17,760,432
|
|
|
|
17,090,583
|
|
|
|
14,628,737
|
|
Diluted
|
|
|
17,827,444
|
|
|
|
17,104,660
|
|
|
|
14,684,639
|
|
|
|
|
(1) |
|
Equity-based compensation is allocated as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
2006
|
|
2005
|
|
Cost of service revenue
|
|
$
|
|
|
|
$
|
|
|
|
$
|
565
|
|
General and administrative expenses
|
|
|
|
|
|
|
|
|
|
|
3,291
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total equity-based compensation expense
|
|
$
|
|
|
|
$
|
|
|
|
$
|
3,856
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
F-3
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY
(Amounts in thousands, except share and per share
data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Additional
|
|
|
|
|
|
|
|
|
|
Issued
|
|
|
Treasury
|
|
|
Paid-In
|
|
|
Retained
|
|
|
|
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Capital
|
|
|
Earnings
|
|
|
Total
|
|
|
Balances at January 1, 2005
|
|
$
|
121
|
|
|
|
15,000,004
|
|
|
$
|
(2,242
|
)
|
|
|
2,914,850
|
|
|
$
|
4,421
|
|
|
$
|
14,051
|
|
|
$
|
16,351
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,102
|
|
|
|
10,102
|
|
Dividends to stockholders ($0.009 per share)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(139
|
)
|
|
|
(139
|
)
|
Sale of 3,500,000 shares of common stock at the initial
public offering price of $14 per share, net of underwriting
discount and offering costs of $7,393
|
|
|
35
|
|
|
|
3,500,000
|
|
|
|
|
|
|
|
|
|
|
|
41,572
|
|
|
|
|
|
|
|
41,607
|
|
Issuance of common stock to two joint venture partners upon
conversion of their equity interests into shares of common stock
|
|
|
5
|
|
|
|
518,036
|
|
|
|
|
|
|
|
|
|
|
|
7,247
|
|
|
|
|
|
|
|
7,252
|
|
Issuance of common stock upon conversion of outstanding KEEP
units
|
|
|
5
|
|
|
|
481,680
|
|
|
|
|
|
|
|
|
|
|
|
5,239
|
|
|
|
|
|
|
|
5,244
|
|
Issuance of nonvested stock
|
|
|
|
|
|
|
8,167
|
|
|
|
|
|
|
|
|
|
|
|
117
|
|
|
|
|
|
|
|
117
|
|
Treasury shares redeemed for payment of income taxes
|
|
|
|
|
|
|
|
|
|
|
(614
|
)
|
|
|
35,209
|
|
|
|
|
|
|
|
|
|
|
|
(614
|
)
|
Recording minority interest in joint venture at redemption value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,476
|
)
|
|
|
(1,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2005
|
|
|
166
|
|
|
|
19,507,887
|
|
|
|
(2,856
|
)
|
|
|
2,950,059
|
|
|
|
58,596
|
|
|
|
22,538
|
|
|
|
78,444
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,594
|
|
|
|
20,594
|
|
Sale of 1,150,000 shares of common stock at $19.25 per
share, net of underwriting discount and offering costs of $1,403
|
|
|
11
|
|
|
|
1,150,000
|
|
|
|
|
|
|
|
|
|
|
|
20,711
|
|
|
|
|
|
|
|
20,722
|
|
Stock option compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
128
|
|
|
|
|
|
|
|
128
|
|
Exercise of stock options
|
|
|
|
|
|
|
8,000
|
|
|
|
|
|
|
|
|
|
|
|
165
|
|
|
|
|
|
|
|
165
|
|
Nonvested stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
484
|
|
|
|
|
|
|
|
484
|
|
Issuance of nonvested stock
|
|
|
|
|
|
|
1,167
|
|
|
|
|
|
|
|
|
|
|
|
23
|
|
|
|
|
|
|
|
23
|
|
Issuance of nonvested stock
|
|
|
|
|
|
|
8,167
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
|
|
|
|
7,096
|
|
|
|
|
|
|
|
|
|
|
|
166
|
|
|
|
|
|
|
|
166
|
|
Change in redemption value of redeemable minority interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,163
|
|
|
|
1,163
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2006
|
|
|
177
|
|
|
|
20,682,317
|
|
|
|
(2,856
|
)
|
|
|
2,950,059
|
|
|
|
80,273
|
|
|
|
44,295
|
|
|
|
121,889
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,589
|
|
|
|
19,589
|
|
Exercise of stock options
|
|
|
|
|
|
|
527
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested stock compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,125
|
|
|
|
|
|
|
|
1,125
|
|
Issuance of nonvested stock
|
|
|
|
|
|
|
25,976
|
|
|
|
|
|
|
|
|
|
|
|
62
|
|
|
|
|
|
|
|
62
|
|
Treasury shares redeemed to pay income tax
|
|
|
|
|
|
|
|
|
|
|
(10
|
)
|
|
|
370
|
|
|
|
|
|
|
|
|
|
|
|
(10
|
)
|
Excess tax benefit vesting of nonvested stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
104
|
|
|
|
|
|
|
|
104
|
|
Issuance of common stock under Employee Stock Purchase Plan
|
|
|
|
|
|
|
16,893
|
|
|
|
|
|
|
|
|
|
|
|
419
|
|
|
|
|
|
|
|
419
|
|
Change in redemption value of redeemable minority interest
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
193
|
|
|
|
193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2007
|
|
$
|
177
|
|
|
|
20,725,713
|
|
|
$
|
(2,866
|
)
|
|
|
2,950,429
|
|
|
$
|
81,983
|
|
|
$
|
64,077
|
|
|
$
|
143,371
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes.
F-4
LHC
GROUP, INC. AND SUBSIDIARIES
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Amounts in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Year Ended December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Operating activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
19,589
|
|
|
$
|
20,594
|
|
|
$
|
10,102
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
3,026
|
|
|
|
2,427
|
|
|
|
1,751
|
|
Provision for bad debts
|
|
|
13,817
|
|
|
|
4,778
|
|
|
|
3,188
|
|
Equity based compensation expense
|
|
|
|
|
|
|
|
|
|
|
3,856
|
|
Stock based compensation expense
|
|
|
1,187
|
|
|
|
635
|
|
|
|
177
|
|
Minority interest in earnings of subsidiaries
|
|
|
5,312
|
|
|
|
4,471
|
|
|
|
4,527
|
|
Deferred income taxes
|
|
|
127
|
|
|
|
(1,253
|
)
|
|
|
673
|
|
Gain on divestitures and sale of assets
|
|
|
|
|
|
|
(979
|
)
|
|
|
(211
|
)
|
Changes in operating assets and liabilities, net of acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
|
Receivables
|
|
|
(31,786
|
)
|
|
|
(15,625
|
)
|
|
|
(14,478
|
)
|
Prepaid expenses, other assets
|
|
|
(772
|
)
|
|
|
(1,466
|
)
|
|
|
(196
|
)
|
Accounts payable and accrued expenses
|
|
|
1,676
|
|
|
|
6,036
|
|
|
|
(2,509
|
)
|
Net amounts due governmental entities
|
|
|
(61
|
)
|
|
|
2,144
|
|
|
|
(105
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
12,115
|
|
|
|
21,762
|
|
|
|
6,775
|
|
Investing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchases of property, building and equipment
|
|
|
(3,346
|
)
|
|
|
(3,938
|
)
|
|
|
(2,134
|
)
|
Proceeds from sale of property and equipment
|
|
|
|
|
|
|
7
|
|
|
|
|
|
Proceeds from sale of entities
|
|
|
|
|
|
|
1,440
|
|
|
|
730
|
|
Cost of acquisitions, primarily goodwill, intangible assets and
patient accounts receivable
|
|
|
(28,935
|
)
|
|
|
(25,009
|
)
|
|
|
(11,137
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(32,281
|
)
|
|
|
(27,500
|
)
|
|
|
(12,541
|
)
|
Financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of common stock, net of underwriting discounts of
$1,104 in 2006 and $3,430 in 2005
|
|
|
|
|
|
|
21,033
|
|
|
|
45,570
|
|
Dividends paid
|
|
|
|
|
|
|
|
|
|
|
(227
|
)
|
Principal payments on debt
|
|
|
(199
|
)
|
|
|
(1,201
|
)
|
|
|
(2,937
|
)
|
Payments on capital leases
|
|
|
(207
|
)
|
|
|
(389
|
)
|
|
|
(1,105
|
)
|
Proceeds from issuance of debt
|
|
|
|
|
|
|
|
|
|
|
24
|
|
Net (payments) proceeds from lines of credit and revolving debt
arrangements
|
|
|
|
|
|
|
|
|
|
|
(14,288
|
)
|
Offering costs incurred
|
|
|
|
|
|
|
(311
|
)
|
|
|
(2,224
|
)
|
Proceeds from exercise of stock options
|
|
|
|
|
|
|
135
|
|
|
|
|
|
Proceeds from issuance of common stock under ESPP
|
|
|
419
|
|
|
|
140
|
|
|
|
|
|
Minority interest contributions, net of (distributions)
|
|
|
(5,572
|
)
|
|
|
(4,190
|
)
|
|
|
(4,560
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
(5,559
|
)
|
|
|
15,217
|
|
|
|
20,253
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in cash
|
|
|
(25,722
|
)
|
|
|
9,479
|
|
|
|
14,487
|
|
Cash at beginning of period
|
|
|
26,877
|
|
|
|
17,398
|
|
|
|
2,911
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash at end of period
|
|
$
|
1,155
|
|
|
$
|
26,877
|
|
|
$
|
17,398
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental disclosures of cash flow information
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest paid
|
|
$
|
376
|
|
|
$
|
342
|
|
|
$
|
1,068
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income taxes paid
|
|
$
|
12,052
|
|
|
$
|
9,370
|
|
|
$
|
5,821
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental
disclosure of non-cash transactions:
In the year ended December 31, 2006 the Company sold a
clinic for promissory notes totaling $946 and recognized a loss
on the sale of $28.
In the year ended December 31, 2005, the Company issued
common stock valued at $7,252 to two joint
venture partners upon the acquisition of their minority
interest. Additionally, the Companys
stockholders equity from the initial public offering was
reduced by offering costs incurred by the
Company of $3,951. The Company financed the purchase of an
airplane for $3.0 million. The Company
also financed the purchase of various types of insurance in the
amount of $2.2 million.
See accompanying notes.
F-5
LHC Group, Inc. (Company) is a health care provider specializing
in the post-acute continuum of care primarily for Medicare
beneficiaries in non-urban markets in the United States. The
Company provides home-based services, primarily through home
nursing agencies and hospices and facility-based services,
primarily through long-term acute care hospitals and outpatient
rehabilitation clinics. The Company, through its wholly and
majority-owned subsidiaries, equity joint ventures and
controlled affiliate, currently operates in Louisiana,
Mississippi, Arkansas, Alabama, Texas, West Virginia, Kentucky,
Florida, Tennessee, Georgia, Ohio and Missouri.
The Company operated as Louisiana Health Care Group, Inc.
(LHCG), until March 2001, when the shareholders of LHCG
transferred to The Health Care Group, Inc. (THCG), all of the
issued and outstanding shares of common stock of LHCG in
exchange for shares in THCG. On January 1, 2003, the
Company began operating as LHC Group, LLC, a Louisiana limited
liability company. The THCG shareholders exchanged their shares
for membership interests in the Company (units).
Prior to February 9, 2005, the Company operated under the
terms of an operating agreement which provided that the Company
did not have a finite life and that the members personal
liability was limited to his or her capital contribution. There
was only one class of member interest.
Plan
of Merger and Recapitalization
In January 2005, LHC Group, LLC established a wholly owned
Delaware subsidiary, LHC Group, Inc. Effective February 9,
2005, LHC Group, LLC merged with and into LHC Group, Inc. In
connection with the merger, each outstanding membership unit in
LHC Group, LLC was converted into shares of the $0.01 par
value common stock of LHC Group, Inc. based on an exchange ratio
of
three-for-two.
Each KEEP Unit was also converted during the initial public
offering into shares of common stock of LHC Group, Inc. pursuant
to the same
three-for-two
ratio. LHC Group, Inc. has 40,000,000 shares of
$0.01 par value common stock authorized and
5,000,000 shares of $0.01 par value preferred stock
authorized. All references to common stock, share and per share
amounts have been retroactively restated to reflect the merger
and recapitalization as if the merger and recapitalization had
taken place as of the beginning of the earliest period presented.
As used herein, the Company includes LHC Group, Inc.
and all predecessor entities.
Initial
Public Offering
On June 9, 2005, the Company began its initial public
offering of 4,800,000 shares of its common stock at a price
of $14.00 per share. The Company offered 3,500,000 shares
along with 1,300,000 shares that were sold by certain
stockholders of LHC Group. The Company received no proceeds from
the sale of the shares by the selling stockholders. The shares
began trading on the NASDAQ National Market under the symbol
LHCG on June 9, 2005. The initial public
offering was completed on June 14, 2005. The underwriters
exercised an option to purchase an additional
720,000 shares from certain stockholders solely to cover
over-allotments. The Company received $45,570,000, net of
underwriting discounts of $3,430,000 in proceeds from the
offering. The Company incurred approximately $3,963,000 in costs
related to the initial public offering through December 31,
2005. The shares are currently traded on the NASDAQ Global
Select Market.
|
|
2.
|
Significant
Accounting Policies
|
Use of
Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States
requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of
the financial statements
F-6
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
and the reported revenue and expenses during the reported
period. Actual results could differ from those estimates.
Critical
Accounting Policies
The most critical accounting policies relate to the principles
of consolidation, revenue recognition, accounts receivable and
allowances for uncollectible accounts and accounting for
goodwill and intangible assets.
Principles
of Consolidation
The consolidated financial statements include all subsidiaries
and entities controlled by the Company. Control is generally
defined by the Company as ownership of a majority of the voting
interest of an entity. The consolidated financial statements
include entities in which the Company absorbs a majority of the
entitys expected losses, receives a majority of the
entitys expected residual returns, or both, as a result of
ownership, contractual or other financial interests in the
entity.
All significant inter-company accounts and transactions have
been eliminated in consolidation. Business combinations
accounted for as purchases have been included in the
consolidated financial statements from the respective dates of
acquisition.
The following describes the Companys consolidation policy
with respect to its various ventures excluding wholly owned
subsidiaries:
Equity
Joint Ventures
The Companys joint ventures are structured as limited
liability companies in which the Company typically owns a
majority equity interest ranging from 51 to 99 percent.
Each member of all but one of the Companys equity joint
ventures participates in profits and losses in proportion to
their equity interests. The Company has one joint venture
partner whose participation in losses is limited. The Company
consolidates these entities as the Company absorbs a majority of
the entities expected losses, receives a majority of the
entities expected residual returns and generally has
voting control over the entity.
License
Leasing Arrangements
The Company, through wholly owned subsidiaries, leases home
health licenses necessary to operate certain of its home nursing
agencies. As with wholly owned subsidiaries, the Company owns
100 percent of the equity of these entities and
consolidates them based on such ownership as well as the
Companys right to receive a majority of the entities
expected residual returns and the Companys obligation to
absorb a majority of the entities expected losses.
Management
Services
The Company has various management services agreements under
which the Company manages certain operations of agencies and
facilities. The Company does not consolidate these agencies or
facilities, as the Company does not have an ownership interest
and does not have a right to receive a majority of the
agencies or facilities expected residual returns or
an obligation to absorb a majority of the agencies or
facilities expected losses.
F-7
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table summarizes the percentage of net service
revenue earned by type of ownership or relationship the Company
had with the operating entity:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Wholly owned subsidiaries
|
|
|
46.4
|
%
|
|
|
41.7
|
%
|
|
|
36.0
|
%
|
Equity joint ventures
|
|
|
43.7
|
|
|
|
46.3
|
|
|
|
49.7
|
|
License leasing arrangements
|
|
|
7.8
|
|
|
|
9.5
|
|
|
|
11.3
|
|
Management services
|
|
|
2.1
|
|
|
|
2.5
|
|
|
|
3.0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
On October 1, 2007, we converted one of our license leasing
arrangements to a joint venture. This will reduce the percentage
of net revenue earned by license leasing arrangements and
increase the percentage of net service revenue from joint
ventures by approximately 8 percent in 2008.
Revenue
Recognition
The Company reports net service revenue at the estimated net
realizable amount due from Medicare, Medicaid, commercial
insurance, managed care payors, patients and others for services
rendered. Under Medicare, the Companys home nursing
patients are classified into a group referred to as a home
health resource group prior to the receipt of services. Based on
this home health resource group the Company is entitled to
receive a prospective Medicare payment for delivering care over
a 60-day
period referred to as an episode. Medicare adjusts these
prospective payments based on a variety of factors, such as low
utilization, patient transfers, changes in condition and the
level of services provided. In calculating the Companys
reported net service revenue from home nursing services, the
Company adjusts the prospective Medicare payments by an estimate
of the adjustments. The Company calculates the adjustments based
on a historical average of these types of adjustments. For home
nursing services, the Company recognizes revenue based on the
number of days elapsed during the episode of care.
For the Companys long-term acute care hospitals, revenue
is recognized as services are provided. Under Medicare, patients
in the Companys long-term acute care facilities are
classified into long-term diagnosis-related groups. Based on
this classification, the Company is then entitled to receive a
fixed payment from Medicare. This fixed payment is also subject
to adjustment by Medicare due to factors such as short stays. In
calculating reported net service revenue for services provided
in the Companys long-term acute care hospitals, the
Company reduces the prospective payment amounts by an estimate
of the adjustments. The Company calculates the adjustment based
on a historical average of these types of adjustments for claims
paid.
For hospice services the Company is paid by Medicare under a per
diem payment system. The Company receives one of four
predetermined daily or hourly rates based upon the level of care
the Company furnished. The Company records net service revenue
from hospice services based on the daily or hourly rate. The
Company recognizes revenue for hospice as services are provided.
Under Medicare the Company is reimbursed for rehabilitation
services based on a fee schedule for services provided adjusted
by the geographical area in which the facility is located. The
Company recognizes revenue as these services are provided.
The Companys Medicaid reimbursement is based on a
predetermined fee schedule applied to each service provided.
Therefore, revenue is recognized for Medicaid services as
services are provided based on this fee schedule. The
Companys managed care payors reimburse the Company in a
manner similar to either Medicare or Medicaid. Accordingly, the
Company recognizes revenue from managed care payors in the same
manner as the Company recognizes revenue from Medicare or
Medicaid.
F-8
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company records management services revenue as services are
provided in accordance with the various management services
agreements to which the Company is a party. The agreements
generally call for the Company to provide billing, management
and other consulting services suited to and designed for the
efficient operation of the applicable home nursing agency or
inpatient rehabilitation facility. The Company is responsible
for the costs associated with the locations and personnel
required for the provision of the services. The Company is
generally compensated based on a percentage of net billings or
an established base fee. In addition, for certain of the
management agreements, the Company may earn incentive
compensation.
Net service revenue was comprised of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Home-based services
|
|
|
81.9
|
%
|
|
|
75.4
|
%
|
|
|
67.8
|
%
|
Facility-based services
|
|
|
18.1
|
|
|
|
24.6
|
|
|
|
32.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table sets forth the percentage of net service
revenue earned by category of payor:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Payor:
|
|
|
|
|
|
|
|
|
|
|
|
|
Medicare
|
|
|
81.7
|
%
|
|
|
82.6
|
%
|
|
|
86.4
|
%
|
Medicaid
|
|
|
5.5
|
|
|
|
5.7
|
|
|
|
4.9
|
|
Other
|
|
|
12.8
|
|
|
|
11.7
|
|
|
|
8.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
100.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home-Based
Services
Home Nursing Services. The Company receives a
standard prospective Medicare payment for delivering care. The
base payment, established through federal legislation, is a flat
rate that is adjusted upward or downward based upon differences
in the expected resource needs of individual patients as
indicated by clinical severity, functional severity and service
utilization. The magnitude of the adjustment is determined by
each patients categorization into one of 80 payment
groups, known as home health resource groups, and the costliness
of care for patients in each group relative to the average
patient. The Companys payment is also adjusted for
differences in local prices using the hospital wage index. The
Company performs payment variance analyses to verify the models
utilized in projecting total net service revenue are accurately
reflecting the payments to be received.
Medicare rates are subject to change. Due to the length of the
Companys episodes of care, a situation may arise where
Medicare rate changes affect prior periods net service
revenue. In the event that Medicare rates experience change, the
net effect of that change will be reflected in the current
reporting period.
Final payments from Medicare may reflect one of five retroactive
adjustments to ensure the adequacy and effectiveness of the
total reimbursement: (a) an outlier payment if the
patients care was unusually costly; (b) a low
utilization adjustment if the number of visits was fewer than
five; (c) a partial payment if the patient transferred to
another provider before completing the episode; (d) a
change-in-condition
adjustment if the patients medical status changes
significantly, resulting in the need for more or less care; or
(e) a payment adjustment based upon the level of therapy
services required in the population base. Management estimates
the impact of these payment adjustments based on historical
experience and records this estimate during the period the
services are rendered.
Hospice Services. The Companys Medicare
hospice reimbursement is based on an
annually-updated
prospective payment system. Hospice payments are also subject to
two caps. One cap relates to individual
F-9
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
programs receiving more than 20 percent of its total
Medicare reimbursement from inpatient care services. The second
cap relates to individual programs receiving reimbursements in
excess of a cap amount, calculated by multiplying
the number of beneficiaries during the period by a statutory
amount that is indexed for inflation. The determination for each
cap is made annually based on the
12-month
period ending on October 31 of each year. This limit is computed
on a
program-by-program
basis. We have not received notification that any of our
hospices have exceeded the cap on inpatient care seniors during
2007. None of the Companys hospices exceeded either cap
during the year ended December 31, 2006, or 2005.
Facility-Based
Services
Long-Term Acute Care Services. The Company is
reimbursed by Medicare for services provided under the long-term
acute care hospital prospective payment system, which was
implemented on October 1, 2002. Each patient is assigned a
long-term care diagnosis-related group. The Company is paid a
predetermined fixed amount applicable to that particular group.
This payment is intended to reflect the average cost of treating
a Medicare patient classified in that particular long-term care
diagnosis-related group. For selected patients, the amount may
be further adjusted based on length of stay and
facility-specific costs, as well as in instances where a patient
is discharged and subsequently readmitted, among other factors.
Similar to other Medicare prospective payment systems, the rate
is also adjusted for geographic wage differences.
Outpatient Rehabilitation Services. Outpatient
therapy services are reimbursed on a fee schedule, subject to
annual limitations. Outpatient therapy providers receive a fixed
fee for each procedure performed, adjusted by the geographical
area in which the facility is located. The Company recognizes
revenue as the services are provided. There are also annual per
Medicare beneficiary caps that limit Medicare coverage for
outpatient rehabilitation services.
Accounts
Receivable and Allowances for Uncollectible
Accounts
The Company reports accounts receivable net of estimated
allowances for uncollectible accounts and adjustments. Accounts
receivable are uncollateralized and primarily consist of amounts
due from third-party payors and patients. To provide for
accounts receivable that could become uncollectible in the
future, the Company establishes an allowance for uncollectible
accounts to reduce the carrying amount of such receivables to
their estimated net realizable value. The credit risk for other
concentrations of receivables is limited due to the significance
of Medicare as the primary payor. The Company does not believe
that there are any other significant concentrations of
receivables from any particular payor that would subject it to
any significant credit risk in the collection of accounts
receivable.
The amount of the provision for bad debts is based upon the
Companys assessment of historical and expected net
collections, business and economic conditions and trends in
government reimbursement. Uncollectible accounts are written off
when the Company has determined the account will not be
collected.
A portion of the estimated Medicare prospective payment system
reimbursement from each submitted home nursing episode is
received in the form of a request for accelerated payment (RAP).
The Company submits a RAP for 60 percent of the estimated
reimbursement for the initial episode at the start of care. The
full amount of the episode is billed after the episode has been
completed. The RAP received for that particular episode is
deducted from the final payment. If the final bill is not
submitted within the greater of 120 days from the start of
the episode, or 60 days from the date the RAP was paid, any
RAPs received for that episode will be recouped by
Medicare from any other claims in process for that particular
provider. The RAP and final payment must then be resubmitted.
For any subsequent episodes of care contiguous with the first
episode for a particular patient, the Company submits a RAP for
50 percent instead of 60 percent of the estimated
reimbursement. The remaining 50 percent reimbursement is
requested upon completion of the episode. The Company has earned
net service revenue in excess of billings rendered to Medicare.
F-10
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Goodwill
and Intangible Assets
Goodwill and other intangible assets with indefinite lives are
reviewed annually, or more frequently if circumstances indicate
impairment may have occurred.
Components of the Companys home nursing operating segment
are generally represented by individual subsidiaries or joint
ventures with individual licenses to conduct specific operations
within geographic markets as limited by the terms of each
license. Components of the Companys facility-based
services are represented by individual operating entities.
Management aggregates the components of these two segments into
two reporting units for purposes of evaluating impairment.
The Company estimates the fair value of its identified reporting
units and compares those estimates against the related carrying
value. For each of the reporting units, the estimated fair value
is determined based on a formula that considers 75 percent
of the estimated value based on a multiple of earnings before
interest, taxes, depreciation and amortization and
25 percent of the estimated value using recent sales of
comparable facilities.
Included in intangible assets, net are other intangible assets
such as licenses to operate home-based
and/or
facility-based services and trade names. The Company has valued
these intangible assets separately from goodwill for each
acquisition completed since January 1, 2006. The Company
has concluded that these licenses and trade names have
indefinite lives, as management has determined that there are no
legal, regulatory, contractual, economic or other factors that
would limit the useful life of these intangible assets and the
Company intends to renew and operate the licenses and use these
trade names indefinitely. Prior to January 1, 2006, the
Company elected to record the fair value of indefinite-lived
licenses and trade names together with goodwill as a single
asset for financial reporting purposes.
Other
Significant Accounting Policies
Due
to/from Governmental Entities
Prior to October 1, 2000, the Company recorded Medicare
home nursing services revenues at the lower of actual costs, the
per visit cost limit, or a per beneficiary cost limit on an
individual provider basis. Additionally, the Companys
long-term acute care hospitals are reimbursed for certain
activities based on tentative rates. Final reimbursement is
determined based on submission of annual cost reports and audits
by the fiscal intermediary. Adjustments are accrued on an
estimated basis in the period the related services were rendered
and further adjusted as final settlements are determined. These
adjustments are accounted for as changes in estimates. There
have been no significant changes in estimates during the years
ended December 31, 2007 and 2006.
Property,
Building and Equipment
Property, building and equipment are stated at cost.
Depreciation is computed using the straight-line method over the
estimated useful lives of the individual assets, generally
ranging from three to ten years and up to 39 years on
buildings. Depreciation expense for the years ended
December 31, 2007, 2006 and 2005 was $3.0 million,
$2.4 million and $1.8 million, respectively.
Capital leases, primarily consisting of transportation
equipment, are included in equipment. Capital leases are
recorded at the present value of the future rentals at lease
inception and are amortized over the shorter of the applicable
lease term or the useful life of the equipment. Amortization of
assets under the capital lease obligations is included in
depreciation and amortization expense.
F-11
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Long-Lived
Assets
The Company reviews the recoverability of long-lived assets
whenever events or circumstances occur which indicate recorded
costs may not be recoverable. If the expected future cash flows
(undiscounted) are less than the carrying amount of such assets,
the Company recognizes an impairment loss for the difference
between the carrying amount of the assets and their estimated
fair value.
Income
Taxes
The Company accounts for income taxes using the liability
method. Under the liability method, deferred taxes are
determined based on differences between the financial reporting
and tax bases of assets and liabilities and are measured using
the enacted tax laws that will be in effect when the differences
are expected to reverse. Management provides a valuation
allowance for any net deferred tax assets when it is more likely
than not that a portion of such net deferred tax assets will not
be recovered.
In July 2006, the FASB issued FASB Interpretation No. 48,
Accounting for Uncertainty in Income Taxes an
Interpretation of FASB Statement No. 109 (FIN 48).
FIN 48 prescribes a recognition threshold and measurement
attribute for financial statement recognition and measurement of
a tax position taken or expected to be taken in a tax return.
FIN 48 is effective for fiscal years beginning after
December 15, 2006. We were required to record the impact,
if any, of adopting FIN 48 as an adjustment to the
January 1, 2007 beginning balance of retained earnings
rather than our consolidated statement of income. The adoption
of FIN 48 had no effect on the Companys retained
earnings. The Company recognizes interest and penalties related
to uncertain tax positions in interest expense and general and
administrative expenses, respectively.
Minority
Interest
The interest held by third parties in subsidiaries owned or
controlled by the Company is reported on the consolidated
balance sheets as minority interest. Minority interest reported
in the consolidated statements of income reflects the respective
interests in the income or loss before income taxes of the
subsidiaries attributable to the other parties, the effect of
which is removed from the Companys consolidated results of
operations.
Two of the Companys home health agencies have agreements
with third parties that allow the third parties to be paid or
recover a fee based on the profits or losses of the respective
agencies. The Company accrues for the settlement of the third
partys profits or losses during the period the amounts are
earned. Under the agreements, the Company has incurred net
amounts due to the third parties of $289,000, $246,000 and
$316,000 for the years ended December 31, 2007, 2006 and
2005, respectively.
For agreements where the third party is a health care
institution, the agreements typically require the Company to
lease building and equipment and receive housekeeping and
maintenance from the health care institutions. Ancillary
services related to these arrangements are also typically
provided by the health care institution.
Minority
Interest Subject to Exchange Contracts and/or Put
Options
During 2004, in conjunction with the acquisition/sale of joint
venture interests, the Company entered into agreements with
minority interest holders in three of its majority owned
subsidiaries that allowed these minority interest holders to put
their minority interests to the Company. Only one of these
agreements remains as of December 31, 2007. The put option
allows the minority interest holder to exchange their minority
interest for cash based on EBITDA and the Companys stock
price. As of March 5, 2008, approximately 76.5 percent
of the minority interest holders have converted their minority
interests to cash.
F-12
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The above put/redemption options and exchange agreements have
been presented in the historical financial statements under the
guidance in Accounting Series Release (ASR) No. 268
and EITF Topic D-98, which generally require a public
companys stock subject to redemption requirements that are
outside the control of the issuer to be excluded from the
caption stockholders equity and presented
separately in the issuers balance sheet. Under EITF Topic
D-98, once it becomes probable that the minority interest would
become redeemable, the minority interest should be adjusted to
its current redemption amount, marked to market.
In connection with the partial redemption of certain minority
interest in the year ended December 31, 2006, the Company
decreased minority interest by approximately $1,039,000 and
increased retained earnings by the same amount. Simultaneously,
The Company recorded goodwill of $979,000 to represent the value
of the minority interest redeemed. Also for the year ended
December 31, 2006, the Company recorded a mark to market
benefit of $124,000.
There were no redemptions in the year ended December 31,
2007. In the year ended December 31, 2007, the Company
recorded a
mark-to-market
benefit of $193,000 for these redeemable minority interests.
Included in minority interests subject to exchange contracts
and/or put
options liability at December 30, 2007 and 2006 is $121,000
and $317,000, respectively, related to these redeemable minority
interests.
Equity-Based
Compensation Expense
During 2003, the Company began sponsoring a Key Employee Equity
Participation (KEEP) Plan whereby certain individuals were
granted participation equity units (KEEP Units). The KEEP Plan
was terminated in conjunction with the initial public offering
when the outstanding units were converted to 481,680 shares
of common stock. The KEEP Plan functioned as a stock
appreciation rights plan whereby an individual was entitled to
receive, on a per KEEP Unit basis, the increase in estimated
fair value of the Companys common stock from the date of
grant until the date that the employee dies, retires, or is
terminated for other than cause. Accordingly, the KEEP Units
were subject to variable accounting until such time as the
obligation to the employee was settled. The Company had a call
right, under which, it could purchase all or a portion of the
KEEP Units. The individuals receiving KEEP Units vested in those
rights in a graded manner over a five-year period and,
accordingly, the Company recorded compensation expense for the
vested portion of the KEEP Units. The KEEP Units had no exercise
price.
Compensation expense and a corresponding increase in paid-in
capital, was also recognized each period for any change in value
associated with certain KEEP Units that were held by an officer
of the Company.
In conjunction with the initial public offering, the outstanding
KEEP Units were converted to common stock. In conjunction with
this conversion, the Company incurred a charge to equity based
compensation of approximately $3.0 million. For the year
ended December 31, 2005, the Company recorded approximately
$3.9 million in equity based compensation related to the
KEEP Units. There was no equity based compensation related to
the KEEP units recorded for the year ended December 31,
2007 or 2006.
Stock-based
Compensation
The Company adopted Statement of Financial Accounting Standards
(SFAS) No. 123(R) (revised 2004), Share-Based
Payment, a revision of SFAS No. 123, Accounting
for Stock-Based Compensation, on January 1, 2006 using
the modified prospective method. This method requires
compensation cost to be recognized beginning with the effective
date (a) based on the requirements of
SFAS No. 123(R) for all share-based payments granted
after the effective date and (b) based on the requirements
of SFAS No. 123 for all awards granted to employees
prior to the effective date of SFAS No. 123(R) that
remain unvested on the effective date. Under this method, prior
periods are not restated to reflect the impact of adopting the
new standard.
F-13
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Prior to adopting SFAS No. 123R, the Company accounted
for issuances of restricted stock and stock option grants in
accordance with Accounting Principles Board Opinion No. 25,
Accounting for Stock Issued to Employees and related
interpretations (APB 25). Accordingly, the Company did not
recognize compensation cost in the Consolidated Statements of
Income for years prior to adoption of SFAS No. 123R in
connection with the issuance of the stock options, as the
options granted had an exercise price equal to the market value
of the Companys common stock on the date of grant. The
Company recorded compensation cost in connection with the
issuance of restricted stock.
The following pro forma information illustrates the effect on
net income and earnings per share as if the Company had applied
the fair value recognition provisions of SFAS No. 123
to options granted in 2005. For purposes of this pro forma
disclosure, the value of the options is estimated using the
Black-Scholes
option pricing formula and amortized to expense over the
options vesting period (in thousands, except per share
amounts):
|
|
|
|
|
|
|
2005
|
|
|
Net income, as reported
|
|
$
|
10,102
|
|
Redeemable minority interests
|
|
|
(1,476
|
)
|
|
|
|
|
|
Net income available to common stockholders, as reported
|
|
|
8,626
|
|
Adjustments:
|
|
|
|
|
Stock-based compensation expense included in reported net income
|
|
|
|
|
Stock-based compensation expense determined under fair value
method
|
|
|
(53
|
)
|
|
|
|
|
|
Pro forma income available to common stockholders
|
|
$
|
8,573
|
|
|
|
|
|
|
Net income per common share:
|
|
|
|
|
As reported:
|
|
|
|
|
Basic
|
|
$
|
0.69
|
|
Diluted
|
|
$
|
0.69
|
|
Pro Forma:
|
|
|
|
|
Basic
|
|
$
|
0.69
|
|
Diluted
|
|
$
|
0.68
|
|
Net income available to common stockholders per common share:
|
|
|
|
|
As reported:
|
|
|
|
|
Basic
|
|
$
|
0.59
|
|
Diluted
|
|
$
|
0.59
|
|
Pro Forma:
|
|
|
|
|
Basic
|
|
$
|
0.59
|
|
Diluted
|
|
$
|
0.58
|
|
Black-Scholes option pricing model assumptions:
|
|
|
|
|
|
|
December 31,
|
|
|
|
2005
|
|
|
Risk free interest rate
|
|
|
3.72-4.54
|
%
|
Expected life (years)
|
|
|
5
|
|
Volatility
|
|
|
41.62-43.50
|
|
Expected annual dividend yield
|
|
|
|
|
F-14
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Earnings
Per Share
Basic per share information is computed by dividing the item by
the weighted-average number of shares outstanding during the
period. Diluted per share information is computed by dividing
the item by the weighted-average number of shares outstanding
plus dilutive potential shares.
The following table sets forth shares used in the computation of
basic and diluted per share information for the years ended
December 31, 2007, 2006 and 2005.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
Weighted average number of shares outstanding for basic per
share calculation
|
|
|
17,760,432
|
|
|
|
17,090,583
|
|
|
|
14,628,737
|
|
Effect of dilutive potential shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
Options
|
|
|
6,461
|
|
|
|
2,399
|
|
|
|
790
|
|
Restricted stock
|
|
|
60,551
|
|
|
|
11,678
|
|
|
|
1,112
|
|
KEEP Units
|
|
|
|
|
|
|
|
|
|
|
54,000
|
|
Adjusted weighted average shares for diluted per share
calculation
|
|
|
17,827,444
|
|
|
|
17,104,660
|
|
|
|
14,684,639
|
|
Recently
Issued Accounting Pronouncements
In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements (SFAS 157), which defines
fair value, establishes a framework for measuring fair value in
generally accepted accounting principles and expands disclosure
requirements about fair value measurements. SFAS 157 is
effective in our fiscal year ended December 31, 2008. The
adoption of SFAS No. 157 is not expected to have a
material effect on the Companys consolidated financial
position or results of operations.
In February 2007, the FASB issued SFAS No. 159, The
Fair Value Option for Financial Assets and Financial
Liabilities, Including an Amendment to SFAS 115
(SFAS 159). SFAS 159 allows the measurement of
many financial instruments and certain other assets and
liabilities at fair value on an
instrument-by-instrument
basis under a fair value option. SFAS 159 is effective in
our fiscal year ended December 31, 2008. The adoption of
SFAS No. 159 is not expected to have a material effect
on the Companys consolidated financial position or results
of operations.
In December 2007, the FASB issued SFAS No. 141
(Revised 2007), Business Combinations (SFAS 141R).
SFAS 141R changes the accounting for business combinations.
Under SFAS 141R, an acquiring entity will be required to
recognize all the assets acquired and liabilities assumed in a
transaction at the acquisition-date fair value with limited
exceptions. SFAS 141R will change the accounting treatment
and disclosure for certain specific items in a business
combination. For instance, acquisition-related costs, with the
exception of debt or equity issuance costs, are to be recorded
in the period that the costs are incurred and the services are
received. SFAS 141R applies prospectively to business
combinations for which the acquisition date is on or after
January 1, 2009. We expect SFAS 141R will have an
impact on accounting for business combinations once adopted but
the effect is dependent upon acquisitions at that time.
In December 2007, the FASB issued SFAS No. 160,
Noncontrolling Interests in Consolidated Financial
Statements an Amendment of ARB No. 51
(SFAS 160). SFAS 160 establishes new accounting
and reporting standards for the noncontrolling interest in a
subsidiary and for the deconsolidation of a subsidiary.
SFAS 160 is effective for our fiscal year ending
December 31, 2009. We have not completed our evaluation of
the potential impact, if any, of the adoption of SFAS 160
on our consolidated financial position, results of operations
and cash flows.
F-15
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
3.
|
Acquisitions
and Divestitures
|
The purchase price of the following acquisitions was determined
based on the Companys analysis of comparable acquisitions
and target markets potential cash flows. Goodwill
generated from the acquisitions was recognized based on the
expected contributions of each acquisition to the overall
corporate strategy. The Company expects the goodwill recognized
in connection with the acquisition of existing operations to be
fully tax deductible. Operations of the entities acquired in
2007, 2006 and 2005 are not considered material to the
consolidated statements of income.
2007
Acquisitions
During the year ended December 31, 2007, the Company
acquired the existing operations of 11 locations and a majority
ownership interest in the existing operations of 12 locations
for $26.0 million in cash, and $2.4 million in
acquisition costs. Goodwill of $21.9 million and other
intangibles of $5.8 million were assigned to the home based
services segment. Certain 2007 acquisitions are accounted for
based on preliminary purchase price allocations. The Company
expects to finalize these allocations in 2008 and any changes
are not expected to be significant to the companys
consolidated balance sheet.
2007
Divestitures
During the year ended December 31, 2007, the Company sold
its critical access hospital for $180,000 and recognized a gain
of $31,000, net of tax of $20,000, on the sale of this hospital.
There was no goodwill related to this hospital. Additionally,
the Company closed a home health pharmacy location in the year
ended December 31, 2007. The assets related to the home
health pharmacy are classified as assets held for sale on the
consolidated balance sheet. The Company retired goodwill of
$48,000 related to the termination of its private duty business.
In 2007, the Company reclassified the operations of one
long-term acute care hospital out of discontinued operations as
the Company no longer holds the assets for sale. The facility
had previously been identified as held for sale and accounted
for in discontinued operations throughout the year ended
December 31, 2006. Goodwill of $402,000 and other assets
related to this hospital were classified as assets held for sale
at December 31, 2006. The operating results for the year
ended December 31, 2006, previously disclosed in
discontinued operations, have been reclassified to continuing
operations in the consolidated statement of income.
2006
Acquisitions
During the year ended December 31, 2006, the Company
acquired the existing operations of seven entities, including
assets of $2.2 million, primarily patient accounts
receivable, the minority interest in one of its joint ventures
and a license which was being leased for $22.1 million in
cash and $1.4 million in acquisition costs. Goodwill of
$13.7 million and other intangibles of $8.1 million
were assigned to the home based services segment.
In conjunction with certain minority interest holders redeeming
their interests in St. Landry, $979,000 of goodwill was
recognized in the facility based services segment.
2006
Divestitures
During the year ended December 31, 2006, the Company sold
one of its long-term acute care hospitals for $1.2 million
and recognized a gain of $958,000 on the sale of this hospital.
In conjunction with this transaction, the Company allocated and
retired $155,000 of goodwill related to this hospital. The
Company also sold a clinic for promissory notes totaling
$946,000 and recognized a loss on the sale of $28,000. Goodwill
of $891,000 was retired in conjunction with the sale of the
clinic. Additionally, the Company closed one location of another
clinic and terminated virtually all of its private duty
business. Finally, the Company
F-16
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
sold one of its home health agencies for $240,000 and retired
goodwill of $50,000. The Company recognized a gain of $98,000 on
the sale of this agency. The Company has identified one
long-term acute care hospital and one pharmacy operation as held
for sale as of December 31, 2006. Goodwill of $402,000 and
other assets related to these operations are classified as
assets held for sale on the consolidated balance sheet.
2005
Acquisitions
During the year ended December 31, 2005, the Company
acquired the existing operations of seven entities for
$9.5 million in cash and a promissory note for $250,000 to
be paid over five years. The Company also obtained the right to
appoint a majority of the members of the Board of Directors of a
non profit critical access hospital which was in arrears in
payment of a promissory note of approximately $2.1 million
to the Company. Goodwill of $10.1 million was assigned to
the home based services segment.
In conjunction with the initial public offering, the Company
issued 518,036 shares of common stock to two of its joint
ventures. The Company accrued a cash payment of
$2.2 million related to one of the acquisitions as of
June 30, 2005 of which the entire amount has been paid as
of December 31, 2005. This transaction resulted in the
recording of goodwill of $8.5 million, which is deductible
for income tax purposes, in the home-based services segment and
$872,000 in the facility-based services segment.
In conjunction with certain minority interest holders redeeming
their interests in St. Landry, $214,000 of goodwill was
recognized in the facility based services segment.
2005
Divestitures
The Company sold a minority interest in an extended care
operation and in a pharmacy operation which was wholly-owned,
during 2005. The Company received $873,000 in cash and
recognized a gain on these sales of $526,000. The Company
retained majority interests in both operations.
In 2005, the Company executed a rescission of the sale of the
pharmacy operation resulting in a loss on the complete
transaction of approximately $8,000. There was no goodwill
recognized in the transaction.
The following table summarizes the operating results of the
divestitures described above which have been presented as loss
from discontinued operations in the accompanying consolidated
statements of income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
2,979
|
|
|
$
|
5,261
|
|
|
$
|
6,863
|
|
Costs, expenses and minority interest and cooperative endeavor
allocations
|
|
|
4,885
|
|
|
|
7,622
|
|
|
|
8,675
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations before income taxes
|
|
|
(1,906
|
)
|
|
|
(2,361
|
)
|
|
|
(1,812
|
)
|
Income taxes
|
|
|
239
|
|
|
|
897
|
|
|
|
688
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from discontinued operations
|
|
$
|
(1,667
|
)
|
|
$
|
(1,464
|
)
|
|
$
|
(1,124
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
F-17
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table summarizes the changes in goodwill by
segment:
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Home-based services segment:
|
|
|
|
|
|
|
|
|
Balances at beginning of period
|
|
$
|
35,740
|
|
|
$
|
21,692
|
|
Goodwill acquired during the period from acquisitions
|
|
|
22,192
|
|
|
|
13,603
|
|
Goodwill retired during the period
|
|
|
(48
|
)
|
|
|
(50
|
)
|
Goodwill acquired during the period from purchase of minority
interest
|
|
|
|
|
|
|
495
|
|
|
|
|
|
|
|
|
|
|
Balance at end of period
|
|
$
|
57,884
|
|
|
$
|
35,740
|
|
|
|
|
|
|
|
|
|
|
Facility-based services segment:
|
|
|
|
|
|
|
|
|
Balance at beginning of period
|
|
$
|
3,941
|
|
|
$
|
4,411
|
|
Goodwill retired during the period
|
|
|
|
|
|
|
(1,046
|
)
|
Goodwill classified (to) from held for sale during the period
|
|
|
402
|
|
|
|
(402
|
)
|
Goodwill acquired during the period from redemption of minority
interest
|
|
|
|
|
|
|
978
|
|
|
|
|
|
|
|
|
|
|
Balance at end of period
|
|
$
|
4,343
|
|
|
$
|
3,941
|
|
|
|
|
|
|
|
|
|
|
The above transactions were considered to be immaterial
individually and in the aggregate. Accordingly, no supplemental
pro forma information is required.
Significant components of the Companys deferred tax assets
and liabilities were as follows:
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
|
|
Amortization of intangible assets
|
|
$
|
(2,166
|
)
|
|
$
|
(842
|
)
|
Tax in excess of book depreciation
|
|
|
(1,563
|
)
|
|
|
(1,407
|
)
|
Prepaid expenses
|
|
|
(1,095
|
)
|
|
|
(931
|
)
|
Non-accrual experience accounting method
|
|
|
(861
|
)
|
|
|
(633
|
)
|
Conversion from cash basis accounting
|
|
|
(11
|
)
|
|
|
(61
|
)
|
|
|
|
|
|
|
|
|
|
Deferred tax liabilities
|
|
|
(5,696
|
)
|
|
|
(3,874
|
)
|
Deferred tax assets:
|
|
|
|
|
|
|
|
|
Allowance for uncollectible accounts
|
|
|
3,392
|
|
|
|
2,045
|
|
Accrued employee benefits
|
|
|
1,005
|
|
|
|
791
|
|
Stock compensation
|
|
|
495
|
|
|
|
181
|
|
NOL carry forward
|
|
|
505
|
|
|
|
|
|
Accrued self-insurance
|
|
|
508
|
|
|
|
688
|
|
Valuation allowance
|
|
|
(505
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred tax assets
|
|
|
5,400
|
|
|
|
3,705
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax liability
|
|
$
|
(296
|
)
|
|
$
|
(169
|
)
|
|
|
|
|
|
|
|
|
|
F-18
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of the Companys income tax expense
(benefit) from continuing operations were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Current:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
$
|
10,542
|
|
|
$
|
10,139
|
|
|
$
|
4,604
|
|
State
|
|
|
1,478
|
|
|
|
1,931
|
|
|
|
775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,020
|
|
|
|
12,070
|
|
|
|
5,379
|
|
Deferred:
|
|
|
|
|
|
|
|
|
|
|
|
|
Federal
|
|
|
111
|
|
|
|
(1,053
|
)
|
|
|
580
|
|
State
|
|
|
16
|
|
|
|
(200
|
)
|
|
|
93
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
127
|
|
|
|
(1,253
|
)
|
|
|
673
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
12,147
|
|
|
$
|
10,817
|
|
|
$
|
6,052
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the differences between income taxes from
continuing operations computed at the federal statutory rate and
provisions for income taxes for each period are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
|
|
(In thousands)
|
|
|
Income taxes computed at federal statutory tax rate
|
|
$
|
11,680
|
|
|
$
|
11,283
|
|
|
$
|
6,047
|
|
State income taxes, net of federal benefit
|
|
|
1,001
|
|
|
|
967
|
|
|
|
516
|
|
Gulf Opportunity Act tax credit
|
|
|
(662
|
)
|
|
|
(1,027
|
)
|
|
|
(164
|
)
|
Nondeductible expenses
|
|
|
128
|
|
|
|
54
|
|
|
|
73
|
|
Tax exempt proceeds from life insurance
|
|
|
|
|
|
|
(380
|
)
|
|
|
|
|
Tax exempt interest income
|
|
|
|
|
|
|
(80
|
)
|
|
|
(78
|
)
|
Tax benefit on compensation charge
|
|
|
|
|
|
|
|
|
|
|
(342
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total provision for income taxes
|
|
$
|
12,147
|
|
|
$
|
10,817
|
|
|
$
|
6,052
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term
Debt
Long-term debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Notes payable:
|
|
|
|
|
|
|
|
|
Due in yearly installments of $50,000 through August 2010 at
6.25%
|
|
|
150
|
|
|
|
190
|
|
Due in monthly installments of $20,565 through October 2015 at
LIBOR plus 2.25% (6.71% at December 31, 2007)
|
|
|
2,870
|
|
|
|
2,898
|
|
Due in monthly installments of $12,500 through November 2009 at
3.08%
|
|
|
260
|
|
|
|
391
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,280
|
|
|
|
3,479
|
|
Less current portion of long-term debt
|
|
|
433
|
|
|
|
428
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
2,847
|
|
|
$
|
3,051
|
|
|
|
|
|
|
|
|
|
|
F-19
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In August 2005, the Company entered into a promissory note with
the seller of
A-1 Nursing
Registry, Inc.
(A-1)
in conjunction with the purchase of the assets of
A-1. The
principal amount of the note is $250,000 and it bears interest
at 6.25 percent.
In August 2005, the Company entered into a promissory note with
Bancorp Equipment Finance, Inc. to purchase an airplane, for a
principal amount of $2,975,000 with interest on any outstanding
principal balance at the one month LIBOR rate plus
2.25 percent (6.71 percent at December 31, 2007).
The note is collateralized by the airplane and is payable in
119 monthly installments of $20,565 followed by one balloon
installment in the amount of $1,920,565. On February 28,
2008, the Company sold this airplane to a third party for
$3,050,000 in cash and paid off the promissory note in full.
On February 20, 2008, the Company entered into a Loan
Agreement with Capital One, National Association for a term note
in the amount of $5,050,000 for the purchase of a 1999 Cessna
560 aircraft. The term note is payable in 84 monthly
installments of principal plus interest commencing on
March 6, 2008 and ending with the final payment on
February 6, 2015. The term note will bear the interest at
the LIBOR Rate (adjusted monthly) plus the Applicable Margin of
1.9 percent.
Certain of the Companys loan agreements contain
restrictive covenants, including limitations on indebtedness and
the maintenance of certain financial ratios. At
December 31, 2007 and December 31, 2006, the Company
was in compliance with all covenants.
The scheduled principal payments on long-term debt are as
follows for each of the next five years following
December 31, 2007 (in thousands):
|
|
|
|
|
2008
|
|
$
|
433
|
|
2009
|
|
|
420
|
|
2010
|
|
|
297
|
|
2011
|
|
|
247
|
|
2012
|
|
|
247
|
|
Thereafter
|
|
|
1,636
|
|
|
|
|
|
|
|
|
$
|
3,280
|
|
|
|
|
|
|
Other
Credit Arrangements
On February 20, 2008, the Company terminated the credit
facility agreement with GMAC (Former Credit Facility) and
entered into a new credit facility agreement with Capital One,
National Association (New Credit Facility). Under the terms of
the Former Credit Facility, which was in effect at
December 31, 2007, the Company was able to be advanced
funds up to a defined limit of eligible accounts receivable not
to exceed the borrowing limit. At December 31, 2007 the
borrowing limit was $22,500,000 and no amounts were outstanding.
Interest accrues on any outstanding amounts at a varying rate
and was based on the Wells Fargo Bank, N.A. prime rate plus
1.5 percent (9.02 percent at December 31, 2007).
The annual facility fee was 0.5 percent of the total
availability. The Former Credit Facility was due to expire on
April 15, 2010.
On February 20, 2008, the Company entered into the New
Credit Facility, which was amended on March 6, 2008 to
include an additional lender, First Tennessee Bank, N.A., to
increase the line of credit and to amend the Eurodollar Margin
for each Eurodollar Loan (as those terms are defined in the New
Credit Facility) issued under the New Credit Facility. The New
Credit Facility is unsecured, has a term of two years and
provides for a line of credit of $37.5 million (with a
letter of credit
sub-limit
equal to $2.0 million). Upon written notice by the Company
to the Agent, the Agent will endeavor to obtain additional
lending commitments from other financial institutions to
increase the line of credit to $50.0 million. The annual
facility fee is 0.125 percent of the total availability.
The interest rate for borrowings under the New Credit
F-20
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Agreement is a function of the prime rate (Base Rate) or the
eurodollar rate (Eurodollar), as elected by the Company, plus
the applicable margin as set forth below:
|
|
|
|
|
|
|
|
|
|
|
Eurodollar
|
|
|
Base Rate
|
|
Leverage Ratio
|
|
Margin
|
|
|
Margin
|
|
< 1.00:1.00
|
|
|
1.75
|
%
|
|
|
(0.25
|
)%
|
³
1.00:1.00 < 1.50:100
|
|
|
2.00
|
%
|
|
|
0
|
%
|
³
1.50:1.00 < 2.00:1.00
|
|
|
2.25
|
%
|
|
|
0
|
%
|
³
2.00:1.00
|
|
|
2.50
|
%
|
|
|
0
|
%
|
Public
Offering
On July 19, 2006, the Company closed its follow-on public
offering of 4,000,000 shares of common stock at a price of
$19.25 per share. Of the 4,000,000 shares of common stock
offered, 1,000,000 shares were offered by the Company, with
the remaining 3,000,000 shares of common stock sold by the
selling stockholders identified in the prospectus supplement.
The underwriters exercised an over-allotment of an additional
600,000 shares, 150,000 of which were sold by the Company.
The additional net cash provided to the Company from this
offering after deducting expenses and underwriting discounts and
commissions amounted to approximately $20.7 million.
Share
Based Compensation
On January 20, 2005, the board of directors and
stockholders of the Company approved the 2005 Long-Term
Incentive Plan (the Incentive Plan). The Incentive Plan provides
for 1,000,000 shares of common stock that may be issued or
transferred pursuant to awards made under the plan. A variety of
discretionary awards for employees, officers, directors and
consultants are authorized under the Incentive Plan, including
incentive or non-qualified statutory stock options and
restricted stock. All awards must be evidenced by a written
award certificate which will include the provisions specified by
the compensation committee of the board of directors. The
compensation committee will determine the exercise price for
non-statutory stock options. The exercise price for any option
cannot be less than the fair market value of our common stock as
of the date of grant.
Also on January 20, 2005, the 2005 Director
Compensation Plan was adopted. The shares issued under the
2005 Director Compensation Plan are issued from the
1,000,000 shares reserved for issuance under the Incentive
Plan. In 2005, 13,500 stock options were granted at the fair
market value of the underlying stock with a weighted average
option price of $14.45. These options vested immediately and
have a contractual life of 10 years. The weighted average
exercise price ranges between $14.00 and $17.05. All 13,500
options were exercisable at December 31, 2005.
Additionally, the independent directors were granted initial
restricted stock awards under the Director Compensation Plan.
During 2005, 24,500 units were granted at an average market
value at the date of the award of $14.44.
The Company accounted for these issuances of restricted stock
and stock option grants in accordance with Accounting Principles
Board Opinion No. 25, Accounting for Stock Issued to
Employees and related interpretations (APB 25).
Accordingly, the Company did not recognize compensation cost in
connection with the issuance of the stock options, as the
options granted had an exercise price equal to the market value
of the Companys common stock on the date of grant. During
the year ended December 31, 2005, the Company did recognize
compensation cost in connection with the issuance of restricted
stock in the amount of $177,000.
F-21
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Stock
Options
The Company uses the Black-Scholes option pricing model to
estimate the fair value of each option on the grant date and
uses the following weighted-average assumptions:
|
|
|
|
|
|
|
Year Ended
|
|
|
|
December 31, 2006
|
|
Risk free interest rate
|
|
|
5.03
|
%
|
Expected life (years)
|
|
|
5
|
|
Expected volatility
|
|
|
38.39
|
|
Expected annual dividend yield
|
|
|
|
|
The following table represents stock options activity for the
year ended December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
Weighted Average
|
|
|
|
|
|
|
Number of
|
|
|
Average Exercise
|
|
|
Remaining
|
|
|
Aggregate
|
|
|
|
Shares
|
|
|
Price
|
|
|
Contractual Term
|
|
|
Intrinsic Value
|
|
|
Options exercisable at January 1, 2007
|
|
|
21,000
|
|
|
|
17.44
|
|
|
|
|
|
|
|
|
|
Options granted
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised
|
|
|
2,000
|
|
|
|
19.75
|
|
|
|
|
|
|
|
|
|
Options forfeited or expired
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options outstanding at December 31, 2007
|
|
|
19,000
|
|
|
|
17.20
|
|
|
|
8.0 years
|
|
|
|
|
|
Options exercisable at December 31, 2007
|
|
|
19,000
|
|
|
|
17.20
|
|
|
|
8.0 years
|
|
|
$
|
147,895
|
|
The weighted average grant date fair value of options granted
during the year 2006 was $8.26. There were no options granted
during 2007. The total intrinsic value of options exercised
during the year ended December 31, 2007 and 2006 was
$14,120 and $29,800, respectively. No options were exercised in
the year ended December 31, 2005. The Company has recorded
$134,000 in compensation expense related to stock option grants
in the year ended December 31, 2006. The pro forma expense
for the same period in 2005 was $53,000. No compensation expense
related to stock option grants was recorded in the year ended
December 31, 2007. All options are fully vested and
exercisable at December 31, 2007.
Nonvested
Stock
During 2007 and 2006, respectively, 16,100 and 3,500 nonvested
shares of stock were granted to our independent directors under
the 2005 Director Compensation Plan. One third of these
shares vested immediately and the remaining vest over the two
year period following the grant date. During 2007, 181,071
nonvested shares were granted to employees pursuant to the 2005
Long-Term Incentive Plan. These shares vest over a five year
period. The fair value of nonvested shares is determined based
on the closing trading price of the Companys shares on the
grant date. The weighted average grant date fair values of
nonvested shares granted during the years ended
December 31, 2007 and 2006 were $27.83 and $18.66,
respectively.
F-22
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table represents the nonvested stock activity for
the year ended December 31, 2007:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted
|
|
|
|
Number of
|
|
|
Average Grant
|
|
|
|
Shares
|
|
|
Date Fair Value
|
|
|
Nonvested shares outstanding at December 31, 2006
|
|
|
86,719
|
|
|
|
18.29
|
|
Granted
|
|
|
197,171
|
|
|
|
27.83
|
|
Vested
|
|
|
(25,607
|
)
|
|
|
18.03
|
|
Forfeited
|
|
|
(39,951
|
)
|
|
|
27.35
|
|
Nonvested shares outstanding at December 31, 2007
|
|
|
218,332
|
|
|
|
24.03
|
|
As of December 31, 2007, there was $1.7 million of
total unrecognized compensation cost related to nonvested shares
granted. That cost is expected to be recognized over the
weighted average period of 3.9 years. The total fair value
of shares vested in the years ended December 31, 2007 and
2006 were $468,361 and $141,294, respectively. The Company
records compensation expense related to nonvested share awards
at the grant date for shares that are awarded fully vested and
over the vesting term on a straight line basis for shares that
vest over time. The Company has recorded $1.2 million and
$445,000 in compensation expense related to nonvested stock
grants in the years ended December 31, 2007 and 2006
respectively.
Employee
Stock Purchase Plan
The Company has a plan whereby eligible employees may purchase
the Companys common stock at 95 percent of the market
price on the last day of the calendar quarter. There are
250,000 shares reserved for the plan. The Company issued
16,893 shares of common stock under the plan at a weighted
average per share price of $24.76 during the year ended
December 31, 2007. At December 31, 2007 there were
226,011 shares available for future issuance.
Treasury
Stock
In conjunction with the conversion of the KEEP units to common
stock during the initial public offering and the vesting of the
nonvested shares of stock, the recipients incurred withholding
tax liabilities. The Company allowed the holders to turn in
shares of common stock at December 30, 2005 to satisfy
those tax obligations. The Company redeemed 371 and
35,209 shares of common stock related to these tax
obligations at December 30, 2007 and 2005, respectively.
|
|
7.
|
Related
Party Transactions
|
Employee
Receivables
As a result of Hurricanes Katrina and Rita, the Company
established a loan fund to allow affected employees to borrow up
to six months of their salary to aid in their recovery from the
hurricanes. The loan agreements bear interest of
3.5 percent. The employees began payment on the loans one
year after the date of the loan agreement through payroll
deductions. As of December 31, 2007 and 2006, these loans
totaled $245,000 and $363,000, respectively and are included in
other assets on the consolidated balance sheet.
Occasionally, the Company enters into lease agreements with
third parties through wholly owned subsidiaries for a Medicare
and a Medicaid license and the associated provider number to
provide home health or hospice services. The Company entered
into such an agreement in 2003. Effective October 1, 2007,
the Company converted this lease into a joint venture.
F-23
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In 2005, the Company entered into two leases, one to provide
home health services and the other to provide hospice services.
The initial terms of these leases expire in 2010.
In 2007, the Company entered into two leases to provide home
health and hospice services. The initial terms of these leases
expire in 2017.
Expense related to these leases was $738,000 in 2007, $525,000
in 2006 and $436,000 in 2005. Payments due under these leases
are $222,000 in 2008. These payments do not include payments for
the licenses granted in 2005 as these are dependent on net
quarterly profits and are each capped at $160,000 per year.
The Company leases office space and equipment at its various
locations. Total rental expense was approximately
$8.1 million in 2007, $7.6 million in 2006 and
$5.4 million in 2005. Future minimum rental commitments
under non-cancelable operating leases, are as follows for the
periods ending December 31 (in thousands):
|
|
|
|
|
2008
|
|
$
|
6,519
|
|
2009
|
|
|
3,523
|
|
2010
|
|
|
1,902
|
|
2011
|
|
|
1,119
|
|
2012
|
|
|
955
|
|
Thereafter
|
|
|
1,616
|
|
|
|
|
|
|
|
|
$
|
15,634
|
|
|
|
|
|
|
As of December 31, 2007, future minimum payments by year
and in the aggregate, under non-cancelable capital leases with
initial terms of one year or more, consisted of the following
(in thousands):
|
|
|
|
|
2008
|
|
$
|
88
|
|
2009
|
|
|
63
|
|
2010
|
|
|
|
|
2011
|
|
|
|
|
2012
|
|
|
|
|
Thereafter
|
|
|
|
|
|
|
|
|
|
Total minimum lease payments
|
|
|
151
|
|
Current portion of capital lease obligations
|
|
|
88
|
|
|
|
|
|
|
Capital lease obligations, long-term
|
|
$
|
63
|
|
|
|
|
|
|
The cost of assets held under capital leases was $456,000 and
$1,070,000 at December 31, 2007 and 2006, respectively. The
related accumulated amortization was $456,000 and $603,000 at
December 31, 2007 and 2006, respectively.
The Company sponsors a profit-sharing 401(k) plan that covers
substantially all eligible full-time employees. The plan allows
participants to contribute up to 15 percent of their
compensation and allows discretionary Company contributions as
determined by the Companys board of directors. Effective
January 1, 2006, the Company implemented a discretionary
match of up to 2 percent of participating employee
contributions. The employer contribution will vest
20 percent after two years and 20 percent each
additional year until it is fully vested in year six. At
December 31, 2007 and December 31, 2006, $215,000 and
$693,000 related to this match is included in salaries, wages
and benefits payable.
F-24
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
10.
|
Commitments
and Contingencies
|
Contingencies
The terms of one joint venture operating agreement grants a
buy/sell option that would require the Company to either
purchase or sell the existing membership interest in the joint
venture within 30 days of the receipt of the notice to
exercise the provision (See Note 2). Either the Company or
its joint venture partner has the right to exercise the buy/sell
option. The party receiving the exercise notice has the right to
either purchase the interests held by the other party, sell its
interests to the other party or dissolve the partnership. The
purchase price formula for the interests is set forth in the
joint venture agreement and is typically based on a multiple of
the earnings before income taxes, depreciation and amortization
of the joint venture. Total revenue earned by the Company from
this joint venture was $13.6 million, $13.9 million
and $13.7 million for the year ended December 31,
2007, 2006 and 2005, respectively. As of December 31, 2007,
approximately 76.5 percent of the minority interest holders
have converted their minority interests to cash.
The Company is involved in various legal proceedings arising in
the ordinary course of business. Although the results of
litigation cannot be predicted with certainty, management
believes the outcome of pending litigation will not have a
material adverse effect, after considering the effect of the
Companys insurance coverage, on the Companys
consolidated financial statements.
Compliance
The laws and regulations governing the Companys
operations, along with the terms of participation in various
government programs, regulate how the Company does business, the
services offered and interactions with patients and the public.
These laws and regulations and their interpretations, are
subject to frequent change. Changes in existing laws or
regulations, or their interpretations, or the enactment of new
laws or regulations could materially and adversely affect the
Companys operations and financial condition.
The Company is subject to various routine and non-routine
governmental reviews, audits and investigations. In recent
years, federal and state civil and criminal enforcement agencies
have heightened and coordinated their oversight efforts related
to the health care industry, including with respect to referral
practices, cost reporting, billing practices, joint ventures and
other financial relationships among health care providers.
Violation of the laws governing the Companys operations,
or changes in the interpretation of those laws, could result in
the imposition of fines, civil or criminal penalties, the
termination of the Companys rights to participate in
federal and state-sponsored programs and the suspension or
revocation of the Companys licenses.
If the Companys long-term acute care hospitals fail to
meet or maintain the standards for Medicare certification as
long-term acute care hospitals, such as average minimum length
of patient stay, they will receive payments under the
prospective payment system applicable to general acute care
hospitals rather than payment under the system applicable to
long-term acute care hospitals. Payments at rates applicable to
general acute care hospitals would likely result in the Company
receiving less Medicare reimbursement than currently received
for patient services. Moreover, all but one of the
Companys long-term acute care hospitals are subject to
additional Medicare criteria because they operate as separate
hospitals located in space leased from and located in, a general
acute care hospital, known as a host hospital. This is known as
a hospital within a hospital model. These additional
criteria include requirements concerning financial and
operational separateness from the host hospital.
The Company anticipates there may be changes to the standard
episode-of-care
payment from Medicare in the future. Due to the uncertainty of
the revised payment amount, the Company cannot estimate the
impact that changes in the payment rate, if any, will have on
its future financial statements.
F-25
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company believes that it is in material compliance with all
applicable laws and regulations and is not aware of any pending
or threatened investigations involving allegations of potential
wrongdoing. While no such regulatory inquiries have been made,
compliance with such laws and regulations can be subject to
future government review and interpretation as well as
significant regulatory action, including fines, penalties and
exclusion from the Medicare program.
|
|
11.
|
Concentration
of Risk
|
The Companys Louisiana facilities accounted for
approximately 50.9 percent, 64.1 percent and
78.6 percent of net service revenue during the years ended
December 31, 2007, 2006 and 2005, respectively. Any
material change in the current economic or competitive
conditions in Louisiana could have a disproportionate effect on
the Companys overall business results.
The Companys segments consist of (a) home-based
services and (b) facility-based services. Home-based
services include home nursing services and hospice services.
Facility-based services include long-term acute care services
and outpatient rehabilitation services. The accounting policies
of the segments are the same as those described in the summary
of significant accounting policies.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
244,107
|
|
|
$
|
53,924
|
|
|
$
|
298,031
|
|
Cost of service revenue
|
|
|
118,451
|
|
|
|
34,126
|
|
|
|
152,577
|
|
General and administrative expenses
|
|
|
88,532
|
|
|
|
18,263
|
|
|
|
106,795
|
|
Operating income
|
|
|
37,124
|
|
|
|
1,535
|
|
|
|
38,659
|
|
Interest expense
|
|
|
250
|
|
|
|
126
|
|
|
|
376
|
|
Non operating (income) loss, including gain on sale of assets
|
|
|
(746
|
)
|
|
|
(327
|
)
|
|
|
(1,073
|
)
|
Income from continuing operations before income taxes and
minority interest and cooperative endeavor allocations
|
|
|
37,620
|
|
|
|
1,736
|
|
|
|
39,356
|
|
Minority interest and cooperative endeavor allocations
|
|
|
5,177
|
|
|
|
807
|
|
|
|
5,984
|
|
Income from continuing operations before income taxes
|
|
|
32,443
|
|
|
|
929
|
|
|
|
33,372
|
|
Total assets
|
|
|
151,540
|
|
|
|
23,445
|
|
|
|
174,985
|
|
F-26
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2006
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
164,701
|
|
|
$
|
53,834
|
|
|
$
|
218,535
|
|
Cost of service revenue
|
|
|
79,070
|
|
|
|
33,025
|
|
|
|
112,095
|
|
General and administrative expenses
|
|
|
55,700
|
|
|
|
15,415
|
|
|
|
71,115
|
|
Operating income
|
|
|
29,931
|
|
|
|
5,394
|
|
|
|
35,325
|
|
Interest expense
|
|
|
210
|
|
|
|
115
|
|
|
|
325
|
|
Non operating (income) loss, including gain on sale of assets
|
|
|
(1,404
|
)
|
|
|
(629
|
)
|
|
|
(2,033
|
)
|
Income from continuing operations before income taxes and
minority interest and cooperative endeavor allocations
|
|
|
31,125
|
|
|
|
5,908
|
|
|
|
37,033
|
|
Minority interest and cooperative endeavor allocations
|
|
|
3,075
|
|
|
|
1,720
|
|
|
|
4,795
|
|
Income from continuing operations before income taxes
|
|
|
28,050
|
|
|
|
4,188
|
|
|
|
32,238
|
|
Total assets
|
|
|
117,585
|
|
|
|
35,109
|
|
|
|
152,694
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2005
|
|
|
|
Home-Based
|
|
|
Facility-Based
|
|
|
|
|
|
|
Services
|
|
|
Services
|
|
|
Total
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
105,588
|
|
|
$
|
50,099
|
|
|
$
|
155,687
|
|
Cost of service revenue
|
|
|
51,255
|
|
|
|
31,741
|
|
|
|
82,996
|
|
General and administrative expenses
|
|
|
33,650
|
|
|
|
12,869
|
|
|
|
46,519
|
|
Equity-based compensation expense
|
|
|
2,699
|
|
|
|
1,157
|
|
|
|
3,856
|
|
Operating income
|
|
|
17,984
|
|
|
|
4,332
|
|
|
|
22,316
|
|
Interest expense
|
|
|
690
|
|
|
|
377
|
|
|
|
1,067
|
|
Non operating (income) loss, including gain on sale of assets
|
|
|
(132
|
)
|
|
|
(442
|
)
|
|
|
(574
|
)
|
Income from continuing operations before income taxes and
minority interest and cooperative endeavor allocations
|
|
|
17,426
|
|
|
|
4,397
|
|
|
|
21,823
|
|
Minority interest and cooperative endeavor allocations
|
|
|
3,142
|
|
|
|
1,403
|
|
|
|
4,545
|
|
Income from continuing operations before income taxes
|
|
|
14,284
|
|
|
|
2,994
|
|
|
|
17,278
|
|
Total assets
|
|
|
70,889
|
|
|
|
33,729
|
|
|
|
104,618
|
|
|
|
13.
|
Fair
Value of Financial Instruments
|
The carrying amounts of the Companys cash, receivables,
accounts payable and accrued liabilities approximate their fair
values because of their short maturity.
The carrying amount of the Companys lines of credit and
capital lease obligations approximate their fair values because
the interest rates are considered to be at market rates. The
carry value of the Companys long-term debt equals its fair
value based on a variable interest rate.
F-27
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
14.
|
Allowance
for Uncollectible Accounts and Property, Building and
Equipment
|
The following table summarizes the activity and ending balances
in the allowance for uncollectible accounts:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beginning
|
|
|
|
|
|
|
|
|
End of
|
|
|
|
of Year
|
|
|
Additions and
|
|
|
|
|
|
Year
|
|
|
|
Balance
|
|
|
Expenses
|
|
|
Deductions
|
|
|
Balance
|
|
|
|
(In thousands)
|
|
|
Year ended December 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007
|
|
$
|
5,769
|
|
|
$
|
13,817
|
|
|
$
|
10,633
|
|
|
$
|
8,953
|
|
2006
|
|
|
2,544
|
|
|
|
4,778
|
|
|
|
1,553
|
|
|
|
5,769
|
|
2005
|
|
|
1,168
|
|
|
|
3,188
|
|
|
|
1,812
|
|
|
|
2,544
|
|
The following table describes the components of property,
building and equipment:
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Land
|
|
$
|
135
|
|
|
$
|
135
|
|
Building and improvements
|
|
|
3,079
|
|
|
|
2,891
|
|
Transportation equipment
|
|
|
3,434
|
|
|
|
3,480
|
|
Furniture and other equipment
|
|
|
13,661
|
|
|
|
10,321
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,309
|
|
|
|
16,827
|
|
Less accumulated depreciation and amortization
|
|
|
7,786
|
|
|
|
5,122
|
|
|
|
|
|
|
|
|
|
|
|
|
$
|
12,523
|
|
|
$
|
11,705
|
|
|
|
|
|
|
|
|
|
|
|
|
15.
|
Unaudited
Summarized Quarterly Financial Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
Second Quarter
|
|
|
Third Quarter
|
|
|
Fourth Quarter
|
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
2007
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
68,727
|
|
|
$
|
70,564
|
|
|
$
|
77,495
|
|
|
$
|
81,245
|
|
Gross margin
|
|
|
34,111
|
|
|
|
34,483
|
|
|
|
37,516
|
|
|
|
39,344
|
|
Net income
|
|
|
5,786
|
|
|
|
5,038
|
|
|
|
6,025
|
|
|
|
2,740
|
|
Net income available to common stockholders
|
|
|
5,820
|
|
|
|
5,160
|
|
|
|
6,082
|
|
|
|
2,720
|
|
Basic earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.33
|
|
|
$
|
0.28
|
|
|
$
|
0.34
|
|
|
$
|
0.15
|
|
Net income available to common shareholders
|
|
$
|
0.33
|
|
|
$
|
0.29
|
|
|
$
|
0.34
|
|
|
$
|
0.15
|
|
Diluted earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.33
|
|
|
$
|
0.28
|
|
|
$
|
0.34
|
|
|
$
|
0.15
|
|
Net income available to common shareholders
|
|
$
|
0.33
|
|
|
$
|
0.29
|
|
|
$
|
0.34
|
|
|
$
|
0.15
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
17,748,369
|
|
|
|
17,754,632
|
|
|
|
17,766,612
|
|
|
|
17,773,116
|
|
Diluted
|
|
|
17,807,338
|
|
|
|
17,798,952
|
|
|
|
17,794,072
|
|
|
|
17,817,777
|
|
F-28
LHC
GROUP, INC. AND SUBSIDIARIES
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In the fourth quarter of 2007, the Company recorded an
adjustment to increase its allowance for uncollectible accounts
$3.9 million and reduce net income available to common
shareholders $2.5 million ($0.14 per share).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
|
Second Quarter
|
|
|
Third Quarter
|
|
|
Fourth Quarter
|
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
2006
|
|
|
|
(In thousands)
|
|
|
Net service revenue
|
|
$
|
45,281
|
|
|
$
|
49,968
|
|
|
$
|
58,626
|
|
|
$
|
64,660
|
|
Gross margin
|
|
|
21,264
|
|
|
|
24,870
|
|
|
|
28,458
|
|
|
|
31,848
|
|
Net income
|
|
|
4,136
|
|
|
|
4,256
|
|
|
|
5,271
|
|
|
|
6,931
|
|
Net income available to common stockholders
|
|
|
4,979
|
|
|
|
4,428
|
|
|
|
5,199
|
|
|
|
7,151
|
|
Basic earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.26
|
|
|
$
|
0.26
|
|
|
$
|
0.30
|
|
|
$
|
0.39
|
|
Net income available to common shareholders
|
|
$
|
0.31
|
|
|
$
|
0.27
|
|
|
$
|
0.30
|
|
|
$
|
0.40
|
|
Diluted earnings per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
0.26
|
|
|
$
|
0.26
|
|
|
$
|
0.30
|
|
|
$
|
0.39
|
|
Net income available to common shareholders
|
|
$
|
0.31
|
|
|
$
|
0.27
|
|
|
$
|
0.30
|
|
|
$
|
0.40
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
16,557,828
|
|
|
|
16,561,398
|
|
|
|
17,557,576
|
|
|
|
17,730,698
|
|
Diluted
|
|
|
16,563,368
|
|
|
|
16,576,068
|
|
|
|
17,574,541
|
|
|
|
17,751,390
|
|
F-29
SIGNATURES
Pursuant to the requirements of Section 13 or 15
(d) of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its
behalf by the undersigned thereunto duly authorized.
LHC GROUP, INC.
Keith G. Myers
Chief Executive Officer
Date March 14, 2008
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Keith G. Myers and Peter
J. Roman and either of them (with full power in each to act
alone) as true and lawful attorneys-in-fact with full power of
substitution, for him and in his name, place and stead, in any
and all capacities, to sign any and all amendments to this
Annual Report on
Form 10-K
and to file the same, with all exhibits thereto and other
documents in connection therewith, with the Securities and
Exchange Commission, hereby ratifying and confirming all that
said attorneys-in-fact, or their substitute or substitutes, may
lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed by the following persons on
behalf of the registrant and in the capacities and on the dates
indicated:
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Keith
G. Myers
Keith
G. Myers
|
|
Chief Executive Officer and Chairman
of the Board of Directors
|
|
March 14, 2008
|
|
|
|
|
|
/s/ Peter
J. Roman
Peter
J. Roman
|
|
Senior Vice President, Chief Financial Officer
|
|
March 14, 2008
|
|
|
|
|
|
/s/ John
L. Indest
John
L. Indest
|
|
President, Chief Operating Officer
Secretary and Director
|
|
March 14, 2008
|
|
|
|
|
|
/s/ Dan
S. Wilford
Dan
S. Wilford
|
|
Director
|
|
March 14, 2008
|
|
|
|
|
|
/s/ Ronald
T. Nixon
Ronald
T. Nixon
|
|
Director
|
|
March 14, 2008
|
|
|
|
|
|
/s/ Ted
W. Hoyt
Ted
W. Hoyt
|
|
Director
|
|
March 14, 2008
|
|
|
|
|
|
/s/ George
A. Lewis
George
A. Lewis
|
|
Director
|
|
March 14, 2008
|
68
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ John
B. Breaux
John
B. Breaux
|
|
Director
|
|
March 14, 2008
|
|
|
|
|
|
/s/ Monica
Azare
Monica
Azare
|
|
Director
|
|
March 14, 2008
|
|
|
|
|
|
/s/ W.J.
Billy Tauzin
W.J.
Billy Tauzin
|
|
Director
|
|
March 14, 2008
|
69
EXHIBIT INDEX
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibits
|
|
|
2
|
.1
|
|
Asset purchase Agreement, dated June 19, 2006, by and among
the Registrant, The Lifeline Health Group, Inc. and various
subsidiaries of The Lifeline Health Group, Inc. (previously
filed as Exhibit 2.1 to the
Form 8-K
on June 19, 2006).
|
|
3
|
.1
|
|
Certificate of Incorporation of LHC Group, Inc. (previously
filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
3
|
.2
|
|
Bylaws of LHC Group, Inc. (previously filed as an exhibit to the
Form S-1/A (File No. 333-120792) on February 14,
2005).
|
|
3
|
.3
|
|
Amendment to LHC Group, Inc. Bylaws (previously filed as
Exhibit 3.1 to Form 8-K filed January 4, 2008).
|
|
3
|
.4
|
|
Certificate of Designations (previously filed as Exhibit B
to Exhibit 4.1 to the
Form 8-A12B
on March 11, 2008).
|
|
4
|
.1
|
|
Specimen Stock Certificate of LHCs Common Stock, par value
$0.01 per share (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
4
|
.2
|
|
Reference is made to Exhibits 3.1 and 3.2 (previously filed
as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005 and May 9, 2005, respectively).
|
|
4
|
.3
|
|
Stockholder Protection Rights Agreement by and between LHC
Group, Inc. and Computershare Trust Company, N.A., as
rights agent (previously filed as Exhibit 4.1 to the
Form 8-A12B
on March 11, 2008).
|
|
10
|
.1
|
|
LHC 2003 Key Employee Equity Participation Plan (previously
filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on November 26, 2004).
|
|
10
|
.2
|
|
LHC Group, Inc. 2005 Long-Term Incentive Plan (previously filed
as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.3
|
|
Form of Award under LHC Group, Inc. 2005 Director
Compensation Plan. (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.4
|
|
Form of Indemnity Agreement between LHC Group and directors and
certain officers (previously filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.5
|
|
LHC Group, Inc. 2005 Director Compensation Plan (previously
filed as an exhibit to the
Form S-1/A
(File
No. 333-120792)
on February 14, 2005).
|
|
10
|
.6
|
|
Amendment to LHC Group, Inc. 2005 Director Compensation
Plan (previously filed as Exhibit 99.1 to the
Form 8-K
on June 12, 2006).
|
|
10
|
.7
|
|
LHC Group, Inc. 2006 Employee Stock Purchase Plan (previously
filed as Exhibit 99.2 to the
Form 8-K
on June 12, 2006).
|
|
10
|
.8
|
|
Severance and Consulting Agreement by and between LHC Group,
Inc. and Barry E. Stewart, dated August 15, 2007
(previously filed as Exhibit 10.1 to the
Form 8-K
on August 15, 2007).
|
|
10
|
.9
|
|
Employment Agreement by and between LHC Group, Inc. and Don
Stelly, dated October 22, 2007 (previously filed as Exhibit
10.1 to the
Form 8-K
on October 30, 2007).
|
|
10
|
.10
|
|
Employment Agreement between LHC Group, Inc. and Keith G. Myers
dated January 1, 2008 (previously filed as
Exhibit 10.1 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.11
|
|
Employment Agreement between LHC Group, Inc. and John L. Indest
dated January 1, 2008 (previously filed as
Exhibit 10.2 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.12
|
|
Employment Agreement by and between LHC Group, Inc. and Peter
Roman, dated January 1, 2008 (previously filed as
Exhibit 10.3 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.13
|
|
Employment Agreement between LHC Group, Inc. and Daryl Doise
dated January 1, 2008 (previously filed as
Exhibit 10.4 to the
Form 8-K
on January 4, 2008).
|
|
10
|
.14
|
|
Loan Agreement by and between LHC Group, Inc., Palmetto Express,
L.L.C. and Capital One, National Association dated
February 6, 2008 (previously filed as Exhibit 10.1 to
the
Form 8-K
on February 13, 2008).
|
70
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibits
|
|
|
10
|
.15
|
|
Credit Agreement by and between LHC Group, Inc. and Capital One,
National Association dated February 20, 2008 (previously
filed as Exhibit 10.1 to the
Form 8-K
dated February 20, 2008 on February 25, 2008).
|
|
10
|
.16
|
|
First Amendment to Credit Agreement by and between LHC Group,
Inc., Capital One, National Association and First Tennessee
Bank, N.A. dated March 6, 2008 (previously filed as
Exhibit 10.1 to the
Form 8-K
on March 10, 2008).
|
|
21
|
.1
|
|
Subsidiaries of the Registrant.
|
|
23
|
.1
|
|
Consent of Ernst & Young LLP.
|
|
31
|
.1
|
|
Certification of Keith G. Myers, Chief Executive Officer
pursuant to
Rule 13a-
14(a)/15d-14(a), as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
31
|
.2
|
|
Certification of Peter J. Roman, Chief Financial Officer
pursuant to
Rule 13a-
14(a)/15d-14(a), as adopted pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
|
32
|
.1*
|
|
Certification of the Chief Executive Officer and Chief Financial
Officer pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
* |
|
This exhibit is furnished to the SEC as an accompanying document
and is not deemed to be filed for purposes of
Section 18 of the Securities Exchange Act of 1934 or
otherwise subject to the liabilities of that Section, and the
document will not be deemed incorporated by reference into any
filing under the Securities Act of 1933. |
71